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PART-I 
CHAPTER 1 
INTRODUCTION 
1.1 Importance of Thioacids  
Thioacids have been known for many years since the first example, 
thioacetic acid, was prepared by Kekule in 1854.1,2 However, until the 1980s the 
study of the chemistry of thioacids was a comparatively unexplored field in 
organic chemistry. In contrast, thioacid derivatives, such as thioesters, which 
could easily be prepared from thiacids by simple nucleophilic substitution, have 
found more applications. Thiocarboxylates are known to exhibit better 
nucleophilicity over their oxygen analogues due to the presence of the larger, 
more polarizable sulfur atom. However the key difference between thioacids and 
carboxylic acids is their acidity. Thioacids are about 25-30 times more acidic than 
the corresponding carboxylic acid: the pKa of thioacetic acid is 3.33 as compared 
to 4.76 for acetic acid in water at 25 °C. 2,3 The larger size of sulfur compared to 
oxygen weakens the S-H bond strength and reduces the charge density in the 
conjugate thiocarboxylate anion, which results in the increased acidity of 
thioacids. Extensive studies using IR, UV/Vis and NMR spectroscopy established 
that thioacids exist as a tautomeric mixture of thiol (1) and thioxo (2) forms 
(Figure 1).4-7 Polar solvents drive the equilibrium more toward the thioxo form as 
hydrogen bonding to the solvent is more favorable with the acidic hydrogen 
connected with more electronegative oxygen (alcohols are better hydrogen bond 
2 
donors than thiols). Hence, the thioxo from predominates in polar solvents like 
methanol, acetone, water, THF etc.8 
 
Figure 1. Hydrogen bonding favoring the thioxo form of thioacids in polar 
solvents 
The enhanced acidity of thioacids makes it possible to selectively deprotonate 
them even at an acidic pH. Thus, in recent years, thioacids have found 
application in amide bond formation due to the fact that they can be selectively 
activated even in presence of carboxylic acids.9-12 The unique reactivity of 
thioacids enables them to employ as nucleophiles in presence of several other 
typically nucleophilic groups leading to their extensive use in peptide synthesis13-
20
 with native chemical legation being the most cited of these.21 
1.1.1 Native Chemical Ligation 
Breakthrough research in thioacid chemistry was done by Schnölzer and 
Kent, who in 1992 came up with a novel strategy for the coupling of unprotected 
peptide fragments in aqueous solution.18 The basis for this new approach is the 
presence in each peptide fragment of a unique, mutually reactive functionality 
which enable a chemoselective reaction between the two components. This 
approach is called ‘native chemical ligation’.21 This chemistry initially used  a 
nucleophilic substitution reaction between the SH group of a thioacid attached to 
the C-terminus of one peptide, and an alkyl bromide attached to the N-terminus 
3 
of the other fragment, leading to the formation of a thioester at the ligation site 
(Scheme 1).21-27  
 
peptide 1
O
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Scheme 1. Ligation of unprotected peptide segments. 
However, the installation of a non-native functional group at the ligation 
site was a major problem associated with this ligation. To circumvent this 
difficulty Dawson et al. replaced the alkyl bromide by a cysteine residue at the N-
terminus of the second fragment. This modification allowed the cysteine to 
undergo transesterification with a C-terminal thioester, leading eventually to 
amide bond formation at the ligation site and hence the term of native chemical 
ligation (Scheme 2).23,28,29 
 
 
Scheme 2. Native chemical ligation of cysteine and peptidyl thioesters. 
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1.1.1.1 Native Chemical Ligation without Cysteine. 
Although Native Chemical Ligation (NCL) addressed the earlier problems, 
the prerequisite of having a cysteine at the ligation site limits its application. In 
order to circumvent this drawback, several modifications of the initial methods 
have been introduced. The introduction of homocysteine,30,31 selenocysteine,32-34 
homoselenocysteine35 and histidine36 in the ligation site as a replacement of 
cysteine, alleviates the dependency on cysteine to a great extent. For example, 
the histidine-based ligation is initiated by nucleophilic attack of an imidazole 
nitrogen of side chain histidine, located at the N-terminus of a peptide, on the C-
terminal thioester. The unstable intermediate upon Nimidazol→Namine acyl transfer 
results in the coupled peptide (Scheme 3).36 
 
 
Scheme 3. Histidine-mediated ligation of peptidyl thioacids. 
1.1.1.2 Native Chemical Ligation with a Removable Auxiliary 
Mimicking the essential β-mercaptoamine of cysteine by the use of a 
removable auxiliary group is another way to overcome this problem. Hence, 
5 
Canne et al. used a thiol group pendant to amine at the N-terminus (Scheme 4). 
This modification allows the expansion of the scope of peptide bonds amenable 
to native chemical ligation.23 
 
 
Scheme 4. Peptidyl thioester ligation through Nα-(mercaptoethyl). amino 
acids 
This method was modified further by replacing the N-terminal cysteine with a 2-
mercaptobenzylamine linker that could be cleaved under conditions typically 
employed for the removal of acid-labile protecting groups in peptide synthesis 
(Scheme 5).37-39 
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Scheme 5. Peptidyl thioesters ligation through a mercaptobenzylamine 
linker. 
1.1.2. Thioacid and Azide Coupling. 
In 2003 Williams and co-workers developed a strategy based on a 
fundamental mechanistic revision of the existing mechanism for the reaction of 
thioacids and organic azides.40-44 Contrary to the conventional methods for the 
chemical synthesis of amides this method does not need active esters and 
amines as precursors for amide synthesis. Moreover the application of this 
methodology for the preparation of several classes of complex amides in 
nonpolar and polar solvents including water was reported (Scheme 6).40 
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Scheme 6. Reaction of thioacids and azides to form amide bonds 
However, azide-based thioacid coupling methods are not without limitations, 
chief among which are the need to prepare azides and the obligate restriction to 
the formation of secondary amides. 
1.1.3 Coupling of Thioacids with Isocyanates and Isothiocyanates 
While several methods have been devised to alleviate the cysteine 
dependency of NCL, most of them lead to amide bond formations which are 
atom-economically less viable. In addition to that the preparation of the key 
substrates for ligation has been a challenge in several of the several coupling 
methods. With this in mind, the Crich group recently developed a new 
methodology based on the reaction of thioacids with the widely available 
isocyanates and isothiocyanates. This condensation involves the synthesis of an 
amide bond with a loss of a simple volatile substance, carbon oxysulfide or 
carbon disulfide (Scheme 7).45 
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Scheme 7. Reaction of thioacids with isocyanates and isothiocyanates.  
1.1.4 Amide Bond Formation by the Tomkinson Reaction  
Fukuyama and co-workers demonstrated the excellence of the 2,4-
dinitrobenzenesulfonamide moiety as a protecting group for amines. This 
protecting group enables the amines to be alkylated under mild condition due to 
the enhanced acidity of N-H and can be easily cleaved under mild conditions by 
nucleophilic aromatic substitution with thiols or amines (Scheme 8).46,47 
  
 
Scheme 8. Formation of sulfonamides and synthesis of secondary amines. 
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Later, Tomkinson and co-workers modified this deprotection strategy by 
replacing the thiol with a thioacid resulting in the formation of an amide (Scheme 
9).48,49 
 
Scheme 9. Formation of an amide bond by Tomkinson's reaction. 
This method despite having scope for much wider application wasn’t utilized until 
the Crich group replaced the simple organic thioacid by an amino thioacid to form 
a peptide bond.  Subsequently, Crich and co-workers applied this reaction in 
various complex systems and extended its application to the synthesis of model 
tetrapeptides. In this manner, a C-terminal thioacid group is employed in the 
synthesis of a native peptide bond by means of the Tomkinson reaction.50 
1.1.5 Coupling of thioacids and amines by Sanger’s and Mukaiyama’s 
reagent. 
The Crich group carried out the Tomkinson coupling reaction in the 
presence of a free amine to gain insight into the mechanistic details of this novel 
reaction. The formation of amide 15, when the reaction is conducted in the 
presence of a  free amine, establishes that at least some of the Meisenheimer 
complex decomposes to a 2,4-dinitrophenyl thioester intermediate 14 (Path-a, 
Scheme 10). This active thioester 14 upon coupling with either the amine 
10 
liberated from the initial sulfonamide or a separately introduced amine gives the 
amide.50 
 
Scheme 10. Mechanism of the Tomkinson reaction. 
On the basis of this mechanism sulfonamides are efficiently replaced by a simple 
amine and Sanger’s 16 or Mukaiyama’s reagent 17, which also undergo 
nucleophilic aromatic substitution with thioacids to give an active thioester that is 
then captured by a nucleophilic amine to give an amide bond (Scheme 11).51  
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Scheme 11. Coupling of thioacids and amines by Sanger’s and 
Mukaiyama’s reagent. 
1.1.6 Oxidative Coupling of Thioacids and Amines promoted by HOBT. 
Danishefsky et al. reported the activation of C-terminal thioacids by 
oxidation followed by reaction with HOBT. The activated HOBT thioester upon 
subsequent reaction with an amine forms an amide bond. Although the 
mechanism is yet to be established, presumably this coupling avoids the 
formation of oxazolone which is not a competent acyl donor.  The available data 
set indicates a low level of oxidation of the C-terminal thioacid to its dimer which 
would form an activated HOBT thioester upon reaction with HOBT (Scheme 12). 
Danishefsky and his group eventually extended this coupling protocol to the 
synthesis of glycopeptides.52 
12 
  
 
Scheme 12. Mechanism of HOBT promoted coupling of thioacid and amine.  
1.1.7 Amide Bond Formation via S-Nitrosothioacids 
Xian et al. reported a novel amide bond formation strategy from simple 
thioacids and amides. This coupling is mediated by the presence of a 
nitrosoalkane, which oxidizes the thioacid to the corresponding S-nitrosothioacid 
(Scheme 13), thereby activating it for displacement by the amine. This reaction 
proceeds under very mild conditions and is reported to be remarkably fast.53 
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Scheme 13. Coupling of a thioacid and an Amine via the S-nitrosothioacid 
derivative 
1.1.8 Application of Thioesters 
Thioesters, which can easily be prepared from thioacids by simple 
nucleophilic substitution, have found more applications than thioacids.11,54-62 For 
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example, Fukuyama and co-workers disclosed the palladium-catalyzed synthesis 
of ketone 25 by the reaction of thioester 24 with organozinc reagents (Scheme 
14).61 
 
 
Scheme 14. Ketone synthesis by a palladium-catalyzed reaction of a 
thioester. 
Srogel, Liebeskind and co-workers reported the palladium-catalyzed cross-
coupling of the thioester 26 with boronic acids to give the corresponding ketones 
27 A pendant iodo group is essential to assist this cross coupling reaction 
(Scheme 15).63  
 
 
Scheme 15. Palladium-catalyzed cross coupling of a thioester with boronic 
acids. 
Spangolo and co-workers have devised a very clever tin-free method for 
generation of acyl radicals in which a simple S-(pent-4-ynyl)ester 28 was made 
14 
use of as radical precursor resulting in the formation of aldehyde 29 (Scheme 
16).64  
 
 
Scheme 16. Aldehyde synthesis by a tin-free radical reaction. 
1.1.8.1 Thioester and Azide Coupling: the “Traceless” Staudinger Ligation 
In its classical form, the Staudinger reaction65 involves a two step process; 
initial electrophilic addition of an azide to the P center of a phosphine to give a 
phosphazide is followed by N2 elimination to give an iminophosphorane (Scheme 
17).66. 
 
 
Scheme 17. Staudinger reaction. 
This iminophosphorane is both electrophilic and oxophilic in nature and can be 
trapped by reagents of various reactivity. Based on the Staudinger reaction, 
Raines67-70 and Bertozzi71,72 independently developed a methodology, known as 
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the Staudinger Ligation in which, the iminophosphorane intermediate was 
trapped intramolecularly by an ester leading to an amidophosphonium salt 32. 
The amidophosphonium salt is then hydrolyzed to produce an amide bond 33 
attached to a phosphine oxide moiety (Scheme 18).71 
  
Scheme 18. Staudinger ligation. 
Shortly after their first reports, Bertozzi et al.72 and Raines et al.67-69 reported a 
traceless Staudinger ligation, in which the phosphine oxide moiety is cleaved 
during the hydrolysis step. This ligation requires two important starting materials; 
one is a C-terminal phosphinothioester69 and the other is a N-terminal azide.73 In 
the first step of this Staudinger ligation, the phosphinothioester reacts with the 
azide to give an iminophosphorane, which then undergoes an intramolecular S to 
N acyl shift leading to an amidophosphonium salt. The amidophosphonium salt is 
then hydrolyzed to produce the amide product and a phosphine oxide 
(Scheme19).74 
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Scheme 19. Ligation of protected peptidyl phosphinothioesters.  
The high reactivity of the aza-ylide does not, however, permit the presence of 
unprotected side-chain functionalities and therefore the Staudinger ligation is 
limited to the coupling of protected peptide fragments 
1.2 Synthesis of Thioacids and Thioesters 
1.2.1 Direct Thiation of Carboxylic Acids 
Direct conversion of carboxylic acids 34 into thioacids 1 using a thiating 
agent such as tetraphosphorous decasulfide or Lawesson’s reagent is low 
yielding and requires high temperature.75 However, in presence of catalytic 
triphenylantimony oxide this conversion turns out to be an efficient way to make 
thioacids and the conditions to carry out this conversion are much milder 
(Scheme 20).76  
 
17 
 
 
Scheme 20: Direct synthesis of thioacids from carboxylic acids. 
1.2.2. Nucleophilic Attack to Carbonyl Sulfide 
Carbon nucleophiles such as Grignard reagents77 or stabilized carbanions 
react with carbonyl sulfide to afford thioacids. For example, deprotonation of α-
fluoroalkylphosphonates 35 with lithium diisopropylamide followed by quenching 
with carbonyl sulfide gives the corresponding α-fluoroalkanyl thioacids 36 
(Scheme 21).76 
 
 
Scheme 21: Preparation of thioacids from carbonyl sulfide. 
1.2.3. Acylation of a Sulfur Source  
Direct acylation of hydrogen sulfide with active esters, acid halides, and 
anhydrides has been a common method for thioacid preparation.78-81 A more 
versatile approach to the acylation of sulfide sources involves the treatment of 
acid halides 37 with N,N-dimethylthioformamide to give an intermediate, which 
opon reaction with hydrogen sulfide decomposes to the thioacids with 
regeneration of the thioformamide (Scheme 22).78 
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Scheme 22. Preparation of thioacids from acid chlorides,  
dimethylthioformamide and hydrogen sulfide. 
1.2.4. Synthesis of Thioacids from Thioesters 
One, out of several available synthesis of thioacids from thioesters, is highly 
diastereoselective Lewis acid promoted Ireland-Claisen rearrangement of a 
thioester 38 to thioacids 39 (Scheme 23).82 
  
Scheme 23. Preparation of a thioacid by an Ireland-Claisen rearrangement 
of a thioester. 
Since the major use of thioacids has been in the field of peptide chemistry, a 
milder method for thioacid synthesis was essential. In that regard, thioesters 
served as convenient precursors to obtain thioacids under conditions compatible 
with peptide chemistry. In 2003 Williams and co-workers developed the 
trimethoxybenzyl (TMOB) thioester 40 as a precursor for thioacids, wherein the 
thioester can be deprotected in mild acidic conditions (Scheme 24). 40 
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Scheme 24. Synthesis of thioacids through TMOB-thioesters. 
 
Crich and coworkers recently developed a mild method for thioacid 
liberation in basic media from 9-fluorenylmethyl (Fm) thioesters 44. Treatment of 
the Fm-thioesters 44 with piperidine in DMF at room temperature gave the 
corresponding thioacids 45 (Scheme 25).50 
 
 
Scheme 25. Synthesis of thioacids through Fm-thioesters. 
1.2.5. Solid Phase Synthesis of Peptidyl Thioacids and Thioesters  
The above-mentioned synthesis of thioacids in solution has been 
successfully carried out by various groups.53,83,84 However, the fundamental 
problem of thioacid synthesis in solution lies with their purification. The practical 
problem in which the product of each individual reaction step has to be isolated 
and purified limits the use of solution-phase thioacid synthesis. In contrast to the 
solution-phase methodology, Solid Phase Peptide Synthesis (SPPS) 
methodology has been employed more prominently for the synthesis of peptidyl 
20 
thioacids. Typically the SPPS involves a linker to attach the growing peptide to 
an insoluble support and therefore, after each reaction step, the byproducts are 
simply removed by filtration and washing. The general principle of SPPS, one of 
repeated cycles of coupling-wash-deprotection-wash, eventually makes the 
automated synthesis of peptide possible.     
1.2.5.1. Synthesis of C-Terminal Peptidyl Thioacids and Thioesters on Solid 
Support by Boc-chemistry Compatible Methods 
The Blake group was the first to report solid-phase preparation of 
unprotected peptides with a thiocarboxylic acid functionality at the C-terminus, 
initially using a preformed benzhydryl thioester handle: 4-[α-(Boc–Gly–
S)benzyl]phenylacetic acid.85,86 Subsequently, several methods have been 
developed based on a modified handle; 2-[4-
(mercapto(phenyl)methyl)phenoxy]acetic acid 46.15,87,88  In this system the C-
terminal amino acid is derivatized with this linker, and the resulting thioester 47 is 
then attached to an aminomethyl polystyrene resin. Standard Boc-SPPS89 is then 
applied for preparation of the desired peptide sequence. Finally, the peptidyl 
thioacid 50 is obtained in the final step by simple acidic cleavage from the resin 
by HF treatment (Scheme 26).87   
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Scheme 26. Peptidyl thioacid synthesis using a carboxylate handle on solid 
support. 
Following the synthesis of partially protected peptidyl S-alkyl thioesters by 
Aimoto et al,90 Tam and co-workers developed a further protocol for SPPS 
containing a C-terminal thioester by the Boc strategy. This protocol involves the 
loading of MBHA resin with S-trityl mercaptopropionic acid. After removal of the 
trityl-protecting group, the desired polypeptide chain is assembled using a 
standard Boc strategy. Finally, the thioester 55 is obtained after cleavage with HF 
(Scheme 27).91 
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Scheme 27. Synthesis of a peptidyl C-terminal thioester. 
More recently, Yangmei et al. made use of volatilizable 
mercaptomethylphenyl-functionalized silica support 56 to synthesize a fully 
deprotected peptide S-benzyl thioester.92 This synthesis starts with the first 
amino acid being derivatized with this linker, and continues with assembly of the  
target peptide by standard Boc chemistry. The peptidyl thioester 48 is finally 
obtained by the cleavage of the peptide from the resin by the treatment of HF 
(Scheme 28).   
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Scheme 28. Synthesis of peptidyl S-benzyl thioester on silica support. 
The above -SPPS methods for peptidyl thioester synthesis make use of 
hazardous HF93,94 for the final cleavage from the resin, which limits their 
application. 
More recently Crich and coworkers devised a novel approach to SPPS of 
thioacids on a mercapto functionalized 9-fluorenylmethyl linker in conjunction 
with standard Boc chemistry.95 The synthesis starts with N-[9-(tritylthiomethyl)-
9H-fluoren-2-yl]succinamic acid (7) that is coupled with divinylbenzene cross-
linked aminomethylpolystyrene resin using standard coupling reagents.  This is 
followed by unmasking of the thiol group. The target peptide is assembled on the 
supported thiol by Boc-SPPS and the final peptidyl thioacid 74 is liberated by the 
treatment with piperdine in DMF (Scheme 29). 
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Scheme 29. Solid-phase synthesis of peptidyl thioacids. 
1.2.5.2. Synthesis of C-Terminal Peptidyl Thioacids and Thioesters on Solid 
Support using Fmoc Chemistry 
Barany et al. described the Backbone Amide Linker (BAL) strategy for 
Fmoc-SPPS. The novelty of Barany’s approach is the fundamental reversion of 
anchoring; the growing peptide chain is anchored through a backbone nitrogen 
instead of the conventional C-terminal carboxylic group. This tuning allows 
25 
considerable flexibility in the modification of termini. In the BAL strategy, an acid 
labile 4-[formyl-3,5-dimethoxyphenoxy]butyric acid-based handle (60) was linked 
with an amino-functionalized PEG-resin. This was followed by on-resin reductive 
amination with an allyl ester of amino acid hydrochloride salt and the target 
peptide was assembled by standard Fmoc chemistry on this support. The C-
terminal allyl ester was selectively removed to give an acid, which was coupled to 
an amino acid thioester to give the backbone amide anchored C-terminal peptidyl 
thioester 64. Thioester 65 then was liberated upon cleavage with TFA (Scheme 
30).96 
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Scheme 30. Preparation of unprotected peptidyl thioesters using the 
backbone amide linker approach. 
The major shortcoming of the BAL method is the need for careful control in the 
activation of the C-terminal carboxylic acid to avoid epimerization. The need for 
special precautions when coupling the second amino acid to prevent 
diketopiperazine formation further limit the scope of this method.  
Another approach to this problem is that of Ellman who adapted Kenner 
safety catch linker. In this chemistry the peptide is linked to the resin via an acyl 
sulfonamide that is stable to the conditions of Boc SPPS. After the peptide chain 
27 
has been assembled the linker is activated by alkylation on nitrogen and then 
subjected to nucleophilic cleavage with an excess of thiol, thereby affording the 
thioester (Scheme 31).  
 
Scheme 31. Synthesis of a peptidyl thioester on a ‘Safety-Catch’ linker. 
1.3. Cyclic Thioanhydrides 
Cyclic thioanhydrides are analogues of cyclic anhydrides in which the ring 
oxygen has been replaced by an atom of sulfur.97,98 Cyclic thioanhydrides are 
effective acylating agents whose treatment with competent nucleophiles should 
provide a practical means of generation of thioacids for subsequent use within 
the one reaction pot. The first example of thioanhydride ring opening was 
reported by Balenovic and co-workers and is shown in Scheme 32.99  However, 
cyclic thioanhydrides were rarely employed in organic synthesis until the Dervan 
group and later the Crich group effectively made use of them. 
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Scheme 32. Nucleophilic ring opening of thiophthalic anhydride. 
In order to prepare artificial transcription factors, Dervan and coworkers 
efficiently utilized thioacids generated in situ by ring opening of thiosuccinic 
anhydride. A primary amine containing polyamide 71 was reacted with 
thiosuccininc anhydride, the resulting thioacid was subsequently coupled with 
benzyl bromide to afford thioester 72. A number of polyamide-peptide conjugates 
then were synthesized based on native chemical ligation between the resulting 
thioesters and functionalized cysteine containing peptides (Scheme 33).  
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Scheme 33. Thiosuccinic anhydride in native chemical ligation. 
In 2007 Crich and coworkers demonstrated this ring opening reaction to 
have much wider scope in synthetic organic chemistry when the range of easily 
prepared cyclic thioanhydrides and the breadth of thioacid chemistry are taken 
into consideration.100 Ring opening of commercially available thiosuccinic 
anhydride with a moderately nucleophilic aniline and subsequent capture of the 
resulting thioacid with N-benzyl-2,4-dinitrobenzenesulfonamide 77 were reported 
(Scheme 34). This reaction sequence worked extremely well at room 
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temperature both in DMF and, more surprisingly, in methanol indicating the 
thioanhydrides to be more reactive toward an stoichiometric amount of aniline 
than to the bulk methanol. 
 
Scheme 34. Multicomponent coupling of a cyclic thioanhydride with amine 
and a 2,4-dinitrobenzenesulfonamide. 
1.3.1 Thiomaleic Anhydride 
Thiomaleic anhydride, a sulfur analogue of maleic anhydride, has the 
potential for broader application because of the presence of the double bond. 
This α,β-unsaturation provides much opportunity to explore some interesting 
chemistry. Although not many reactions of thiomaleic anhydride have been 
reported, extensive studies have been done on maleic anhydride. The C=C bond 
of maleic anhydride has been explored in a number of ways and some of them 
are mentioned here. 
1.3.1.1. Diels Alder Reaction 
Both [4+2] and [2+2]-cycloadditions of maleic anhydride have been very well 
studied. A representative example with furan and maleic anhydride is presented 
here in Scheme 35.101-103 
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Scheme 35. Diels Alder reaction of maleic anhydride. 
1.3.1.2. Ene Reactions 
Maleic anhydride serves as an efficient eneophile in the ene reaction with 
82, when alkenylsuccinic anhydride 84 is the product (Scheme 36).104 
 
 
Scheme 36. Ene reaction with maleic anhydride. 
1.3.1.3. Free-Radical Reactions 
Maleic anhydride is well known as a free radical acceptor and is extensively 
used in radical copolymerization.105 Nucleophilic radicals react with maleic 
anhydride to form the corresponding alkylsuccinic anhydride; a representative 
example of the addition of a free radical, generated by the Barton 
decarboxylation is shown in Scheme 37.106-108 In this particular example the 
succinic anhydride resulting from the radical addition is unstable and is converted 
to an alkylmaleic anhydride by elimination of a 2-mercaptothiazole. 
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Scheme 37. Barton decarboxylation reaction with maleic anhydride as 
radical trap. 
Giese and coworker107 demonstrated the excellence of monothiomaleic 
anhydride as a trap of alkyl radical that was generated from alkylmercuric acetate 
(Scheme 38).  
 
Scheme 38. Cyclohexyl radical addition to thiomaleic anhydride 
1.3.1.4. Michael Addition Reactions 
The α,β-unsaturated double bond of maleic anhydride is highly electron 
deficient, and thus acts as an excellent acceptor of soft nucleophiles via  Michael 
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addition. A wide variety of thiol adducts of maleic anhydride have been prepared 
and a representative example with thiophenol is given in Scheme 39.109 
 
 
Scheme 39. Michael addition reaction with maleic anhydride. 
  Clearly, thiomaleic anhydride can be expected to undergo many of the 
same reactions as maleic anhydride, and the combination of these reactions at 
the alkene with nucleophilic ring opening processes affords considerable scope 
for the preparation of a range of thioacids. 
 
1.4. Objectives 
The objective of the work presented here was to explore the potential of 
thiomaleic anhydride and other cyclic monothioanhydrides in multicomponent 
coupling reactions of which at least one step involved the capture of an in situ 
generated thioacid. In this respect it is important to note that heterocycles and 
their amide derivatives are among the most common pharmacophores developed 
by the pharmaceutical industry as drug candidates. New methods such as the 
one proposed here are therefore widely sought after, all the more so when they 
are multicomponent based.110 This is because multicomponent sequences 
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provide extensive opportunities for diversification of substitutents in efficient 
manner.  
The results of this work are presented in the following two chapters and the 
experimental chapter that follows them.  
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CHAPTER 2 
An exploration of thiomaleic anhydride as a central building block in 
multicomponent coupling reactions  
2.1. Background  
Multicomponent coupling reactions are those reactions that combine 
multiple building blocks to form interesting and/or novel structures for possible 
exploitation in bioorganic chemistry and in material science among others. The 
ability to combine multiple units into a single molecule in a minimum number of 
reaction steps provides rapid access to a diverse range of chemical entities.  
The use of cyclic anhydrides in multicomponent coupling reactions has been 
extensively explored and reviewed by Shaw.111 The focus of this chapter is on a 
corresponding use of cyclic monothioanhyrides. In particular the goal was to take 
advantage of the high reactivity of the alkene in monothiomaleic anhydride to 
form a covalent bond between two components giving substituted thiosuccinic 
anhydrides. It was anticipated that after cyclization to form a heterocycle, the 
high reactivity of the so liberated thioacid would enable combination to a third 
component either through a amide bond formation or C-C bond formation 
(Scheme 40). 
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Scheme 40. Multicomponent coupling reaction of thiomaleic anhydride with 
aminothiols and amines. 
2.2. Synthesis of Thiomaleic Anhydride 
Thiomaleic anhydride was prepared by initial protection of the double bond 
of maleic anhydride as the Diels-Alder adduct 94 with furan. Treatment of this 
Diels-Alder adduct with Na2S gave the corresponding thioanhydride 95. Finally,  
retro-Diels-Alder reaction was achieved by thermolysis and was accompanied by 
distillation of the pure thiomaleic anhydride at 100-105 °C and under 15 torr 
pressure (Scheme 41).112  Isolation by distillation in this way makes this a very 
convenient preparation of thiomaleic anhydride, especially as the final pyrolysis 
could be conducted on a gram scale.  Thiomaleic anhydride is a pale yellow 
crystalline solid whose needle-like crystals have a melting point of 28 °C.  It has 
IR carbonyl absorptions at 1710 and 1690 cm-1, and a chemical shift of δ 192 for 
the carbonyl carbons in the 13C NMR spectrum. 
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Scheme 41. Preparation of thiomaleic anhydride. 
2.3. Multicomponent Coupling by Reaction of Thiomaleic Anhydride with 
Aminothiols and Subsequent Amide Bond Formation with Electron-
Deficient Sulfonamides 
In this initial reaction sequence it was envisaged that a protected 
mercaptoamine or a protected mercapto alcohol would be coupled to thiomaleic 
anhydride by initial Michael addition reaction taking advantage of the high 
nucleophilicity of thiols and/or thiolates. After deprotection of the amine or alcohol, 
cyclization to form a lactam or lactone would liberate a thioacid for a second 
coupling (Scheme 42).  
 
Scheme 42. Multicomponent coupling reaction of thiomaleic anhydride with 
aminothiols and sulfonamides 
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A number of reactions were conducted according to this general scheme. Both 
aromatic and aliphatic thiols were employed with linkers containing two or three 
carbon atoms coupling them to aromatic or aliphatic amines and alcohols both 
protected in the form of Boc derivatives. Following cyclization the thioacids were 
captured by the Tomkinson sulfonamide reaction using a variety of secondary 
and tertiary sulfonamides. The results of these reactions are presented in Table 
1. 
Table 1. Three Component Coupling of Thiomaleic Anhydride with 
Aminothiols and 2,4-Dinitrobenzenesulfonamides  
entry aminothiol sulfonamide
a product (% yield, 
cis:trans)b 
1 
 
SH
NH2
 
97 
N SO2Ar
 
 
98 
S
N
H
O O
N
 
102 (59) 
2 
SH
NH2
 
97 
N
H
CO2MeArSO2
 
99 
S
N
H
O O
H
N CO2Me
 
103 (67) 
3 H2N
SH
CO2Et
 
100 
N SO2Ar
 
98 
S
N
H
O O
N
EtO2C
 
104 (72, 3:1) 
4 H2N
SH
CO2Et
 
100 
N
H
CO2MeArSO2
 
99 
S
N
H
O O
H
N CO2Et
EtO2C
 
105 (63, 3:1) 
5 H2N
SH
CO2Me
 
101 
N SO2Ar
 
98 
S
N
H
O O
N
EtO2C
 
106 (53, 3:1) 
6 H2N
SH
CO2Me
 
101 
N
H
CO2MeArSO2
 
99 
S
N
H
O O
H
N CO2Et
EtO2C
 
107 (41, 3:1) 
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a Ar = 2,4-dinitrophenyl; b conditions: i) 1.2 equiv thioanhydride, 1 equiv amine, DMF, 30 min; ii) 1 equiv CsCO3, 1 equiv 
sulfonamide, DMF 1 h.   
 
A single cyclic product was isolated for entries 1 and 2 of Table 1 which were 
assigned the six membered cyclic benzothiazine structure rather than the 
alternative seven membered benzothiazepin alternative. The basis for this 
assignment is taken from the 13C NMR spectrum which in both cases displays a 
carbonyl carbon at δ 168. Literature values for carbonyl carbon chemical shift of 
benzothiazinones are approximately 167 ppm and those for (benzothiazepinone) 
are around 174 ppm.113 In addition it is anticipated that cyclization to form a six 
membered ring will be faster than that to form a seven membered ring (Scheme 
43).114 
 
 
 
Scheme 43. Cyclization onto thioanhydride to lead to 7-memberred ring 
The percentage yield was not affected by the change of the binucleophile from 
an aromatic to an aliphatic system (entries 3 and 4). However due to the 
generation of a second stereogenic center, two diastereomers were isolated with 
3:1 ratio favoring the cis-isomer over the trans-one when a chiral amino thiol was 
employed as a nucleophile. The stereochemistry of each diastereomers of 104 
and 105 was determined by 2-D NMR spectroscopy (NOESY) as depicted in 
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Figure 2. For the cis-isomer an interaction between Ha and Hc was observed, 
while no such interaction between Ha and Ht was observed for the trans-isomer in 
the 2-D NOESY spectra. 
 
 
Figure 2. NOESY based relative stereochemistry determination of 
compounds 104 and 105  
Interestingly, the more bulky aminothiol, D-penicilamine, afforded the heterocyclic 
amide with moderate yield (entries 4 and 5) and with similar diastereoselectivity, 
favoring the cis- over the trans-isomer. The relative stereochemistry of these two 
isomers was determined by NOE measurements between the hydrogens marked 
in Figure 3.  
 
 
Figure 3. NOESY based stereochemistry determination of compounds 106 
and 107. 
It is noteworthy that the use of the α-aminoisobutyric acid derivative penicillamine, 
which despite being sterically crowded, still results in formation of the amide 
bond with moderate yield (entries 2, 4 and 6). 
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2.4. Multicomponent Coupling by Reaction of Thiomaleic Anhydride and 
Aminothiols and Subsequent Amide Bond Formation With Amines 
Promoted by Sanger’s Reagent. 
Attention was next focused on a closely related multicomponent coupling 
sequence in which the use of an electron-deficient sulfonamide in the final amide 
bond formation was replaced by that of an amine and Sanger’s reagent.  A 
number of reactions were according to this protocol (Scheme 43) with the results 
presented in Table 2. 
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Table 2 Three Component Coupling of Thiomaleic Anhydrides with 
Aminothiols and Amines Promoted by Sanger’s Reagent  
 
NH2
SH
R1
R2
R3
R4
S
O
O
NH2
S
R1
R2
R3
R4
S
N
H
S
R1
R2
R3
R4
SH
O
N
H
S
R1
R2
R3
R4
NR5R6
O
O
O
O
O
R5R6NH2 Cs2CO3
O2N
NO2
F
 
entry aminothiol amine product (% yield, cis:trans)a 
1 
 
SH
NH2
 
97 
NH
 
108 
S
N
H
O O
N
 
102 (51) 
2 
SH
NH2
 
97 
H2N CO2Me
 
109 
S
N
H
O O
H
N CO2Me
 
103 (53) 
3 H2N
SH
CO2Et
 
100 
NH
 
108 
S
N
H
O O
N
EtO2C
 
104 (65, 3:1) 
4 H2N
SH
CO2Et
 
100 
H2N CO2Me
 
109 
 
S
N
H
O O
H
N CO2Et
EtO2C
 
105 (70, 3:1) 
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5 H2N
SH
CO2Me
 
101 
NH
 
108 
S
N
H
O O
N
EtO2C
 
106 (46, 3:1) 
6 H2N
SH
CO2Me
 
101 
H2N CO2Me
 
109 
 
S
N
H
O O
H
N CO2Et
EtO2C
 
107 (53, 3:1) 
a Ar = 2,4-dinitrophenyl; b conditions: i) 1.2 equiv thioanhydride, 1 equiv amine, DMF, 30 min; ii) 1 equiv CsCO3, 1 equiv 
sulfonamide, DMF 1 h.   
 
It is obvious from the comparable yields for the examples presented in Tables 1 
and 2 that multicomponent coupling reactions involving Sanger’s reagent are 
equally efficient for the synthesis of heterocyclic diamides as those employing the 
Tomkinson sulfonamide chemistry in the final step. For example, the coupling 
involving aminothiol 97, thiomaleic anhydride and sulfonamide 98 gave 
benzothiazine 102 in 59% yield (Table 1, entry 1), while the same compound was 
obtained in very similar yield (51%, Table 2, entry 1) when the sulfonamide was 
replaced by  piperidine and Sanger’s reagent. Likewise coupling of aminothiol 
101, thiomaleic anhydride and sulfonamide 99 afforded thiazine 107 in 41 % yield 
(Table 1, entry 6), while the same compound was obtained in very similar yield 
(53%, Table 2, entry 6) when the sulfonamide 99 was replaced by amine 109. In 
general the couplings employing Sanger’s reagent and an amine have the 
advantage over the Tomkinson method that prior synthesis of a sulfonamide is 
not necessary.  
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2.5. Heterocycle Synthesis Based on Diels-Alder Reaction. 
Following the success of the aminothiol based multicomponent coupling 
process with thiomaleic anhydride, a second system was designed exploiting a 
different reactivity manifold of the anhydride, namely the Diels-Alder reaction.  
This system was based on the Diels Alder reaction of a diene carrying a suitably 
appended protected amine, such that after cycloaddition, deprotection of the 
amine would result in cyclization of the amine onto the anhydride resulting in 
heterocycle synthesis and thioacid generation ready for final amide bond 
formation.  Commercially available 2-aminomethylfuran was selected as the 
diene and protected in the form of its Boc derivative. 
 
 
Scheme 44. Diels Alder reaction with thiomaleic anhydride. 
[4+2]-Cycloaddition of thiomaleic anhydride with 2-tert-
butyloxycarbamoylmethylfuran 110 afforded the cycloadduct 111 in 68% yield, as 
a single diastereomer, after 4 days at room temperature in benzene (Scheme 
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44). These slightly unusual reaction conditions were selected as thiomaleic 
anhydride is not stable to prolonged heating. Working in this manner it was 
possible to isolate a cycloadduct but characterization was complicated by the fact 
that it underwent slow decomposition on standing at room temperature due to the 
retro Diels-Alder reaction. To avoid this complication it was necessary to prevent 
the retro Diels-Alder reaction. Initially, dihydroxylation using osmium tetraoxide 
and reduction using diimide were tried; however neither of these reactions was 
compatible with the thioanhydride ring. Eventually, hydrogenation was conducted 
over Raney nickel, as described by Dauben et. al. for the adduct with furan itself, 
affording the dihydro analogue 112 in 94% yield.115 Compound 112 is a white 
solid with melting point 167.8-168.3 °C. The exo-st ereochemistry of the saturated 
cycloadduct was readily ascertained by NOE measurements, thereby confirming 
the stereochemistry of the initial adduct (Figure 4). The exo-stereochemistry of 
this adduct corresponds to that of the reported in the literature for the adduct 
between furan and maleic anhydride.112 
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Figure 4. Determination of the relative stereochemistry of the saturated 
Diels-Alder adduct 112. 
Treatment of both 111 and 112 with trifluoroacetic acid to remove the Boc group 
followed by the addition of excess collidine to liberate the free amine, provoked 
the anticipated cyclization to give a piperidone.  This process generated a 
thioacid that was immediately captured with a 2,4-dinitrobenzenesulfonamide 
leading, overall, to oxazatricyclodecanes 113 and 114 in 84 and 63% yield, 
respectively (Scheme 44).  
 
Attention was next turned toward the exploitation of the affinity of thiomaleic 
anhydride for nucleophilic radicals. As discussed in the introduction Giese and 
Kretzschmar had previously demonstrated thiomaleic anhydride to be an 
excellent trap for the cyclohexyl radical, indeed they showed it to trap this radical 
285 times faster than does diethyl maleate and equally as fast as does maleic 
anhydride. Armed with this information a strategy for the conjugate addition of 
protected amino or hydroxyl alkyl radicals to thiomaleic anhydride was conceived, 
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whereby, after addition, deprotection of the amine or alcohol would result in 
cyclization to give nitrogen- or oxygen-based heterocycles functionalized by a 
thiocarboxylic acid.  This latter functionality would then be employed in the 
standard manner in the formation of an amide bond (Scheme 45). 
 
 
Scheme 45. Heterocycle synthesis involving free radical reaction with 
thiomaleic anhydride. 
2.6. Synthesis of Radical Precursors  
As a precursors for the radical reaction, several Boc-protected nucleophiles 
amino or hydroxyl alkyl iodides were prepared. Synthesis of these radical 
precursors typically involved controlled introduction of a Boc group to an amino 
alcohol or a diol, so as to leave a single free hydroxyl group.  Boc protection of 
amino alcohols or diols was carried out according to a literature protocol to give 
the known mono protected analogues.116 Reaction with triphenylphosphine and 
iodine then converted the remaining hydroxyl group into an iodide as reported in 
Table 3.  
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Scheme 46. Boc protection followed by iodination. 
Table 3. Preparation of Radical Precursors 
entry substrate iodide, % yield 
1 
 
 
2 
 
 
3 
 
 
4 OH
NHBoc
117
 
I
NHBoc
123, 62
 
5 
 
 
6 
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2.7. Radical Addition to Thiomaleic Anhydride 
Radical additions to thiomaleic anhydride were carried out in toluene at 90 
oC using a catalytic amount of azobisisobutyronitrile (AIBN) as the initiator and 
TTMS as both hydrogen atom donor as well as radical propagator (Table 4). The 
typical procedure involved dropwise addition of TTMS and AIBN in dry degassed 
toluene into a hot reaction mixture of thiomaleic anhydride and functionalized 
iodide. As thiomaleic anhydride decomposed slowly during the course of the 
reaction further thiomaleic anhydride solution in toluene was added dropwise 
during the course of the reaction. 
Table 4. Free radical addition reactions with thiomaleic anhydride 
TTMS, AIBN
Toluene, 90 oC, 4 h
+
X = NH, O; n = 1,2
SO O
S
XBoc
OO
R
nXBoc
R
n
I
 
entry iodide adduct, % yield 
1 
 
S
NHBoc
O
O
126, 86
 
2 
 
S
OO
BocHN
127, 92
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3 
 
S
CO2Me
O
O
BocHN
H
128, 85
 
4 I
NHBoc
123
 
S
O
O
NHBoc
129, 70
 
5 
 
S
OBoc
O
O
130, 79
 
6 
 
S
OO
BocO
131, 82
 
 
The resulting thiosuccinic anhydrides were obtained as colorless gums after 
chromatographic purification and have a distinct IR carbonyl absorption at around 
1710 cm-1 and 13C NMR chemical shifts at around 200 ppm for the carbonyl 
carbons. The high yields of all radical addition reactions in Table 4 clearly 
vindicate the early designation of thiomaleic anhydride as an excellent radical 
acceptor, although it has not been used as such in the interim. Even the 
somewhat less nucleophilic benzyl radical (Table 4, entry 4)117 surprisingly 
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afforded the radical adduct with a moderate yield. In the case of the iodoalanine 
radical precursor, the addition product was formed as a 1:1 mixture of 
stereoisomers, which were not separated (Table 4, entry 3). Interestingly, the 
Boc- protecting group remained intact throughout the course of these reactions 
even on prolonged heating in presence of AIBN and TTMS. 
2.8. Removal of the Boc Group, Cyclization and Subsequent Amide Bond 
Formation 
The radical adducts were treated with trifluoroacetic acid to remove the Boc 
protecting system, followed by immediate exposure to 2,4,6-collidine to liberate 
the amine from its trifluoroacetate salt and enable intramolecular attack onto the 
thioanhydride. Upon cyclization, the liberated thioacid was captured by an 
electron-deficient sulfonamide in the standard manner to complete the three 
component coupling process with an amide bond forming reaction. 
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Table 5. Deprotection and Cyclization of Radical Adducts with Subsequent 
Amide Bond Formation 
 
iii) Cs2CO3, ArSO2NR1R2
DMF, 25 oC,1 h
i) 25% TFA in CH2Cl2,
0 oC, 40 min
ii) 2,4,6-collidine
DMF, 0 oC, 1 h
S
XBoc
OO
R
X OR
COSH
nn
X OR
CONR1R2n
R = H, CO2Me; X = NH, O; n = 1, 2; Ar = 2,4-dinitrophenyl
XR
COSH
O
+
n
XR
CON1R2
O
n
+
major minor
 
entry substrate R1R2NH products, % yield 
1 
 
piperidine H
N
O
O
N
134, 81
 
2 
 
2-
phenylethyla
mine 
 
53 
 
3 S OO
BocHN
127
 
2-
Phenylethyla
mine 
NH
O
NH
Ph
O
136, 55
 
4 S OO
BocHN
127
 
piperidine NH
O
O
N
137, 75
 
5 
 
piperidine 
 
6 
 
Ph(CH2)2NH2 
 
54 
 
7 
 
piperidine 
NH
O
O
N
142, 82
 
8 
 
Ph(CH2)2NH2 
NH
O
O
HN
Ph143, 71
 
9 S
OBoc
O
O
130
 
piperidine O
O
O
N
144, 72
 
10 S
OBoc
O
O
130
 
Ph(CH2)2NH2 
 
11 S OO
BocO
131
 
piperidine O
O
O
N
146, 85
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12 S OO
BocO
131
 
Ph(CH2)2NH2 
 
 
In each of the examples studied the cyclization step took place to give the 
kinetically favored smaller of the two possible rings (lactone or lactam), although 
for the substrates derived originally from iodoalanine approximately 10% of a 
minor regioisomer was observed in the crude reaction mixture.  In keeping with 
their application as 1:1 mixtures of isomers the lactam amides derived from 130 
formed as equimolar mixtures of diastereomers (Table 5, entries 5 and 6). 
A comparison between the literature and observed values of 13C NMR 
chemical shifts, along with IR absorption frequencies helped determinie the 
lactone and lactam ring sizes. For example, γ-lactam 134 has a carbonyl 
chemical shift of 180.5 ppm in its 13C NMR spectra, and an IR carbonyl 
absorption at 1693 cm-1 which is very similar to the reported 13C NMR chemical 
shift and IR absorption for γ-lactams in general, which are typically 180 ppm and 
1680 cm-1 respectively.118 For γ-lactones, reported 13C carbonyl chemical shifts 
and IR absorptions are 177.7 ppm and 1772 cm-1, respectively, while the 
observed values for synthesized γ-lactone 144 are 179.7 ppm and 1766 cm-1 
respectively.119 13C chemical shifts and IR absorptions for the carbonyl groups  of 
the various δ- lactones also correlated well with literature values: reported values 
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of 13C chemical shifts and IR absorptions for the carbonyl group are 171.9 ppm 
and 1712 cm-1 respectively, while the observed values for the synthesized δ- 
lactone 146 are 174.8 ppm and 1728 cm-1 respectively.120,121 Interestingly, when 
the (3-tert-butyloxycarbonyloxypropyl)thiosuccinic anhydride 131 was subjected 
to the deprotection, cyclization sequence and the resulting thiocarboxylate 
trapped with N-(2-phenylethyl) dinitrobenzenesulfonamide the isolated product 
was not the anticipated amido lactone 147 but rather the Imide 148 which was 
isolated in 74% yield.  This imide 148 arises from cyclization of the amide onto 
the initially formed δ-lactone 147 (Table 5, entry 12) as shown in Scheme 47.   
 
 
Scheme 47. δ-Lactone to imide rearrangement 
This result stands in contrast to that of Table 5, entry 10 for which the substrate 
was the lower homolog 130 when the expected γ-lactone 145 was readily 
isolated and characterized. The difference in reactivity of the two lactones toward 
the side chain amide group, however, is in complete agreement with the general 
pattern according to which δ-valerolactones are considerably more susceptible to 
alkaline hydrolysis than the γ-butyrolactones, and with the greater stability of γ- 
rather than δ-lactones in the uronic acid series.122 However isolation of the δ-
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lactone 146 (Table 5 entry 11) in 85% yield testifies to the fact that tertiary 
amides are insufficiently nucleophilic to open a δ-lactone.  
2.9. Deprotection of Boc Group, Cyclization and Subsequent Thioester 
Formation  
The thioacid chemistry was taken beyond amide bond formation and utilized 
for C-C bond formation in various ways.  Thus, three thioesters were synthesized 
by the capture of thioacids, which were generated in situ by standard Boc 
removal followed by cyclization of the unprotected amine onto the thioanhydride, 
and final alkylation with alkyl iodides as shown in Table 6. 
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Table 6. Cyclization with Thioester Formation 
i) 25% TFA in CH2Cl2,
0 oC, 40 min
ii) 2,4,6-collidine
DMF, 0 oC, 1 h
iii) RI
S OO
X O
COSRBocX
 
Entry Subs. Alkyl halide Product 
1 129 5-iodopentyne 
 
2 131 5-iodopentyne 
 
3 133 1,4-diiodobutane 
 
 
With substrates 129 and 131 the thioacid generated in situ was captured by 5-
iodo-1-pentyne to afford thioesters 149 and 150, setting up the scene for 
application to the Spagnolo method for acyl radical formation and capture. 
Interestingly no vinyl thioester, which would form out of thioacid addition to 
alkyne, was isolated.  The thioacid generated from compound 133 was captured 
by 1,4-diiodobutane to give the iodobutyl thioester 151. Excess 1,4-diiodobutane 
was used in this process to prevent formation of any dimer. All thioesters were 
isolated as colorless oils having IR absorptions at around 1680 cm-1 and 13C 
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chemical shifts around 200 ppm, a signature of the thioester group, as well as a 
13C carbonyl chemical shift at 173 ppm and an IR absorption of 1732 cm-1 for the 
lactone.  
2.10. Generation of Acyl Radical and Subsequent Capture 
Following the method of Spagnolo and co-workers,64 pentynyl thioesters 149 
and 150 were treated with thiophenol and AIBN in benzene at 80 oC to generate 
acyl radicals which were captured by a H atom donor (thiophenol) resulting in the 
formation of the corresponding aldehydes (Table 7).  
 
 
 
Table 7. Radical Chemistry of Thioesters 
 
entry subs propagating  
agent 
product 
1 149 Thiophenol H
N O
O
H
152, 69
 
2 150 Thiophenol 
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Thioesters 149 and 150 afforded the corresponding aldehydes 152 and 153 with 
good yield, both of which displayed signatory 1H and 13C chemical shifts around 
9.80 and 200 ppm, respectively. These reactions proceed via a mechanism 
involving homolytic addition of the phenylthiyl radical to the terminal position of 
the alkyne generating a vinyl radical, which undergoes intramolecular homolytic 
substitution on the thioester to give the acyl radical (Scheme 48).  Thiophenol 
serves as a chain transfer providing a hydrogen atom and generating a further 
thiophenyl radical to propagate the chain. 
 
Scheme 48. Mechanism of acyl radical generation and subsequent 
aldehyde formation 
In a related process 149 was heated with the electron-deficient allyl phenyl 
sulfide 154 and a radical initiator resulting in transformation of the thioester to the 
ketone 155 in excellent yield (Scheme 49).   
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Scheme 49. Ketone synthesis by radical allylation of a thioester. 
In this process the acyl radical is trapped by an electron deficient olefin moiety of 
allyl phenyl sulfide 154. The resulting radical adduct, in absence of a hydrogen 
donor, undergoes homolytic cleavage of the alkyl-SPh bond resulting in the 
ketone 155 and regeneration of the phenylthiyl radical whose purpose is to 
propagate the reaction (Scheme 50). 
 
 
Scheme 50. Mechanism of radical based ketone formation from a thioester. 
Finally, ketone 156 was synthesized from thioester 151 using a cross-
coupling method conducted under the conditions of Liebeskind and co-workers.63 
In this method the iodobutyl thioester 151 was treated with phenylboronic acid in 
the presence of copper thiophenecarboxylate, 
bis(dibenzylideneacetone)palladium(0), and tris(o-tolyl)phosphine to give the 
phenyl ketone 156 in 70% yield (Scheme 51). According to Liebeskind, this type 
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of coupling proceeds via oxidative addition of the alkyl iodide to Pd(0) followed by 
substitution of thilate by iodide and subsequent release of tetrahydrothiophene.  
This eventually leads to an acyl complex with Pd, which upon reductive 
elimination with the phenyl group results in the ketone 156. 
 
 
 
Scheme 51. Cross coupling of thioester. 
2.11. Conclusions 
The above results demonstrate the obvious utility of thiomaleic anhydride as a 
central component in the synthesis of thiazines and benzothiazines by 
multicomponent couplings. Lactams, lactones, aldehydes, and ketones were 
accessed by free radical addition to thiomaleic anhydride followed by cyclization 
and subsequent thioacid coupling. The electron-deficient nature of the double 
bond of thiomaleic anhydride has been efficiently utilized in a Diels-Alder reaction 
to synthesize oxazatricyclodecanes. Thiomaleic anhydride has been established 
to be an excellent trap for functionalized alkyl radicals. Finally it is evident that 
cyclic monothioanhydrides provide a useful extension to the application of cyclic 
anhydrides in multicomponent coupling reactions developed previously by 
Shaw.111 
O O
S
O O O O
Ph
PhB(OH)2 , Pd(dba)2,
(p-tol)3P,
S CO2Cu
156, 70%
I
151
63 
 
CHAPTER 3 
Multicomponent coupling reactions with thioitaconic anhydrides 
3.1 Background 
After the successful demonstration of the use of monothiomaleic anhydride 
in multcomponent couplings, the focus was turned to multicomponent couplings 
involving a cyclic thioanhydride bearing an exocyclic olefin. Accordingly, the goal 
was to synthesize a number of substituted thioitaconic anhydrides and have  
them react with a binucleophilic species whose softer site would first undergo 
Michael addition to the alkene with subsequent ring closure onto the 
thioanhydride by the harder site. As before, the sequence would be completed by 
capture of the thioacid generated in the ring closure step (Scheme 52).  
 
 
Scheme 52. Synthesis of substituted thioitaconic anhydrides and their use 
in multicomponent coupling reactions. 
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3.2 Synthesis of Dihydro-3-(triphenylphosphoranylidene)-2,5-
thiophendione. 
Monothiomaleic anhydride was expected to undergo Michael addition with a 
soft nucleophile like a phosphine, based on the precedent observed between 
maleic anhydride and triphenylphosphine.123 In practice when monothiomaleic 
anhydride was treated with triphenylphosphine in glacial acetic acid Michael 
addition was followed by proton transfer to afford dihydro-3-
(triphenylphosphoranylidene)-2,5-thiophendione in good yield (Scheme 53). This 
reaction was extremely simple to perform and simple removal of the solvent gave 
a gum that was transformed into an essentially pure off-white solid on trituration 
with diethyl ether. 
 
 
Scheme 53. Synthesis of dihydro-3-(triphenylphosphoranylidene)-2,5-
thiophendione 
The ylide 157 has two distinct IR carbonyl absorptions at 1700 and 1611 cm-1, 
two distinctly different carbonyl chemical shifts in the 13C NMR spectrum, one at 
δ 205.6 and the second at δ 178.8 and a phosphorus chemical shift at δ 12.78 in 
31P NMR spectrum. 
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3.3 Synthesis of Monothioitaconic Anhydrides 
The ylide 157 subsequently was reacted with a selection of aromatic and 
aliphatic aldehydes at room temperature to give corresponding substituted 
monothioitaconic anhydrides as shown in Table 8. A typical procedure for this 
reaction involved mixing the ylide with an aldehyde at room temperature followed 
by simple chromatographic purification of the crude reaction mixture. 
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Table 8. Olefination reactions of dihydro-3-(triphenylphosphoranylidene)-
2,5-thiophendione. 
 
 
 
entry substrate  product % yield 
1 PhCHO S OO
Ph
158
 
78 
2 MeCHO S OO
Me
159
 
76 
3 C7H15CHO S OO
C7H15
160
 
72 
4 c-C3H5CHO S OO
161
 
84 
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The yields of all olefination reactions with aromatic as well as aliphatic aldehydes 
to afford corresponding thioitaconic anhydrides were good (Table 9). 
Benzaldehyde reacted as efficiently as its aliphatic counterparts giving the adduct 
158 in 78% yield (Table 8, entry 1). The employment of cyclopropane 
carboxaldehyde afforded the product 161 in 84% yield (Table 8, entry 4). All the 
olefination reactions attempted were highly stereoselective providing the E-
isomer as the only product. The assignment of olefin geometry in each case was  
based on the NOE correlations between the two sets of allylic protons (Ht and Ha) 
as shown in Figure 5. 
 
 
 
Figure 5. Diagnostic NOE correlations in E-thioitaconic anhydrides. 
 
3.4. Multicomponent Coupling Reactions of Alkylidene Monothiosuccinic 
Anhydrides with Mercaptoamines and 2,4-Dinitrobenzenesulfonamides. 
With a series of alkylidene monothiosuccinic anhydrides in hand, attention 
was turned to the proposed tandem Michael addition–nucleophilic ring opening 
processes with suitably constituted mercapto amines, with subsequent trapping 
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of the released thioacid by reaction with 2,4-dinitrobenzenesulfonamides. A 
series of reactions were conducted in which either 2-mercaptoaniline or 2-
mercaptoethylamine were treated with alkylidene monothiosuccinic anhydrides 
before the addition of cesium carbonate and a 2,4-dinitrobenzenesulfonamide 
leading, ultimately, to the isolation of a series of substituted 1,4-thiazepin-5-ones, 
or their benzo-fused analogues, as presented in Table 9. 
 
 
 
 
Table 9. Reactions of Alkylidene Monothiosuccinic Anhydrides with 
Mercaptoamines and 2,4-Dinitrobenzenesulfonamides. 
 
entry substrate aminothio
l 
sulfonamide 
(Ar = 
C6H3(NO2)2) 
product % 
yield 
(cis:tr
ans) 
ratio 
69 
 
1 S OO
Ph
158
 
 
 
 
72 
(1:5) 
2 S OO
Ph
158
 
 
 
 
76 
(1:5) 
3 S OO
Ph
158
 
 
 
 
65 
(1:4) 
4 S OO
Ph
158
 
 
 
 
67 
(1:4) 
70 
 
5 S OO
Me
159
 
 
 
 
74 
(1:1) 
6 S OO
Me
159
 
 
 
 
72 
(1:1) 
7 S OO
Me
159
 
 
 
 
58 
(1:1) 
8 S OO
Me
159
 
 
 
 
62 
(1:1) 
71 
 
9 S OO
C7H15
160
 
 
 
 
67 
(2:5) 
10 S OO
C7H15
160
 
 
 
 
61 
(2:5) 
11 S OO
161
 
 
 
 
57 
(2:3) 
12 S OO
161
 
 
 
 
60 
(2:3) 
 
As evident from the moderate to excellent yields, each of the coupling sequences 
reported in Table 9 proceeded well. Only the regioisomer, arising from ring 
closure of the amine onto the proximal carbonyl group after the conjugate 
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addition, with formation of the thiazepin nucleus, was isolated (Scheme 54). 
 
Scheme 54. Ring closure to form thiazepins 
The possibility that the product might be a thiazocine, such as  would arise from 
ring closure of the amine onto the distal carbonyl group after the conjugate 
addition (Scheme 54), was ruled out based on HMBC studies on compound 164 
(Figure 6). 
 
Figure 6. HMBC correlations diagnostic for thiazepin formation 
The observed HMBC correlation between the benzylic hydrogen and the ring 
carbonyl carbon Cr, and absence of a correlation to exocyclic carbonyl carbon CP 
established the ring size to be seven. For a thiazocine moiety, with an eight 
membered ring, the opposite would have been true.  
With respect to stereoselectivity, which was determined by a combination of 
3JHH coupling constants and NOE studies, the general trend in Table 9 indicates 
the couplings to be more selective with bulkier substitution on the olefin, favoring 
the trans over the cis isomer. In the case of the ethylidene monothiosuccinic 
anhydride (Table 9, entries 5-8) two diastereomeric isomers were formed in an 
approximate equimolar ratio and no attempt was made to separate the two 
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isomers. With moderately more bulky octylidene and cyclopropylidene systems 
160 and 161 (Table 9, entries 9-12) low to moderate selectivity was observed in 
favor of the trans–isomer, whereas in the case of the somewhat more hindered 
benzylidene system 158 the trans-isomer was typically favored by a factor of 4-
5:1 over the cis-isomer (Table 9, entries 1-4). This preferential formation of the 
trans-isomers, with selectivity increasing with the size of the olefinic substituent, 
can be attributed to the stereoselective protonation of the enolates bearing a 
stereogenic center β-to the incipient carbonyl group. Thus, following conjugate 
addition of the thiolate anion, the enolate adopts a conformation that minimizes 
A1,3 strain124,125 leading to protonation through either of transitions states A or B 
(Scheme 55). As the size of the alkene substitutent (R) increases transition state 
B is increasingly favored, resulting in overall increased trans-selectivity (Scheme 
73).  
 
 
Scheme 55. Model for stereoselective protonation en route to the 1,4-
thiazepin-5-ones. 
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3.5. Free Radical Addition Reactions of Thioitaconic Anhydrides. 
Having demonstrated the 1,4-addition sequence with aminothiols, attention 
was turned to the conjugate addition of functionalized carbon radicals and the 
preparation of piperidinone-based systems. A functionalized alkyl radical 
precursor N-(tert-butoxycarbonyl)-2-iodoethylamine 122 was prepared following 
the standard procedure discussed in Chapter 2, Section 6. Free radical addition 
to ethylidene succinic anhydride 165 was carried out in toluene at 90 oC with 
TTMS as the hydrogen atom donor and AIBN as the initiator (Scheme 56). 
 
 
Scheme 56. Free radical addition reaction to ethylidene succinic anhydride 
Upon chromatographic purification over silica gel a white gum was obtained in 
52% yield as a 3:1 mixture of diastereoisomers. The lesser yield as compared to 
that of monothiomaleic anhydride in a similar reaction, as presented in Chapter 2, 
Section 8, perhaps can be attributed to the less activated nature of the alkene in 
165 as compared to that in monothiomaleic anhydride. The sense of 
diastereoselectivity was determined based on 13C analysis of the final cyclized 
product as discussed below. The isolated thiosuccinic anhydride moieties have 
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characteristic carbonyl IR absorption peaks at 1709 cm-1 and chemical shifts at δ 
203 and 199.9 in 13C NMR spectra consistent with the assigned structures.  
3.5.1. Heterocycle Synthesis from the Free Radical Adduct 
Subsequent treatment of this mixture of diastereomers with trifluoroacetic 
acid removed the tert-butyloxycarbonyl protecting groups resulting, after removal 
of the acid under vacuum and treatment with base, in the cyclization of the 
liberated amine onto the proximal carbonyl carbon and the formation of the 
piperidinone skeleton bearing a thioacid. Without isolation, this last species was 
captured by reaction with electron-deficient sulfonamides resulting overall in the 
piperidinonyl acetamides 177 and 178 (Scheme 57). 
 
 
 
Scheme 57. Removal of Boc groups, cyclization and subsequent amide 
bond formation 
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The use of a 3:1 mixture of diastereomeric thioanhydrides derived from free 
radical addition resulted in the formaton of a 3:1 mixture of piperidinones 177 and 
178 (Scheme 57). The ring size of the resulting piperidinones were assigned 
based on the observed chemical shift at δ 174 in 13C NMR spectra and a IR 
carbonyl absorption at around 1640 cm-1, which accord well with the reported 
values for δ-lactams.126 The stereochemistry of the resulting piperidinone 
moieties were determined following the 13C NMR analysis described by Crews for 
a series of 2,3-disubstituted cyclohexanones based on the well-known γ-gauche 
effect.127 Thus, the methyl group at the β-carbon in the piperidinone ring 
experiences an upfield shift in the 13C NMR spectrum in the cis series relative to 
the corresponding trans isomer (Figure 7).  
 
 
 
Figure 7. Diagnostic chemical shifts for stereochemical assignment of 
piperidinones 177 and 178 
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3.6. Conclusions 
Thioitaconic anhydrides are readily prepared and function as good Michael 
acceptors for thiols as is evident from the success of the multicomponent 
coupling reactions developed in this chapter. However; they display lower affinity 
for nucleophilic radicals than thiomaleic anhydride presumably because of their 
less electron-deficient nature. Overall, the readily accessible thioitaconic 
anhydrides gave rapid access to a series of thiazepinones and piperidinones, 
each carrying a pendant amide group, through a series of very simple 
multicomponent coupling reactions. 
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CHAPTER 4 
EXPERIMENTAL 
General Procedure form multicomponent coupling reactions  
Method-A: General procedure for three component coupling of 
thiomaleic anhydrides with aminothiols and 2,4-
dinitrobenzenesulfonamides (Table 2). Aminothiol (0.41 mmol, 1.0 equiv) was 
added to a stirred solution of maleic thioanhydride (0.5 mmol, 1.2 equiv) in 1 mL 
DMF at 0 oC. The reaction mixture turned purple and further deepened in color 
as it was warmed to room temperature. The reaction mixture was allowed to stir 
for 1 h then cooled to 0 ºC and Cs2CO3 (0.5 mmol, 1.2 equiv) was added, 
followed immediately by the sulfonamide (0.4 mmol, 1.0 equiv). The reaction 
mixture was allowed to warm to room temperature and stirred for a further 3 h. 
The solvent was then removed under vacuum and the crude reaction mixture 
was dissolved in EtOAc, washed with saturated aqueous NaHCO3 solution 
followed by brine and dried over Na2SO4. The product was purified by silica gel 
column chromatography.  
Method-B: General procedure for three component coupling of 
thiomaleic anhydrides with aminothiols and amines promoted by Sanger’s 
reagent (Table 3). Aminothiol (0.4 mmol, 1.0 equiv) was added to a stirred 
solution of maleic thioanhydride (0.5 mmol, 1.2 equiv) in 1 mL DMF at 0 oC. The 
reaction turned purple, which deepened as it was warmed to room temperature. 
The reaction mixture was allowed to stir for 1 h, then cooled to 0º C and (0.5 
mmol, 1.2 equiv) Cs2CO3 was added, followed immediately by Sanger’s reagent 
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(1-fluoro-2,4-dinitrobenzene) (0.4 mmol, 1.0 equiv). The reaction mixture was 
allowed to warm to room temperature and stirred for 5 mins. Then amine (0.4 
mmol, 1.0 equiv) was added and stirred for further 3 h.  The solvent was then 
removed under vacuum and the crude reaction mixture was dissolved in EtOAc, 
washed with saturated aqueous NaHCO3 solution followed by brine and dried 
over Na2SO4. The product was purified by silica gel column chromatography. 
2-(2,3-Dihydrobenzo-1,4-thiazin-3-on-2-yl)acetyl piperidine (102). 
Chromatographic purification eluting with 70% EtOAc/hexanes afforded a light 
yellow oil in 59% yield (Method-A) or 51% yield (method-B, which employed 2.0 
equiv of Cs2CO3 instead of 1.2 equiv to liberate amine from the corresponding 
hydrochloride salt). 1H NMR (400 MHz, CDCl3): δ 9.00 (br. s, 1H), 7.29 (dd, J = 
1.6, 8.0 Hz, 1H), 7.15 (dt, J = 1.6, 9.0 Hz, 1H), 6.99 (dt, J =1.6, 7.4 Hz, 1H), 6.89 
(dd, J = 1.6, 8.0 Hz, 1H), 4.19 (dd, J = 4.8, 8.0 Hz, 1H), 3.65-3.50 (m, 2H), 3.41-
3.32 (m, 2H), 3.10 (dd, J = 4.8, 16.0 Hz, 1H), 2.57 (dd, J = 8.0, 16.0 Hz, 1H), 
1.67-1.58 (m, 2H), 1.58-1.52 (m, 4H); 13C NMR (100 MHz, CDCl3): δ 168.0, 
167.3, 136.2, 128.2, 127.4, 124.0, 120.0, 117.3, 46.8, 43.4, 38.5, 32.6, 26.6, 25.7, 
24.7; ESIHRMS: m/z calcd. for C15H18N2O2S (M + Na)+ 313.0987, found 
313.0995. 
N-(1-Methoxycarbonyl-1-methylethyl) 2-(2,3-dihydrobenzo-1,4-thiazin-
3-on-2-yl) acetamide (103). Chromatographic purification eluting with 70% 
EtOAc/hexanes afforded a light yellow solid in 67% yield (method-A) or 53% yield 
(method-B, which employed 2.0 equiv of Cs2CO3 instead of 1.2 equiv to liberate 
amine from the corresponding hydrochloride salt). Mp: 173.9-174.4 oC; 1H NMR 
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(400 MHz, CDCl3): δ 9.27 (br. d, J = 20.8 Hz , 1H), 7.26 (d, J = 8.8 Hz, 1H), 7.15 
(t, J = 7.2 Hz, 1H), 6.98 (t, J = 7.0 Hz, 1H), 6.92 (d, J = 7.2 Hz, 1H), 6.68 (br. s, 
1H), 3.98 (t, J = 6.8 Hz, 1H), 3.71 (s, 3H), 2.91 (dd, J = 6.4, 14.4 Hz, 1H), 2.47 
(dd, J = 7.0, 15.0 Hz, 1H), 1.54 (s, 6H); 13C NMR (100 MHz, CDCl3): δ 175.2, 
168.6, 168.0, 136.1, 128.1, 127.5, 124.2, 119.9, 117.5, 56.9, 52.9, 38.4, 36.1, 
24.9; ESIHRMS: m/z calcd. for C15H18N2O4S (M + Na)+ 345.0885, found 
345.0896. 
2-(5-Ethoxycarbonyl-2,3,5,6-tetrahydro-1,4-thiazin-3-on-2-yl)acetyl 
piperidine (104). Chromatographic purification eluting with 3% 
methanol/dichloromethane afforded a light yellow oil with 72% yield (method-A) 
or 65% yield (method-B) with 3:1 cis/trans selectivity. Cis: [α]24D = +45.3 (c = 1.0, 
CHCl3) ; 1H NMR (400 MHz, CDCl3): δ 6.44 (br. s, 1H), 4.36 (dt, J = 3.6, 10.4 Hz, 
1H), 4.26 (q, J = 7.2 Hz, 2H), 4.11 (dd, J = 14, 18 Hz, 1H), 3.61-3.49 (m, 2H), 
3.46-3.35 (m, 2H), 3.24 (dd, J = 4.0, 12.0 Hz, 1H), 3.18 (dd, J = 12.0, 14.0 Hz, 
1H), 2.96 (dd, J = 9.6, 12.0 Hz, 1H), 2.54 (dd, J = 18.0, 21.0 Hz, 1H), 1.65-1.50 
(m, 6H), 1.29 (t, J = 7.4 Hz, 3H) ; NOE correlation between H1 (δ 4.36) and H4 (δ 
4.11) was found in 2-D H-H NOESY spectra; 13C NMR (100 MHz, CDCl3): δ 
169.8, 169.1, 167.9, 62.8, 55.7, 46.7, 43.2, 37.6, 34.6, 29.6, 26.5, 25.7, 24.7, 
14.3; ESIHRMS: m/z calcd. for C14H22N2O4S (M + Na)+ 337.1198, found 
337.1208. 
Trans: [α]24D = -41.2 (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3): δ 6.31 (br. s, 
1H), 4.47 (dd, J = 2.8, 16.4 Hz, 1H), 4.26 (q, J = 6.8 Hz, 2H), 3.99 (dd, J = 3.2, 
8.4 Hz, 1H), 3.63-3.44 (m, 2H), 3.44-3.32 (m, 2H), 3.22 (dd, J = 4.0, 14.0 Hz, 1H), 
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3.10 (dd, J = 3.6, 16.4 Hz, 1H), 3.01 (dd, J = 9.0, 13.4 Hz, 1H), 2.83 (dd, J = 7.6, 
16.8 Hz, 1H), 1.67-1.50 (m, 6H), 1.29 (t, J = 8.2 Hz); no NOE correlation between 
H1 (δ 4.47) and H4 (δ 3.99) was found in 2-D NOESY spectra; 13C NMR (125 MHz, 
CDCl3): 169.2, 169.2, 167.7, 62.6, 57.9, 46.7, 43.2, 38.5, 36.2, 28.2, 26.5, 25.7, 
25.7, 24.8, 24.7, 14.3;  ESIHRMS: m/z calcd. for C14H22N2O4S (M + Na)+ 
337.1198, found 337.1214. 
N-(1-Ethoxycarbonyl-1-methylethyl) 2-(5-ethoxycarbonyl-2,3,5,6-
tetrahydro-1,4- thiazin-3-on-2-yl)acetamide (105). Chromatographic 
purification eluting with 3% methanol/dichloromethane afforded a light yellow oil 
in 63% yield (method-A) or 70% yield (Method-B, which employed 2.0 equiv of 
Cs2CO3 instead of 1.2 equiv to liberate amine from the corresponding 
hydrochloride salt) with 3:1 cis/trans selectivity. Cis: [α]24D = +28.4 (c = 1.0, 
CHCl3) ; 1H NMR (400 MHz, CDCl3): δ 6.62 (br. s, 1H), 6.44 (br. s, 1H), 4.34-4.24 
(m, 3H),  3.94 (t, J = 6.4 Hz, 1H), 3.72 (s, 3H), 3.27 (dd, J = 4.0, 12.0 Hz, 1H), 
3.00-2.90 (m, 2H), 2.41 (dd, J = 5.6, 15.8 Hz, 1H), 1.53 (s, 6H), 1.30 (t, J = 7.4, 
3H) ; NOE correlation between H1 (δ 4.32) and H4 (δ 3.94) was found in 2-D H-H 
NOESY spectra; 13C NMR (100 MHz, CDCl3): δ 175.1, 169.8, 169.2, 168.9, 62.9, 
56.8, 55.4, 52.8, 37.9, 37.6, 29.9, 24.9, 14.3 ; ESIHRMS: m/z calcd. for 
C14H22N2O6S (M + Na)+ 369.1096, found 369.1103. 
Trans: [α]24D = -19.8 (c = 1.0, CHCl3) ; 1H NMR (400 MHz, CDCl3): δ 6.60 (br. s, 
1H), 6.30 (br. s, 1H), 4.44-4.40 (m, 1H), 4.26 (q, J = 6.8 Hz, 2H), 3.89 (t, J = 6.0 
Hz, 1H), 3.73 (s, 3H), 3.18 (dd, J = 4.0, 13.6 Hz, 1H), 3.00 (dd, J = 9.0, 13.8 Hz, 
1H), 2.91 (dd, J = 5.6, 15.6 Hz, 1H), 2.60 (dd, J = 6.4, 14.8 Hz, 1H), 1.54 (s, 6H), 
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1.30 (t, J = 7.0 Hz, 3H) ; no NOE correlation between H1 (δ 4.42) and H4 (δ 3.89) 
was found in 2-D NOESY spectra; 13C NMR (125 MHz, CDCl3): δ 175.2, 169.0, 
62.7, 58.0, 56.8, 52.9, 39.1, 28.2, 24.9, 24.9, 14.3; ESIHRMS: m/z calcd. for 
C14H22N2O6S (M + Na)+ 369.1096, found 369.1107.  
cis and trans-2-(5R-5-Ethoxycarbonyl-6,6-dimethyl-2,3,5,6-tetrahydro-
1,4- thiazin-3-on-2-yl)acetyl piperidine (106).  Cs2CO3 (1 equiv) was added to 
liberate penicillamine from corresponding hydrochloride salt and stirred overnight 
instead of 1 h. Chromatographic purification eluting with 3% 
methanol/dichloromethane afforded a light yellow oil with 53% yield (method-A) 
or 46% yield (method-B) with 3:1 cis/trans selectivity. Cis: [α]24D = -65.0 (c = 1.0, 
CHCl3); 1H NMR (400 MHz, CDCl3): δ 6.48 (br. d, J = 3.2 Hz, 1H), 4.27 (t, J = 6.4 
Hz, 1H), 4.23 (d, J = 4.0 Hz, 1H), 3.83 (s, 3H), 3.60-3.49 (m, 2H), 3.49-3.37 (m, 
2H), 3.16 (dd, J = 6.6, 16.2 Hz, 1H), 2.34 (dd, J = 6.6 16.2 Hz, 1H), 1.67-1.47 (m, 
9H), 1.24 (s, 3H); irradiation at H1 (δ 4.27) produced 14.4% enhancement at H4 
(δ 4.23); 13C NMR (125 MHz, CDCl3): δ 170.7, 168.7, 167.9, 63.1, 53.2, 50.2, 
46.7, 43.3, 38.1, 32.5, 29.6, 26.5, 26.4, 25.7, 24.7; ESIHRMS: m/z calcd. for 
C15H24N2O4S (M + Na)+ 351.1354, found 351.1357.  
Trans (Trans/Cis 4:1 mixture) : 1H NMR (500 MHz, CDCl3): δ 6.29 (br. s, 1H), 
4.51 (s, 1H), 4.19 (dd, J = 3.0, 8.5 Hz, 1H), 3.82 (s, 3H), 3.64-3.48 (m, 2H), 3.42-
3.32 (m, 2H), 3.18-3.10 (m, 1H), 3.05 (s, 1H), 2.97 (s, 1H), 2.83 (dd, J = 8.5, 15.5 
Hz, 1H), 1.68-1.50 (m, 15 H), 1.45 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 169.2, 
169.0, 167.6, 67.0, 53.0, 46.6, 43.2, 43.0, 37.7, 36.4, 27.2, 26.5, 25.7, 24.7, 23.9; 
ESIHRMS: m/z calcd. for C15H24N2O4S (M + Na)+ 351.1354, found 351.1368. 
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Ethyl (3R)-2-dimethyl-5-oxo-6-[2’-(1”-ethoxycarbonyl-1”-
methylethylamino)-2’- oxoethyl]-2,3,5,6-tetrahydro-1,4-thiazin-3-
ylcarboxylate (107). Cs2CO3 (1 equiv) Was added to liberate penicillamine from 
corresponding hydrochloride salt and stirred overnight instead of 1 h. 
Chromatographic purification eluting with 3% methanol/dichloromethane afforded 
a light yellow oil in 41% yield (method-A) or 53% yield (method-B, which 
employed 2.0 equiv of Cs2CO3 instead of 1.2 equiv to liberate amine from the 
corresponding hydrochloride salt) with 3:1 cis/trans selectivity. Cis: [α]24D = -43.2 
(c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3): δ 6.70 (s, 1H), 6.54 (br. d, J = 3.6 
Hz, 1H), 4.15 (d, J = 5.2 Hz, 1H), 4.02 (dd, J = 4.8, 8 Hz, 1H), 3.84 (s, 3H), 3.71 
(s, 3H), 2.86 (dd, J = 8.2, 14.6 Hz, 1H), 2.27 (dd, J = 4.0, 14.4 Hz, 1H), 1.60 (s, 
3H), 1.53 (s, 3H), 1.51 (s, 3H), 1.23 (s, 3H); NOE correlation between H1 (δ 4.15) 
and H4 (δ 4.02) was found in 2-D H-H NOESY spectra; 13C NMR (125 MHz, 
CDCl3): δ 175.1, 170.8, 169.4, 168.5, 62.9, 56.7, 53.3, 52.8, 50.4, 38.3, 36.0, 
29.7, 26.4, 24.9; ESIHRMS: m/z calcd. for C15H24N2O6S (M + Na)+ 383.1253, 
found 383.1263. 
Trans: [α]24D = +38.8 (c = 0.5, CHCl3) ; 1H NMR (500 MHz, CDCl3): δ 6.65 (br. s, 
1H), 6.29 (br. s, 1H), 4.43 (d, J = 1.0 Hz, 1H), 4.12 (t, J = 6.0 Hz, 1H), 3.82 (s, 
3H), 3.74 (s, 3H), 2.88 (dd, J = 5.5, 15.0 Hz, 1H), 2.58 (dd, J = 6.5, 15.0 Hz, 1H), 
1.56 (s, 3H) 1.55 (s, 3H), 1.53 (s, 3H), 1.44 (s, 3H); no NOE correlation between 
H1 (δ 4.43) and H4 (δ 4.12) was found in 2-D H-H NOESY spectra; 13C NMR (125 
MHz, CDCl3): δ 175.2, 168.9, 168.9, 67.2, 56.9, 53.1, 52.8, 42.8, 39.1, 37.6, 27.3, 
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24.9, 23.7; ESIHRMS: m/z calcd. for C15H24N2O6S (M + Na)+ 383.1253, found 
383.1270. 
O-tert-Butyl rel-(1R,2S,6R,7S)-N-10-oxa-3,5-dioxo-4-
thiatricyclo[5.2.1.02,6]- dec-8-en-1-ylmethyl carbamate (111). O-tert-Butyl N-
(furan-2-ylmethyl) carbamate (34, 0.050 g, 0.25 mmol, 1 equiv) was mixed with 
maleic thioanhydride (0.172 g, 1.5 mmol, 6 equiv) in 1 mL dry benzene and the 
reaction mixture was stirred for 4 days at room temperature under N2. The solvent 
was removed and chromatographic purification eluting with 30% EtOAc/Hexanes 
afforded 0.053 g product, in 68% yield. 1H NMR (500 MHz, CDCl3): δ 6.56 (s, 2H), 
5.33 (s, 1H), 5.08 (s, 1H), 3.82-3.72 (m, 2H), 3.45 (d, J = 6.5 Hz, 1H), 3.33 (d, J = 
6.5 Hz, 1H), 1.46 (s, 9H);  13C NMR (125 MHz, CDCl3): δ 199.8, 199.6, 156.1, 
139.7, 138.0, 93.1, 83.3, 80.1, 63.3, 61.0, 40.0, 28.5; ESIHRMS: m/z calcd. for 
C14H17NO5S (M + Na)+ 334.0725, found 334.0729. Because of the retro Diels-
Alder reaction the isolated compound was not stable and the NMR spectra are 
contaminated with the fragmentation products. 
O-tert-Butyl rel-(1R,2S,6R,7S)-N-10-oxa-3,5-dioxo-4-
thiatricyclo[5.2.1.02,6] decan-1-ylmethyl carbamate (112). Diels-Alder adduct 
35 (0.120 g, 0.385 mmol, 1 equiv) was dissolved in 1,2-dimethoxyethane (15 mL) 
and Raney Ni slurry (1 equiv) in dioxane (5 mL) was added to it under H2 gas 
and stirred for 4 hours. Reaction mixture was filterated through celite and washed 
with ethyl acetate. Filtrate was concentrated and chromatographic purification  
eluting with 20 % EtOAc/hexanes afforded 36 (113 mg, 94%) as a white solid. IR 
(film): 1698 cm-1 (νC=O); mp: 167.8-168.3 ºC; 1H NMR (500 MHz, CDCl3): δ 5.07 
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(br. s, 1H), 4.96 (d, J = 5.5 Hz, 1H), 3.81 (dd, J = 7.5, 11.5 Hz, 1H), 3.55 (dd, J = 
5.7, 15.2 Hz), 3.38 (d, J=8.0 Hz, 1H), 3.32 (d, J = 7.5 Hz, 1H), 2.04-1.95 (m, 1H), 
1.95-1.85 (m, 1H), 1.70-1.64 (m, 2H), 1.46 (s, 9H); irradiation at δ 3.38 produced 
2.55% NOE enhancement at δ 1.70-1.67 and irradiation at 3.32 produced 2.55% 
enhancement at δ 1.66-1.64; 13C NMR (125 MHz, CDCl3): δ 202.2, 202.0, 156.1, 
90.1, 81.2, 79.9, 64.1, 63.2, 41.8, 32.6, 29.7, 28.6; ESIHRMS: m/z calcd. for 
C14H19NO5S (M + Na)+ 336.0882, found 336.0866. 
General Procedure for (113) and (114).  Thioanhydride 111 or 112 (0.12 
mmol, 1 equiv) was dissolved in 7.5 mL dichloromethane and cooled down to 0 
ºC, then 2.5 mL TFA was dropwise added to it and stirred for 40 min at room 
temperature. The solvent was then removed after addition of toluene (5 mL). The 
crude reaction mixture was dissolved in dichloromethane (20 mL) and 2,4,6-
collidine (0.255 mmol, 2 equiv) was dropwise added to it at 0 ºC and stirred for 2 
h. Then solvent was removed under vacuum and crude reaction mixture was 
dissolved in DMF (2 mL) and cooled down to 0 ºC. Cs2CO3 (0.15 mmol, 1.2 
equiv) followed by N-[(2,4-dinitrophenyl)sulfonyl] phenylethylamine (0.19 mmol, 
1.5 equiv) was added to it and heated to room temperature. The reaction mixture 
was allowed to stir for 1 h, and then solvent was removed under vacuum. The 
crude reaction mixture was dissolved in EtOAc (20 mL) and was washed with 
water followed by brine solution and dried over Na2SO4. Product was purified by 
silica gel column chromatography. 
rel-(1R,5S,6R,7S)-N-Phenethyl-3-aza-10-oxa-4-
oxotricyclo[5.2.1.01,5]dec-8-en-6-ylcarboxamide (113). Chromatographic 
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purification eluting with 3% methanol/dichloromethane afforded a light yellow 
solid in 63% yield, IR (film): 1699 and 1652 cm-1 (νC=O); mp: 156.1-156.6 ºC; 1H 
NMR (500 MHz, CDCl3): δ 7.32-7.28 (m, 2H), 7.24-7.20 (m, 3H), 6.68 (br. s, 1H), 
6.51 (d, J = 5.5 Hz, 1H), 6.41 (dd, J = 1.5, 5.5 Hz, 1H), 5.71 (br. s, 1H), 6.15 (d, J 
= 1.5 Hz, 1H), 3.91 (d, J = 11.5 Hz, 1H), 3.70 (dd, J = 1.0, 11.5 Hz, 1H), 3.58-
3.46 (m, 2H), 2.89-2.78 (m, 2H), 2.67 (d, J = 0.5 Hz); 13C NMR (125 MHz, 
CDCl3): δ 173.9, 171.0, 139.4, 136.5, 135.8, 129.1, 128.7, 126.5, 91.9, 82.8, 50.0, 
46.9, 44.2, 40.9, 35.4; ESIHRMS: m/z calcd. for C17H18N2O3(M + Na)+ 321.1215, 
found 321.1213. 
rel-(1R,5S,6R,7S)-N-phenethyl-3-aza-10-oxa-4-
oxotricyclo[5.2.1.01,5]decan-6- ylcarboxamide (114). Chromatographic 
purification eluting with 3% methanol/dichloromethane afforded a light yellow 
solid in 84% yield, IR (film): 1700 and 1654cm-1 (νC=O); mp: 220.1-220.6 ºC; 1H 
NMR (500 MHz, CDCl3): δ 7.33-7.28 (m, 2H), 7.24-7.20 (m, 3H), 6.57 (br. s, 1H), 
5.73 (br. s, 1H), 4.69 (d, J = 6.0 Hz, 1H), 3.58 (dd, J = 11.7, 14.2 Hz, 2H), 3.48 
(dd, J = 7, 13 Hz, 2H), 2.96 (d, J = 10.0 Hz, 1H), 2.87 (d, J = 9.5 Hz, 1H), 2.84-
2.76 (m, 2H), 2.03-1.96 (m, 1H), 1.80-1.74 (m, 2H), 1.62-1.57 (m, 1H); 13C NMR 
(125 MHz, CDCl3): δ 174.7, 171.3, 139.4, 129.1, 128.7, 126.5, 89.6, 80.5, 54.5, 
53.2, 44.5, 40.7, 35.3, 29.9, 29.2; ESIHRMS: m/z calcd. for C17H20N2O3(M + Na)+ 
323.1372, found 323.1371. 
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General procedure for Boc-protected alkyl iodide preparation. 
Following the literature procedure, iodine (305 mg, 1.2 mmol) was added portion-
wise to a stirred mixture of triphenylphosphine (262 mg, 1 mmol) and imidazole 
(62 mg, 1 mmol) in dichloromethane (10 mL) under N2, at room temperature. The 
reaction mixture was stirred for 5 min, then the alcohol (1 mmol) in 
dichloromethane (2 mL) was added to it drop-wise. Stirring was continued for 2 h 
before the reaction mixture was washed successively with water, saturated 
sodium thiosulfate solution and brine, and dried over Na2SO4. Concentration of 
the organic layer was followed by purification by silica gel column 
chromatography give the target iodides. 
O-tert-Butyl N-[2-(iodomethyl)phenyl] carbamate (123). 
Chromatographic purification over silica gel eluting with 10% EtOAc/hexanes 
afforded a light yellow oil in 62 % yield. 1H NMR (500 MHz, CDCl3): δ 7.77 (d, J = 
8 Hz, 1H), 7.32-7.29 (m, 2H), 7.06-7.03 (m, 1H), 6.44 (br s, 1H), 4.40 (s, 2H), 
1.56 (s, 9H); 13C NMR (125 MHz, CDCl3): 13C NMR (125 MHz, CDCl3): δ 153.3, 
136.8, 130.0, 129.9, 129.0, 124.8, 123.8, 81.5, 28.8, 3.9; ESIHRMS: m/z Calcd. 
for C12H16INO2Na (M + Na)+ 356.0123, found 356.0093. 
tert-Butyl 2-iodoethyl carbonate (124). Chromatographic purification over 
silica gel eluting with 10% EtOAc/hexanes afforded a light yellow oil in 82 % yield. 
1H NMR (500 MHz, CDCl3): δ 4.25 (t, J = 7 Hz, 2H), 3.24 (t, J = 7 Hz, 2H), 1.43 (s, 
9H); 13C NMR (125 MHz, CDCl3): δ 152.8, 82.5, 66.8, 27.7, 0.0; ESIHRMS: m/z 
Calcd. for C7H13O3I Na (M + Na)+ 294.9807, found 294.9819. 
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tert-Butyl 3-iodopropyl carbonate (125). Chromatographic purification 
over silica gel eluting with 10% EtOAc/hexanes afforded a light yellow oil in 88 % 
yield. 1H NMR (500 MHz, CDCl3): δ 4.12 (t, J = 6 Hz, 2H), 3.23 (t, J = 6.7 Hz, 2H), 
2.16 (p, J = 6.5 Hz, 2H), 1.48 (s, 9H); 13C NMR (125 MHz, CDCl3): δ 151.9, 80.9, 
65.1, 31.1, 26.4, 0.0; ESIHRMS: m/z Calcd. for C8H15O3INa (M + Na)+ 308.9964, 
found 308.9965. 
General procedure for free radical addition to monothiomaleic 
anhydride. Tris(trimethylsilyl)silane (373 mg, 1.5 mmol) and AIBN (33 mg, 0.2 
mmol) in dry degassed toluene (3 mL) were added drop-wise to a stirred mixture 
of alkyl iodide (1 mmol) and thiomaleic anhydride (228 mg, 2 mmol) in dry 
degassed toluene (5 mL) at 90 oC over 3 h by syringe pump under a N2 
atmosphere. Simultaneously, thiomaleic anhydride (342 mg, 3 mmol) in dry 
degassed toluene (2 mL) was added to the reaction mixture separately by 
syringe pump over 3 h. When the addition was complete, the reaction mixture 
was allowed to stir for an additional 1 h at 90 oC before it was cooled to room 
temperature and the solvent was removed under vacuum. Purification was 
achieved by rapid chromatography of the concentrate over silica gel that had 
been pre-washed with acetone followed by hexanes.  
2-(2-tert-Butyloxycarbonylaminoethyl)succinic thioanhydride (126). 
Rapid chromatographic purification over silica gel, pre-washed with acetone 
followed by hexanes, eluting with 30% EtOAc/hexanes afforded a colorless oil in 
82% yield. IR (film): 1709 cm-1; 1H NMR (500 MHz, CDCl3): δ 4.67 (br s, 1H), 
3.32-3.21 (m, 4H), 2.88 (dd, J = 5.7, 16.7 Hz, 1H), 2.16-2.09 (m, 1H), 1.89-1.82 
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(m, 1H), 1.44 (s, 9H); 13C NMR (125 MHz, CDCl3): δ 203.4, 199.1, 156.2, 80.0, 
50.6, 47.0, 38.3, 32.3, 28.6; ESIHRMS: m/z Calcd. for C11H17O4SNa (M + Na)+ 
282.0776, found 282.0767. 
2-(3-tert-Butyloxycarbonylaminopropyl)succinic thioanhydride (127). 
Rapid chromatographic purification over silica gel, pre-washed with acetone 
followed by hexanes, eluting with 30% EtOAc/hexanes afforded a colorless oil in 
92 % yield. IR (film): 1709 cm-1 (νC=O); 1H NMR (500 MHz, CDCl3): δ 4.62 (br s, 
1H), 3.24-3.12 (m, 4H), 2.78 (dd, J = 9.7, 21.2 Hz, 1H), 2.01-1.94 (m, 1H), 1.69-
1.54 (m, 3H), 1.43 (s, 9H); 13C NMR (125 MHz, CDCl3): δ 203.0, 199.4, 154.2, 
79.6, 52.5, 47.1, 28.9, 28.6, 27.8; ESIHRMS: m/z Calcd. for C12H19O4S Na (M + 
Na)+ 296.0932, found 296.0923. 
2-[2-(tert-Butyloxycarbonylamino)-2-(methoxycarbonyl)ethyl]succinic 
thioanhydride (128). Rapid chromatographic purification over silica gel, pre-
washed with acetone followed by hexanes, eluting with 30% EtOAc/hexanes 
afforded a colorless oil in 85 % yield as a 1:1 inseparable diastereomeric mixture. 
IR (film): 1708 cm-1; 1H NMR (500 MHz, CDCl3): δ 5.16 (br s, 1H), 4.45 (br d, J = 
6.5 Hz, 0.5H), 4.36 (br s, 0.5H), 3.78 (s, 3H), 3.47-3.41 (m, 0.5H), 3.39-3.35 (m, 
0.5H), 3.33-3.27 (m, 0.5H), 3.24 (dd, J = 9, 16.5 Hz, 0.5H), 3.02-2.96 (m, 0.5H), 
2.91 (dd, J = 7.5, 18 Hz, 0.5H), 2.54 (td, J = 5.5, 14.5 Hz, 0.5H), 2.36-2.30 (m, 
0.5H), 2.13-2.03 (m, 1H), 1.45 (s, 9H); 13C NMR (125 MHz, CDCl3): δ 202.8, 
198.5, 172.1, 155.8, 155.4, 80.9, 53.1, 53.0, 51.9, 51.8, 50.2, 50.0, 47.0, 46.3, 
35.1, 33.9, 28.5; ESIHRMS: m/z Calcd. for C13H19NO6SNa (M + Na)+ 340.0831, 
found 340.0833. 
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2-[(2-tert-Butyloxycarbonylaminophenyl)methyl]thiosuccinic anhydride 
(129). Rapid chromatographic purification over silica gel, pre-washed with 
acetone followed by hexanes, eluting with 30% EtOAc/hexanes afforded a 
colorless oil in 70 % yield. IR (film): 1708 cm-1; 1H NMR (500 MHz, CDCl3): δ 
7.62 (d, J = 7.5 Hz, 1H), 7.30-7.26 (m, 1H), 7.13 (dd, J = 1, 5 Hz, 2H), 6.45 (br s, 
1H), 3.58-3.51 (m, 1H), 3.33 (dd, J = 4.5, 14.5 Hz, 1H), 3.07 (dd, J = 8.5, 18.0 Hz, 
1H), 2.91 (dd J = 8.5, 14.5 Hz, 1H), 2.88 (dd, J = 7.0, 18.0 Hz, 1H), 1.53 (s, 9H); 
13C NMR (125 MHz, CDCl3): δ 203.3, 198.4, 153.8, 136.2, 130.5, 129.7, 128.5, 
125.6, 125.1, 81.1, 53.1, 46.5, 32.5, 28.5; ESIHRMS: m/z Calcd. for 
C16H19NO4SNa (M + Na)+ 344.0932, found 344.0930. 
2-(2-tert-Butyloxycarbonyloxyethyl)succinic thioanhydride (130). Rapid 
chromatographic purification over silica gel, pre-washed with acetone followed by 
hexanes, eluting with 30% EtOAc/hexanes afforded a colorless oil in 79 % yield.  
IR (film): 1737 and 1709 cm-1; 1H NMR (500 MHz, CDCl3): δ 4.26-4.16 (m, 2H), 
3.37-3.31 (m, 1H), 3.27 (dd, J = 9.0, 17.5 Hz, 1H), 2.87 (dd, J = 7.5, 17.5 Hz, 1H), 
2.43-2.36 (m, 1H), 1.97-1.90 (m, 1H), 1.49 (s, 9H); 13C NMR (125 MHz, CDCl3): δ 
202.5, 198.8, 153.4, 82.9, 64.3, 50.1, 47.0, 30.5, 28.0;  ESIHRMS: m/z Calcd. for 
C11H16O5SNa (M + Na)+ 283.0616, found 283.0623. 
2-(2-tert-Butyloxycarbonyloxypropyl)succinic thioanhydride (131). 
Rapid chromatographic purification over silica gel, pre-washed with acetone 
followed by hexanes, eluting with 30% EtOAc/hexanes afforded a colorless oil in 
82% yield. IR (film): 1737 and 1709 cm-1; 1H NMR (500 MHz, CDCl3): δ 4.10 (t, J 
= 6 Hz, 2H), 3.25-3.19 (m, 2H), 2.78 (dd,  J = 9.5, 20.5 Hz, 1H), 2.08-2.02 (m, 
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1H), 1.82-1.72 (m, 3H), 1.49 (s, 9H); 13C NMR (125 MHz, CDCl3): δ 202.7, 199.2, 
153.7, 82.6, 66.1, 52.4, 47.0, 28.4, 27.9, 26.5; ESIHRMS: m/z Calcd. for 
C12H18O5SNa (M + Na)+ 297.0773, found 297.0760. 
General procedure for heterocycle synthesis from the radical adducts. 
To a stirred solution of the radical adduct (1 mmol) in dicholoromethane (20 mL) 
at 0 oC, TFA (5 mL) was added drop-wise. Stirring was maintained for 40 min 
before TFA was removed by azeotropic distillation with toluene (5 mL x 3), after 
which the residue was dried under vacuum. For amino thioanhydrides the 
residue was dissolved in DMF (20 mL) and cooled down to 0 oC before 2,4,6-
collidine (182 mg, 1.5 mmol) was drop-wise added and the reaction mixture was 
stirred for 1 h at 0 oC. For hydroxy thioanhydrides the residue was dissolved in 
DMF (20 mL) and the reaction mixture was stirred overnight at room temperature. 
For both amino thioanhydrides and hydroxy thioanhydrides, the resulting reaction 
mixture was cooled to 0 oC and Cs2CO3 (391 mg, 1.2 mmol) followed by 
sulfonamide (1.2 mmol) was added before the reaction mixture was warmed to 
room temperature and stirred for 1.5 h. The solvent was removed under vacuum 
and the residue was dissolved in EtOAc (50 mL) and the organic layer was 
washed successively with water and brine, dried over Na2SO4, concentrated and 
purified by silica gel column chromatography. 
N-[(2-Oxopyrrolidin-3-yl)acetyl]piperidine (134). Chromatographic 
purification over silica gel eluting with 4% methanol/dichloromethane afforded 
white needles in 81 % yield. Mp: 131.2-131.9 oC; IR (film): 1693 and 1633 cm-1; 
1H NMR (500 MHz, CDCl3): δ 5.75-5.55 (m, 1H), 3.53-3.49 (m, 1H), 3.37-3.30 (m, 
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2H), 3.28-3.23 (m, 3H), 2.88 (dd, J = 3, 11.5 Hz, 1H), 2.72 (dq, J = 3.2, 10.2 Hz, 
1H), 2.48-2.42 (m, 1H), 2.21 (dd, J = 5, 16.5 Hz, 1H), 1.71 (qd, J = 9.5, 12.5 Hz, 
1H), 1.55-1.49 (m, 2H), 1.47-1.42 (m, 4H); 13C NMR (125 MHz, CDCl3): δ 180.5, 
169.3, 46.7, 43.0, 40.8, 38.2, 34.9, 28.8, 26.6, 25.8, 24.7; ESIHRMS: m/z Calcd. 
for C11H18N2O2Na (M + Na)+ 233.1266, found 233.1245. 
N-(2-Phenylethyl) (2-oxopyrrolidin-3-yl)acetamide (135). 
Chromatographic purification over silica gel eluting with 4% 
methanol/dichloromethane afforded white needles in 57 % yield. Mp: 137.2-137.8 
oC; IR (film): 1692 and 1652 cm-1; 1H NMR (500 MHz, CDCl3): δ 7.31 (t, J = 7.5 
Hz, 2H), 7.24-7.20 (m, 3H), 6.59 (br s, 1H), 5.91 (br s, 1H), 3.52 (dd, J = 7, 13 Hz, 
2H), 3.36-3.30 (m, 2H), 2.82 (t, J = 7.2 Hz, 2H), 2.75-2.70 (m, 1H), 2.63 (dd, J = 
6.2, 14.7 Hz, 1H), 2.42-2.36 (m, 1H), 2.30 (dd, J = 6, 15 Hz, 1H), 1.91-1.83 (m, 
1H); 13C NMR (125 MHz, CDCl3): δ 179.8, 171.3, 139.2, 129.0, 128.8, 126.7, 
40.8, 40.6, 38.4, 37.6, 35.9, 28.3; m/z Calcd. for C14H18N2O2Na (M + Na)+ 
269.1266, found 269.1253.  
N-(2-Phenylethyl) (2-oxopiperdin-3-yl)acetamide (136). Chromatographic 
purification over silica gel eluting with 4% methanol/dichloromethane afforded 
white needles in 55 % yield. Mp: 139-139.5 oC; IR (film): 1644 cm-1; 1H NMR (500 
MHz, CDCl3): δ 7.32-7.29 (m, 2H), 7.23-7.20 (m, 3H), 6.50 (br s, 1H), 5.86 (br s, 
1H), 3.58-3.46 (m, 2H), 3.33-3.24 (m, 2H), 2.82 (t, J = 7.2 Hz, 2H), 2.66-2.60 (m, 
2H), 2.41 (dd, J = 7.5, 16.5 Hz, 1H), 2.05-1.99 (m, 1H), 1.90-1.84 (m, 1H), 1.79-
1.72 (m, 1H), 1.61-1.54 (m, 1H); 13C NMR (125 MHz, CDCl3): δ 174.6, 171.9, 
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139.3, 129.0, 128.7, 126.6, 42.7, 40.8, 39.2, 38.6, 35.9, 27.3, 22.3; m/z Calcd. for 
C15H20N2O2Na (M + Na)+ 283.1422, found 283.1406.  
N-[(2-Oxopiperidine-3-yl)acetyl]piperidine (137). Chromatographic 
purification over silica gel eluting with 4% methanol/dichloromethane afforded 
white needles in 75 % yield. Mp: 112.2-112.8 °C; IR (film): 1640 cm-1;  1H NMR 
(500 MHz, CDCl3): δ 5.80 (br s, 1H), 3.63-3.58 (m, 1H), 3.51-3.30 (m, 5H), 2.94 
(dd, J = 3, 16 Hz, 1H), 2.78-2.72 (m, 1H), 2.56 (dd, J = 8.5, 16 Hz, 1H), 2.10-2.04 
(m, 1H), 1.90-1.76 (m, 2H), 1.68-1.61 (m, 3H), 1.58-1.50 (m, 4H); 174.6, 169.6, 
46.7, 43.0, 42.8, 38.4, 34.9, 27.4, 26.6, 25.8, 24.8, 22.5; ESIHRMS: m/z Calcd. 
for C12H20N2O3Na (M + Na)+ 247.1422, found 247.1411 
N-[(5-Methoxycabonyl-2-oxopyrrolidin-3-yl)acetyl]piperidine (138) and 
N-(piperidin-1-yl) (6-methoxycabonyl-2-oxopiperidine-4-yl)formamide (139). 
Chromatographic purification over silica gel eluting with 4% 
methanol/dichloromethane afforded 17 and 18 with yields of 63 % and 6 % yield 
respectively. (138): yellow gum,IR (film): 1743, 1702 and 1631 cm-1;  1H NMR 
(500 MHz, CDCl3): δ 6.02 (br s, 0.6h), 5.98 (br s, 0.4H), 4.28-4.22 (m, 1H), 3.77 
(s, 3H), 3.64-3.58 (m, 1H), 3.50-3.33 (m, 3H), 3.04-2.86 (m, 2.6H), 2.72-2.67 (m, 
0.4H), 2.41 (dd, J = 9.5, 16.5 Hz, 0.4H), 2.34 (dd, J = 9.5, 16.5 Hz, 0.6H), 2.28-
2.21 (m, 0.4H), 1.89-1.81 (m, 0.6H), 1.69-1.50 (m, 6H); 13C NMR (125 MHz, 
CDCl3): δ 179.4, 178.4, 173.0, 172.4, 168.9, 168.8, 53.8, 52.8, 52.7, 46.7, 46.6, 
43.0, 42.9, 38.3, 36.7, 35.1, 34.6, 32.9, 32.2, 32.2, 26.6, 25.8, 24.7; ESIHRMS: 
m/z Calcd. for C13H20N2O4Na (M + Na)+ 291.1321, found 291.1301. (139): yellow 
gum, IR (film): 1739 and 1637(broad) cm-1;  1H NMR (500 MHz, CDCl3): δ 6.07 
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(br s, 1H), 4.25-4.23 (m, 1H), 3.80 (s, 3H), 3.64-3.58 (m, 1H), 3.56-3.51 (m, 1H), 
3.48-3.42 (m, 2H), 3.16-3.10 (m, 1H), 2.67 (dd, J = 9.2, 16.7 Hz, 1H), 2.46 (dd, J 
= 5.5, 18 Hz, 1H), 1.70-1.50 (m, 6H); 13C NMR (125 MHz, CDCl3): δ 171.8, 170.7, 
53.1, 53.0, 51.7, 46.8, 44.7, 43.4, 37.9, 34.2, 32.7, 27.7, 27.0, 25.8, 24.7; 
ESIHRMS: m/z Calcd. for C13H20N2O4Na (M + Na)+ 291.1321, found 291.1310. 
N-(2-Phenylethyl) (5-methoxycabonyl-2-oxopyrrolidin-3-yl)acetamide 
(140) and N-(2-Phenylethyl) (6-methoxycabonyl-2-oxopiperidine-4-
yl)formamide (141). Chromatographic purification over silica gel eluting with 4% 
methanol/dichloromethane afforded 19 and 20 with yields of 76% and 10%, 
respectively. (140): yellow gum, IR (film): 1743, 1704 and 1651 cm-1; 1H NMR 
(500 MHz, CDCl3): δ 7.30 (t, J = 6.7 Hz, 2H), 7.24-7.18 (m, 3H), 6.60-6.45 (m, 
1H), 6.36 (br s, 1H), 4.23 (t, J = 7.5 Hz, 0.5H), 4.15 (d, J = 9.5 Hz, 0.5H), 3.76 (s, 
3H), 3.54-3.47 (m, 2H), 2.88-2.73 (m, 3.5H), 2.68 (dd, J = 5.5, 15.0 Hz, 0.5H), 
2.61 (dd, J = 5.7, 15.2 Hz, 0.5H), 2.53 (t, J = 11 Hz, 0.5H), 2.32-2.19 (m, 1.5H), 
1.92-1.85 (m, 0.5H);  13C NMR (125 MHz, CDCl3): δ 179.5, 178.5, 172.7, 172.1, 
170.8, 139.1, 129.0, 128.9, 128.8, 126.6, 53.9, 52.9, 40.9, 40.8, 38.6, 37.5, 37.1, 
37.0, 35.9, 35.8, 32.1, 31.6; ESIHRMS: m/z Calcd. For C16H20N2O4Na (M + Na)+ 
327.1321, found 327.1315. (141): IR (film): 1742 and 16501cm-1; 1H NMR (500 
MHz, CDCl3): δ 7.35-7.30 (m, 2H), 7.25-7.17 (m, 3H), 6.23 (br s, 0.5H), 6.08 (br s, 
0.5H), 5.51 ((br s, 1H), 4.22-4.18 (m, 0.5H), 4.07 (dd, J = 4.5, 11.5 Hz, 0.5H), 
3.81 (s, 1.5H), 3.78 (s, 1.5H), 3.61-3.45 (m, 2H), 2.88-2.78 (m, 2H), 2.62-2.38 (m, 
3.5H), 2.30-2.12 (m, 1H), 1.93-1.86 (m, 0.5H); 13C NMR (125 MHz, CDCl3): δ 
171.9, 170.6, 169.8, 138.7, 129.0, 128.9, 126.9, 54.0, 53.1, 53.0, 53.1, 40.1, 39.8, 
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37.3, 35.7, 35.7, 34.1, 34.0, 28.9, 27.9; ESIHRMS: m/z Calcd. For C16H20N2O4Na 
(M + Na)+ 327.1321, found 327.1316. 
N-[(2-Oxo-1,2,3,4-tetrahydroquinolin-3-yl)acetyl]piperidine (142). 
Chromatographic purification over silica gel eluting with 4% 
methanol/dichloromethane afforded white needles in 82 % yield. Mp: 138.0-138.4 
oC; IR (film): 1680 and 1634 cm-1; 1H NMR (500 MHz, CDCl3): δ 7.67 (br s, 1H), 
7.20-7.16 (m, 2H), 6.99 (t, J = 7.5 Hz, 1H), 6.73 (dd, J = 1.5, 7.5 Hz, 1H), 3.68-
3.62 (m, 1H), 3.58-3.40 (m, 3H), 3.24-3.14 (m, 3H), 2.83 (t, J = 15.2 Hz, 1H), 
2.44-2.38 (m, 1H), 1.70-1.54 (m, 6H); 13C NMR (125 MHz, CDCl3): δ 173.0, 
169.1, 137.1, 128.5, 127.7, 124.1, 123.3, 115.0, 46.8, 43.1, 37.1, 33.2, 31.8, 29.9, 
26.7, 25.8, 24.8; m/z Calcd. For C16H20N2O2Na (M + Na)+ 295.1422, found 
295.1434. 
N-(2-Phenylethyl) (2-oxo-1,2,3,4-tetrahydroquinolin-3-yl)acetamide 
(143). Chromatographic purification over silica gel eluting with 4% 
methanol/dichloromethane afforded a white amorphous solid in 71 % yield. IR 
(film):1674 and 1637 cm-1; 1H NMR (500 MHz, CDCl3): δ 7.54 (br s, 1H), 7.29-
7.26 (m, 2H), 7.21-7.18 (m, 4H), 7.16 (t, J = 7.0 Hz, 1H), 7.01 (dt, J = 1.0, 7.5 Hz, 
1H), 6.73 (d, J = 7.5 Hz, 1H), 6.19 (br s, 1H), 3.62-3.49 (m, 2H), 303-2.96 (m, 2H), 
2.88-2.74 (m, 4H), 2.46 (dd, J = 5.5, 19.7 Hz, 1H); 13C NMR (125 MHz, CDCl3): δ 
172.9, 171.2, 139.1, 136.8, 129.0, 128.8, 128.4, 127.9, 126.7, 124.0, 123.6, 
115.2, 40.8, 37.7, 36.7, 35.9, 31.4; ESIHRMS: m/z Calcd. for C19H20N2O2Na (M + 
Na)+ 331.1422, found 331.1429. 
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N-[(2-Oxotetrahydrofuran-3-yl)acetyl]piperidine (144). Chromatographic 
purification over silica gel eluting with 70% EtOAc/hexanes afforded a white gum 
in 71 % yield. IR (film): 1766 and 1639 cm-1; 1H NMR (500 MHz, CDCl3): δ 4.41 
(dt, J = 2.0, 9.0 Hz, 1H), 4.27-4.22 (m, 1H), 3.63-3.58 (m, 1H), 3.51-3.46 (m, 1H), 
3.44-3.34 (m, 2H), 3.05-2.95 (m, 2H), 2.66-2.56 (m, 1H), 2.48 (dd, J = 9.0, 16.5 
Hz, 2.04-1.96 (m, 1H), 1.67-1.62 (m, 2H), 1.59-1.53 (m, 4H); 13C NMR (125 MHz, 
CDCl3): δ 179.7, 168.3,67.1, 46.6, 43.1, 36.5, 34.4, 29.6, 26.6, 25.7, 24.6; 
ESIHRMS: m/z Calcd. for C11H17NO3Na (M + Na)+ 234.1106, found 234.1086. 
N-(2-Phenylethyl) (2-oxotetrahydrofuran-3-yl)acetamide (145). 
Chromatographic purification over silica gel eluting with 70% EtOAc/hexanes 
afforded a light yellow gum in 71 % yield. IR (film): 1767 and 1659 cm-1; 1H NMR 
(500 MHz, CDCl3): δ 7.32 (t, J = 7.5 Hz, 2H), 7.26-7.19 (m, 3H), 5.73 (br s, 1H), 
4.38 (dt, J = 1.5, 9 Hz, 1H), 4.25-4.19 (m, 1H), 3.55 (ddd, J = 2.2, 7.0, 13.2 Hz, 
2H), 2.99-2.91 (m, 1H), 2.83 (t, J = 7 Hz, 2H), 2.70 (dd, J = 4.7, 15.2 Hz, 1H), 
2.54-2.48 (m, 1H), 2.34 (dd, J = 7.7, 15.2 Hz, 1H), 2.06-1.98 (m, 1H); 13C NMR 
(125 MHz, CDCl3): δ 179.2, 170.1, 138.9, 129.0, 128.9, 126.8, 67.0, 40.1, 36.8, 
36.7, 35.8, 29.1; ESIHRMS: m/z Calcd. for C14H17NO3Na (M + Na)+ 270.1106, 
found 270.1089. 
N-[(2-Oxotetrahydropyran-3-yl)acetyl]piperidine (146). Chromatographic 
purification over silica gel eluting with 70% EtOAc/hexanes afforded a white oil in 
85 % yield. IR (film): 1728 and 1636 cm-1;  1H NMR (500 MHz, CDCl3): δ 4.44-
4.36 (m, 2H), 3.62-3.48 (m, 2H), 3.46-3.36 (m, 2H), 3.02-2.95 (m, 1H), 2.83 (dd, 
J = 3.5, 16.5 Hz, 1H), 2.67 (dd, J = 6.5, 16.5 Hz, 1H), 2.18-2.10 (m, 1H), 1.98-
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1.88 (m, 2H), 1.72-1.62 (m, 3H), 1.62-1.52 (m, 4H); 13C NMR (125 MHz, CDCl3): 
δ 174.8, 168.7, 68.8, 46.6, 43.1, 36.8, 35.0, 26.6, 25.8, 25.7, 24.7,22.8; 
ESIHRMS: m/z Calcd. for C12H20NO3Na (M + Na)+ 248.1263, found 248.1246. 
3-(3-Hydroxypropyl)-1-(phenylethyl)pyrrolidine-2,5-dione (148). 
Chromatographic purification over silica gel eluting with 70% EtOAc/hexanes 
afforded a light yellow oil in 74 % yield. IR (film): 1697 cm-1 ; 1H NMR (500 MHz, 
CDCl3): δ 7.29 (t, J = 7.2 Hz, 2H), 7.24-7.21 (m, 3H), 3.81-3.72 (m, 2H), 3.66 (t, J 
= 5.7 Hz, 2H), 2.91 (t, J = 7.5 Hz, 2H), 2.83-2.76 (m, 2H), 2.33 (dd, J = 8.2, 21.7 
Hz, 1H), 1.91-1.85 (m, 1H), 1.65-1.53 (m, 4H); 13C NMR (125 MHz, CDCl3): δ 
179.9, 176.5, 137.9, 129.1, 128.7, 126.9, 62.4, 39.9, 39.7, 34.6, 33.6, 29.8, 28.1; 
ESIHRMS: m/z Calcd. for C15H19NO3Na (M + Na)+ 284.1263, found 284.1259. 
General Procedure for thiester synthesis from the radical adducts. TFA 
(5 mL) was added drop-wise to a stirred solution of thioanhydride (1 mmol) in 
dicholoromethane (20 mL) at 0 oC. After stirring for 40 min, toluene (5 mL) was 
added and then removed under vacuum. Two further portions of toluene (5 mL 
each) were added and striped off under vacuum and the residue dried under 
vacuum. For amino thioanhydrides the residue was dissolved in DMF (20 mL) 
and cooled down to 0 oC before 2,4,6-collidine (182 mg, 1.5 mmol) was dropwise 
added and the mixture stirred for 1 h at 0 oC. For hydroxy thioanhydrides the 
residue was dissolved in DMF (20 mL) and the reaction mixture was stirred 
overnight at room temperature. For both amino thioanhydrides and hydroxy 
thioanhydrides, the resulting reaction mixture was cooled down to 0 oC and alkyl 
iodide (4 mmol) in DMF (2 mL) was drop-wise added followed by triethylamine 
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(102 mg, 1 mmol) followed by stirring for 5 h at room temperature. The solvent 
was removed under vacuum and the residue was dissolved in EtOAc (50 ml) and 
the organic layer was successively washed with water and brine, dried over 
Na2SO4, concentrated and purified by silica gel column chromatography.  
S-Pent-4-ynyl 2-(2-oxopiperidin-3-yl)ethanethiocarboxylate (149). 
Chromatographic purification over silica gel eluting with 4% 
methanol/dichloromethane afforded a colorless gum in 69% yield. IR (film): 1685 
and 1663 cm-1;  1H NMR (500 MHz, CDCl3): δ 5.67 (br s, 1H), 3.37-3.31 (m, 2H), 
3.22 (dt, J = 8.0, 11.5 Hz, 1H), 3.01 (t, J = 7.2 Hz, 2H), 2.84-2.77 (m, 2H), 2.29 
(dt, J = 3.5, 10.0 Hz, 2H), 2.05-1.99 (m, 1H), 1.98 (t, J = 2.7 Hz, 1H), 1.90 (dt, J = 
4.5, 13.5 Hz, 1H), 1.85-1.74 (m, 3H), 1.62-1.54 (m, 1H); 13C NMR (125 MHz, 
CDCl3): δ 198.1, 173.1, 83.3, 69.3, 45.5, 42.7, 38.7, 28.6, 28.0, 26.7, 22.2, 17.8; 
ESIHRMS: m/z Calcd. for C12H17NO2SNa (M + Na)+ 262.0878, found 262.0875. 
S-Pent-4-ynyl 2-(2-oxo-1,2,3,4-tetrahydroquinolin-3-
yl)ethanethiocarboxylate (150). Chromatographic purification over silica gel 
eluting with 4% methanol/dichloromethane afforded a colorless gum in 65% yield. 
IR (film): 1677 cm-1; 1H NMR (500 MHz, CDCl3): δ 7.71 (br s, 1H), 7.19 (t, J = 7.7 
Hz, 1H), 7.16 (d, J = 7.5 Hz, 1H), 7.00 (t, J = 7.5 Hz, 1H), 6.74 (d, J = 8.0 Hz, 1H), 
3.32 (dd, J = 5.0, 16.0 Hz, 1H), 3.19-3.12 (m, 1H), 3.06-2.99 (m, 3H), 2.85 (t, J = 
14.5 Hz, 1H), 2.73 (ddd, J = 0.5, 7.5, 16.0 Hz, 1H), 2.30 (dt, J = 2.5, 7.0 Hz, 2H), 
1.99 (dt, J = 1.0, 2.5 Hz, 1H), 1.84 (p, J = 7 Hz, 2H); 13C NMR (125 MHz, CDCl3): 
δ 197.6, 171.8, 136.9, 128.4, 127.9, 123.5, 123.4, 115.4, 83.2, 69.5, 43.8, 37.3, 
99 
 
31.2, 28.6, 28.1, 17.8; ESIHRMS: m/z Calcd. For C16H17NO2SNa (M + Na)+ 
310.0878, found 310.0872. 
S-4-Iodobutyl 2-(2-oxotetrahydro-2H-pyran-3-yl)ethanethiocarboxylate 
(151). Chromatographic purification over silica gel eluting with 60% 
EtOAc/hexanes afforded a light brown gum in 61% yield. IR (film): 1732 and 
1684 cm-1; 1H NMR (500 MHz, CDCl3): δ 4.42-4.32 (m, 1H), 3.56 (t, J = 6.5 Hz, 
1H), 3.20 (t, J = 7 Hz, 1H), 3.16 (dd, J = 5, 16.5 Hz, 1H), 3.04-2.98 (m, 1H), 2.94 
(ddd, J = 1.5, 5.5, 12.5 Hz, 2H), 2.84 (dd, J = 7.5, 16.5 Hz, 1H), 2.16-2.00 (m, 
1H), 1.97-1.83 (m, 4H), 1.80-1.70 (m, 2H), 1.68-1.60 (m, 1H); 13C NMR (125 MHz, 
CDCl3): δ 197.5, 173.3, 68.8, 45.2, 44.5, 36.8, 32.5, 31.6, 30.6, 28.4, 28.0, 27.1, 
24.9, 22.4, 5.8; ESIHRMS: m/z Calcd. for C11H17IO3SNa (M + Na)+ 378.9841, 
found 378.9856. 
General procedure for aldehyde synthesis from S-pentynylthioesters. 
Thiophenol (34 mg, 0.30 mmol) and AIBN (10 mg, 0.06 mmol) in dry degassed 
benzene (3 mL) was drop-wise added to a refluxing solution of S-
pentenylthioester (0.15 mmol) in dry degassed benzene (3 mL) over 3 h. The 
reaction mixture was stirred for additional 6 h at reflux before the solvent was 
removed under vacuum and the residue purified by column chromatography over 
silica gel. 
2-(2-Oxopiperidin-3-yl)acetaldehyde (152). Chromatographic purification 
over silica gel eluting with 4% methanol/dichloromethane afforded a colorless oil 
in 69% yield. 1H NMR (500 MHz, CDCl3): δ 9.82 (d, J = 1Hz, 1H), 5.98 (br s, 1H), 
3.38-3.34 (m, 2H), 2.99 (dd, J = 5.2, 17.7 Hz, 1H), 2.88-2.82 (m, 1H), 2.62 (dd, J 
100 
 
= 7.0, 17.5 Hz, 1H), 2.05-2.01 (m, 1H), 1.93-1.88 (m, 1H), 1.86-1.78 (m, 1H), 
1.57 (ddd, J = 3.5, 11.8, 25.5 Hz, 1H);  13C NMR (125 MHz, CDCl3): δ 200.8, 
173.6, 45.7, 42.7, 36.8, 27.3, 22.3; ESIHRMS: m/z Calcd. for C7H11NO2Na (M + 
Na)+ 164.0687, found 164.0667. 
2-(2-Oxo-1,2,3,4-tetrahydroquinolin-3-yl)acetaldehyde (153). 
Chromatographic purification over silica gel eluting with 4% 
methanol/dichloromethane afforded a colorless gum in 64% yield. 1H NMR (500 
MHz, CDCl3): δ 9.83 (s, 1H), 7.86 (br s, 1H), 7.14-7.08 (m, 2H), 6.95 (dd, J = 7.0, 
19.5 Hz, 1H), 6.70 (t, J = 8.7 Hz, 1H), 3.15-3.05 (m, 1H), 3.04-2.86 (m, 2H), 2.78 
(t, J = 14.5 Hz, 1H), 2.58-2.49 (m, 1H); 13C NMR (125 MHz, CDCl3): δ 200.1, 
172.2, 136.9, 128.3, 128.0, 123.8, 123.6, 115.5, 43.7, 35.2, 31.5; ESIHRMS: m/z 
Calcd. for C11H11NO2Na (M + Na)+ 212.0687, found 212.0696. 
Ethyl 2-methylen-4-oxo-5-(2-oxopiperidin-3-yl)pentanoate (155). 
Thioester 149 (44 mg, 0.184 mmol) and  ethyl 2-(phenylthiomethyl)acrylate (82 
mg, 0.37 mmol) were heated to reflux with stirring in benzene (4 mL) and a 
mixture of thiophenol (10 mg, 0.09 mmol) and AIBN (15 mg, 0.09 mmol) in 
benzene (4 mL) was added over 7 h by syringe pump. Stirring was continued for 
3 h before the solvent was removed under vacuum and the residue purified by 
chromatography over silica gel eluting with 4% methanol/dichloromethane to 
afford a colorless oil in 68% yield. 1H NMR (500 MHz, CDCl3): δ 6.35 (s, 1H), 
5.69 (br s, 1H), 5.67 (s, 1H), 4.20 (q, J = 7.0 Hz, 2H), 3.45 (d, J = 4.0 Hz, 1H), 
3.44-3.28 (m, 2H), 3.09 (dd, J = 4.0, 17.0 Hz, 1H), 2.84-2.76 (m, 2H), 2.73 (dd, J 
= 7.5, 17.5 Hz, 1H), 2.04-1.98 (m, 1H), 1.92-1.86 (m, 1H), 1.84-1.75 (m, 2H), 
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1.29 (t, J = 7.2 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ 205.9, 174.1, 166.6, 134.6, 
128.9, 61.2, 46.2, 44.1, 42.8, 37.7, 27.1, 22.4, 14.4; ESIHRMS: m/z Calcd. for 
C13H19NO4Na (M + Na)+ 276.1212, found 276.1225. 
3-(2-Oxo-2-phenylethyl)tetrahydro-2H-pyran-2-one (156). Thioester 151 
(36 mg, 0.1 mmol), PhB(OH)2 (19 mg, 0.15 mmol), copper(I) thiophene-2-
carboxylate (32 mg, 0.17 mmol), tris-p-tolylphosphine (1.2 mg, 0.004 mmol), 
bis(dibenzylideneacetone)palladium(0) (1.2 mg, 0.002 mmol) were mixed in dry 
THF (5 mL) and heated to 55 oC with stirring for 60 h under N2 gas. The solvent 
was removed under vacuum and the residue purified by chromatography over 
silica gel eluting with 40% EtOAc/hexanes to afford a colorless oil in 70% yield. 
1H NMR (500 MHz, CDCl3): δ 8.00 (d J = 7.5 Hz, 2H), 7.59 (t, J = 7.5 Hz, 1H), 
7.48 (t, J = 7.7 Hz, 2H), 4.46 (t, J = 5.7 Hz, 2H), 3.62 (dd, J = 3.7, 18.2 Hz, 1H), 
3.29 (dd, J = 6.7, 18.2 Hz, 1H), 3.20-3.14 (m, 1H), 2.23-2.16 (m, 1H), 2.03-1.94 
(m, 2H), 1.71-1.63 (m, 1H); 13C NMR (125 MHz, CDCl3): δ 197.7, 174.4, 136.8, 
133.6, 128.9, 128.3, 68.9, 40.4, 35.8, 25.4, 22.7;  ESIHRMS: m/z Calcd. For 
C13H14O3Na (M + Na)+ 241.0841, found 241.0820. 
Dihydro-3-(triphenylphosphoranylidene)-2,5-thiophendione (157). 
Triphenylphosphine (2.62 g, 10 mmol) was added to monothiomaleic anhydride 
(1.14 g, 10 mmol) in glacial acetic acid (5 mL) at room temperature and stirred for 
3 h.  Removal of the solvent under vacuum at room temperature and trituration of 
the residue with diethyl ether (3 X 5 mL) afforded an off-white solid in 86 % yield. 
Mp: 137-137.5 oC (decomp.); IR (film) 1700 and 1611 cm-1; 1H NMR (500 MHz, 
CDCl3) δ 7.69-7.67 (m, 9H), 7.56 (dt, J = 2.5, 7.5 Hz, 6H), 3.34 (d, J = 1Hz, 2H); 
102 
 
13C NMR (125 MHz, CDCl3) δ 205.6, 178.8, 133.6, 129.6, 124.8, 124.07, 50.0; 
31P NMR (400 MHz, CDCl3) δ 12.78; ESIHRMS, m/z calcd. for  C22H17O2PSNa 
(M + Na)+: 399.0585, found: 399.0588. 
General Proceedure for Wittig Reactions.  Reagent 157 (376 mg, 1 
mmol) was stirred with excess aldehyde at room temperature for 10 h. Excess 
aldehyde was removed under vacuum at room temperature followed by 
chromatographic purification over silica gel, that had been prewashed with 
acetone followed by hexanes, to give the alkylidene monothiosuccinic 
anhydrides. 
E-2-(Benzylidene)thiosuccinic Anhydride (158). Rapid chromatographic 
purification over silica gel eluting with 10 % EtOAc in hexanes afforded a pale 
yellow oil in 78 % yield. IR (film) 1731 and 1692 cm-1; 1H NMR (500 MHz, CDCl3) 
δ 7.68 (t, J = 2.5 Hz, 1H), 7.51-7.46 (m, 5H), 3.98 (d, J = 2.5 Hz, 2H); 13C NMR 
(125 MHz, CDCl3) δ 197.7, 192.7, 135.3, 133.8, 131.2, 131.1, 130.8, 130.1, 
129.5, 128.4, 45.3; ESIHRMS m/z calcd for C11H7O2S (M 1)-: 203.0172, found: 
203.0180. 
E-2-(Ethylidene)thiosuccinic Anhydride (159). Rapid chromatographic 
purification over silica gel eluting with 10 % EtOAc in hexanes afforded a 
colorless oil in 76 % yield. IR (film) 1742 and 1706 cm-1;  1H NMR (500 MHz, 
CDCl3) δ 6.99-6.94 (m, 1H), 3.66-3.65 (m, 2H), 1.91 (dt J = 2.0, 7.5 Hz, 3H); 13C 
NMR (125 MHz, CDCl3) δ 197.6, 191.3, 135.2, 134.0, 43.2, 16.5; ESIHRMS m/z 
calcd for  C6H5O2S (M-1)-: 141.0016, found: 141.0022. 
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E-2-(Octylidene)thiosuccinic Anhydride (160). Rapid chromatographic 
purification over silica gel eluting with 10 % EtOAc in hexanes afforded a 
colorless oil in 72 % yield. IR (film) 1742 and 1706 cm-1;  1H NMR (500 MHz, 
CDCl3) δ 6.91-6.87 (m, 1H), 3.64 (dd, J = 1.0, 2.5 Hz, 2H), 2.19 (q, J = 7.5 Hz, 
2H), 1.56-1.50 (m, 2H), 1.38-1.24 (m, 8H), 0.89 (t, J = 7.0 Hz, 3H); 13C NMR (125 
MHz, CDCl3) δ 197.7, 191.5, 140.5, 132.8, 43.3, 31.9, 31.0, 29.6, 29.2, 28.2, 
22.8, 14.3; ESIHRMS m/z cald for C12H17O2S (M-1)-: 225.0955, found: 225.0941. 
E-2-(Cyclopropylmethylidene)thiosuccinic Anhydride (161). Rapid 
chromatographic purification over silica gel eluting with 10 % EtOAc in hexanes 
afforded a colorless oil in 84 % yield. IR (film) 1737 and 1699 cm-1; 1H NMR (500 
MHz, CDCl3) δ 6.27 (dt, J = 11.0, 2.5 Hz, 1H), 3.77 (d, J = 2.0 Hz, 2H), 1.45-1.38 
(m, 1H), 1.16-1.12 (m, 2H), 0.85-0.81 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 
198.2, 190.9, 145.6, 130.0, 43.6, 14.4, 10.3; ESIHRMS m/z calcd for  C8H7O2S 
(M-1)-: 167.0172, found: 167.0166. 
General Procedure for the Three Component Coupling of Alkylidene 
Thiosuccinic Anhydrides with Aminothiols and 2,4-
Dinitrobenzenesulfonamides. The aminothiol (0.5 mmol) was added to a stirred 
solution of the alkylidene thiosuccinic anhyride (0.5 mmol) in DMF (5 mL) at 0 oC.  
The reaction mixture was stirred for overnight at 0 ºC before Cs2CO3 (0.6 mmol) 
was added, followed immediately by the sulfonamide (0.5 mmol). Stirring was 
continued while the reaction mixture was allowed to warm to room temperature 
and the subsequently for a further 1 h. The solvent was then removed under 
vacuum and the residue was dissolved in ethyl acetate, washed with water 
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followed by brine, and dried over Na2SO4. Purification was then realized by silica 
gel column chromatography. 
cis- and trans-N-[(Benzo[b]-5-oxo-7-phenyl-1,4-thiazepin-
6yl)acetyl]piperidine (164). Chromatographic purification by eluting with 70% 
ethyl acetate in hexanes afforded trans and cis isomer with yields of 60 % and 12 
% yield respectively.  
trans-Isomer: pale yellow solid, Mp 226-227 oC; . IR (film) 1678 and 1631 cm-
1;  1H NMR (500 MHz, CDCl3) δ 7.53 (d, J = 7.5 Hz, 1H), 7.44 (t, J = 7.7 Hz, 1H), 
7.35 (d, J = 7.5 Hz, 1H), 7.30-7.24 (m, 3H), 7.20 (t, J = 7.2 Hz, 2H), 7.11 (d, J = 
7.5 Hz, 2H), 4.32 (d, J = 12.5 Hz, 1H), 3.61 (dt, J = 2;0, 11.5 Hz,2H), 3.46-3.39 
(m, 1H), 3.36-3.24 (m, 2H), 3.18-3.12 (m, 1H), 3.08 (dd, J = 11.0, 16.0 Hz, 1H), 
1.80 (d, J = 16.0 Hz, 1H), 1.56-1.32 (m, 6H); 13C NMR (125 MHz, CDCl3) δ 174.5, 
169.0, 143.4, 141.7, 136.0, 130.8, 129.2, 128.1, 126.7, 126.6, 126.3, 124.0, 56.9, 
46.5, 44.6, 43.0, 33.9, 26.3, 25.6, 24.6; ESIHRMS m/z calcd for C22H24N2O2SNa 
(M + Na)+: 403.1456, found: 403.1473.  
cis-Isomer: yellow solid, Mp.163-163.8 oC; . IR (film) 1676 and 1637 cm-1; 1H 
NMR (500 MHz, CDCl3) δ 7.66 (dd, J = 1.5, 8.0 Hz, 1H), 7.54 (br s, 1H), 7.51 (d, 
J = 7.0 Hz, 2H), 7.42-7.34 (m, 4H), 7.21 (t, J = 7.0 Hz, 2H), 5.02 (d, J = 7.0 Hz, 
1H), 3.66-3.61 (m, 1H), 3.59-3.54 (m, 1H), 3.34-3.29 (m, 1H), 3.17-3.07 (m, 2H), 
3.53(dd, J = 8.0, 16.5 Hz, 1H), 2.07 (dd, J = 5.5, 16.5 Hz, 1H), 1.55-1.37 (m, 6H); 
13C NMR (125 MHz, CDCl3) δ 173.8, 168.6, 141.9, 137.2, 135.3, 130.6, 129.7, 
128.8, 128.6, 126.7, 123.4, 57.8, 46.5, 43.0, 42.1, 32.9, 26.3, 25.7, 24.7; 
ESIHRMS m/z calcd for C12H24N2O2SNa (M + Na)+: 403.1456, found: 403.1469. 
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cis- and trans-N-(2-Phenylethyl) (Benzo[b]-5-oxo-7-phenyl-1,4-
thiazepin-6yl)acetamide (165).  Chromatographic purification eluting with 70% 
ethyl acetate in hexanes afforded trans and cis isomer with yields of  63 % and 
13 % yield respectively.  
trans-Isomer: pale yellow solid, Mp 214-214.7 oC; . IR (film) 1665 and 1642 cm-
1; 1H NMR (500 MHz, CDCl3) δ 7.56 (d, J = 8 Hz, 1H), 7.50-7.45 (m, 2H), 7.34-
7.26 (m, 5H), 7.24-7.20 (m, 2H), 7.14 (d, J = 7.5 Hz, 3H), 7.09 (d, J = 6.5 Hz, 2H), 
5.56 (br s, 1H), 4.27 (d, J = 12 Hz, 1H), 3.55 (dt, J = 2.5, 11.5 Hz, 1H), 3.39 (q, J 
= 6.5 Hz, 2H), 2.73-2.65 (m, 3H), 1.82 (dd, J = 2.5, 15 Hz, 1H); 13C NMR (125 
MHz, CDCl3) δ 173.9, 170.7, 142.9, 141.1, 139.0, 136.2, 130.8, 129.3, 129.0, 
128.8, 128.2, 127.1, 126.7, 126.4, 123.9, 57.1, 44.9, 40.8, 36.6, 35.8; ESIHRMS 
m/z calcd for C25H24N2O2SNa (M + Na)+: 439.1456, found: 439.1457.  
cis-Isomer: pale yellow solid, Mp 150.8-151.5oC; . IR (film) 1671 cm-1;  1H NMR 
(500 MHz, CDCl3) δ 7.66 (d, J = 6.5 Hz, 1H), 7.60 (br s, 1H), 7.47-7.38 (m, 3H), 
7.35-7.28 (m, 4H), 7.24-7.12 (m, 6H), 5.45 (br s, 1H), 4.94 (d, J = 7 Hz, 1H), 
3.57-3.52 (m, 1H), 3.47-3.34 (m, 2H), 2.72 (t, J = 7 Hz, 2H), 2.28 (dd, J = 9, 15 
Hz, 1H), 1.89 (dd, J = 5, 15 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 173.4, 170.7, 
141.5, 138.9, 136.8, 135.4, 130.6, 129.7, 128.9, 128.8, 128.4, 127.0, 126.7, 
123.4, 58.2, 42.5, 40.1, 36.2, 35.7; ESIHRMS m/z calcd for C25H24N2O2SNa (M + 
Na)+: 439.1456, found: 439.1462. 
cis- and trans-N-[(5-Oxo-7-phenyl-1,4-thiazepin-6yl)acetyl]piperidine 
(166). Chromatographic purification eluting with 4% methanol in dichloromethane 
afforded trans and cis isomer with yields of 52 % and 13 % yield respectively. 
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trans-Isomer: light yellow gum, IR (film) 1675 and 1614 cm-1;  1H NMR (500 MHz, 
CDCl3) δ 7.28-7.25 (m, 2H), 7.22-7.19 (m, 3H), 5.85 (br s, 1H), 4.15 (d, J = 9.5 
Hz, 1H), 3.66-3.54 (m, 2H), 3.52-3.43 (m, 2H), 3.33-3.28 (m, 1H), 3.14-3.05 (m, 
3H), 2.96-2.85 (m, 3H), 1.50-1.18 (m, 6H); 13C NMR (125 MHz, CDCl3) δ 171.7, 
171.6, 139.4, 129.7, 128.5, 126.7, 47.0, 43.8, 43.4, 43.0, 42.0, 37.3, 28.5, 25.5, 
24.6; ESIHRMS m/z calcd for  C18H24N2O2SNa (M + Na)+: 355.1456, found: 
355.1445.  
cis-Isomer: light yellow gum, IR (film) 1638 cm-1;   1H NMR (500 MHz, CDCl3) δ 
7.37-7.27 (m, 5H), 5.95 (t, J = 6.5 Hz, 1H), 4.10-4.00 (m, 2H), 3.89 (d, J = 10 Hz, 
1H), 3.68-3.61 (m, 1H), 3.52-3.46 (m, 1H), 3.44-3.36 (m, 1H), 3.28-3.22 (m, 1H), 
3.16-3.10 (m, 1H), 2.97-2.89 (m, 1H), 2.87-2.81 (m, 2H), 1.88 (dd, J = 3, 16 Hz, 
1H), 1.58-1.30 (m, 6H); 13C NMR (125 MHz, CDCl3) δ 177.0, 169.5, 140.5, 131.6, 
129.3, 129.1, 128.1, 128.0, 47.3, 46.5, 46.0, 43.2, 43.0, 34.0, 32.1, 26.3, 25.6, 
24.7; ESIHRMS m/z calcd for C18H24N2O2SNa (M + Na)+: 355.1456, found: 
355.1454. 
cis- and trans-N-(2-Phenylethyl) (5-Oxo-7-phenyl-1,4-thiazepin-
6yl)acetamide (167). Chromatographic purification eluting with 4% methanol in 
dichloromethane afforded a pale yellow gum in 67 % yield as 1:4 cis:trans-
mixture.   
trans-Isomer: IR (film) 1666 and 1640 cm-1;    1H NMR (500 MHz, CDCl3) δ 7.35-
7.28 (m, 7H), 7.24-7.19 (m, 2H), 7.16 (d, J = 7.0 Hz, 2H), 6.01 (br s, 1H), 5.52 (br 
s, 1H), 4.02-3.84 (m, 3H), 3.66-3.60 (m, 1H), 3.49-3.35 (m, 2H), 2.96-2.87 (m, 1 
H), 2.82-2.71 (m, 2.8H), 2.43 (dd, J = 11.0, 14.7 Hz, 1H), 1.91 (dd, J = 3.2, 14.7 
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Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 176.8, 171.5, 139.9, 139.0, 129.1, 129.0, 
128.8, 128.3, 128.1, 126.6, 46.3, 43.6, 40.9, 37.5, 35.8, 32.5; ESIHRMS m/z 
calcd for  C21H24N2O2SNa (M + Na)+ 391.1456, found 391.1449. 
cis-Isomer: the minor cis isomer was identified in the mixture by characteristic 
signals at δ 6.09 (br s, 1H), 5.63 (br s, 1H), 3.06-3.01 (m, 1H), 2.53 (dd, J = 8.2, 
14.7 Hz, 1H), 2.09 (dd, J = 4.7, 14.7 Hz, 1H) in the 1H-NMR spectrum, and by δ 
175.2, 171.2, 139.3, 128.7, 128.2, 126.7, 48.0, 45.9, 40.7, 38.1, 29.8 in the 13C-
NMR spectrum. 
cis- and trans-N-[(Benzo[b]-5-oxo-7-methyl-1,4-thiazepin-
6yl)acetyl]piperidine (168). 
Chromatographic purification eluting with 70 % ethyl acetate in hexanes afforded 
a pale yellow solid in 74 % yield as 1:1 cis:trans-mixture. 
trans-Isomer: IR (film) 1674 and 1633 cm-1;    1H NMR (500 MHz, CDCl3) δ 7.61 
(dd, J = 1.5, 7.5 Hz, 1 H), 7.42 (br s, 1H), 7.40-7.32 (m, 1 H), 7.24 (d, J = 7.0 Hz, 
1H), 7.19-7.13 (m, 1H), 3.57-3.51(m, 1H), 3.47-3.38(m, 2H), 3.33-3.27(m, 1H), 
3.16 (dd, J = 10.5, 16 Hz, 1H), 2.92 (dt, J = 2.5, 11 Hz, 1H), 2.24 (dd, J = 2.7, 
16.2 Hz, 1H), 1.65-1.42 (m, 6H), 1.39 (d, J = 6.5Hz, 3H); 13C NMR (125 MHz, 
CDCl3) δ 175.0, 169.1, 141.5, 136.6, 135.0, 130.7, 128.3, 126.5, 125.8, 123.7, 
48.3, 47.7, 46.7, 45.9, 43.2, 33.6, 26.5, 23.1, 16.9; ESIHRMS m/z calculated for 
C17H22N2O2SNa (M + Na)+ 341.1300, found 341.1291.  
cis-Isomer: the cis isomer was identified in the mixture by characteristic signals 
at δ 7.57 (dd, J = 12.0 , 7.7 Hz, 1H), 3.95-3.87 (m, 1H), 2.17 (dd, J = 3.7 , 16.2 
Hz, 1H), 1.37 (d, J = 6.5Hz, 3H) in the 1H-NMR spectrum, and by δ 173.3, 168.7, 
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141.8, 123.4, 126.4, 130.2, 47.7, 43.1, 41.5,  32.5, 25.7, 24.7 in the 13C-NMR 
spectrum. 
cis- and trans-N-(2-Phenylethyl) (Benzo[b]-5-oxo-7- methyl -1,4-
thiazepin-6yl)acetamide (169).   
Chromatographic purification eluting with 70 % ethyl acetate in hexanes afforded 
a pale yellow oil in 72 % yield as 1:1 cis:trans-mixture. 
trans-Isomer: IR (film) 1670 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.62 (d, J = 7.5 
Hz, 1H), 7.57-7.30 (m, 4H), 7.25-7.14(m, 5H), 6.15 (br s, 1H),  3.50-3.40 (m, 2H), 
3.26-3.20 (m, 1H), 2.82-2.76 (m, 3H), 2.70 (dd, J = 10.5, 14.5 Hz, 1H), 2.30 (dd, 
J = 2.2, 14.2 Hz, 1H), 1.39 (d, J = 7.0 Hz, 3H),; 13C NMR (125 MHz, CDCl3) δ 
173.1, 170.8, 141.3, 139.0, 136.7, 130.7, 129.0, 128.8, 126.8, 125.8, 123.6, 48.0, 
46.6, , 41.0, 35.9, 35.6, 23.0, 16.5; ESIHRMS m/z calculated for C20H22N2O2SNa 
(M + Na)+ 377.1300, found 377.1284. 
cis-Isomer: the cis isomer was identified in the mixture by characteristic signals 
at δ 7.57 (d, J = 7.5 Hz, 1H), 7.08 (d, J = 7.5 Hz, 1H), 5.72 (br s, 1H), 3.87 (q, J = 
6.5 Hz, 1H), 3.36-3.32 (m, 2H), 2.06 (dd, J = 3.5, 14.7 Hz, 1H), 1.31 (d, J = 6.5 
Hz, 3H) in the 1H-NMR spectrum, and by δ 175.1, 170.9, 141.1, 139.2, 135.1, 
130.2, 128.1, 126.7, 123.4, 48.8, 42.3, 40.8, 36.5, 35.87 in the 13C-NMR 
spectrum. 
cis- and trans-N-[(5-Oxo-7-methyl-1,4-thiazepin-6yl)acetyl]piperidine 
(170).Chromatographic purification eluting with 4% methanol in dichloromethane 
afforded a pale yellow oil in 58 % yield as 1:1 cis:trans-mixture. 
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trans-Isomer: IR (film) 1663 cm-1;   1H NMR (500 MHz, CDCl3) δ 6.00 (br s , 1H), 
3.93-3.97(m, 1H), 3.60-3.49 (m, 5H), 3.40 (dt, J = 3.5, 9.7 Hz, 1H), 3.11-3.05 (m, 
1H), 2.98 (dd, J = 11.7, 14.2 Hz, 1H), 2.54 (dd, J = 11.5, 14.5 Hz, 1H), 2.37 (dd, J 
= 3.2, 16.2 Hz, 1H), 1.70-1.51 (m, 6H), 1.38 (d, J = 7.0 Hz, 3H),); 13C NMR (125 
MHz, CDCl3) δ 176.2, 169.2, 48.5, 46.7, 45.7, 43.1, 36.0, 33.2, 26.6, 25.8, 24.8, 
20.3, 16.7; ESIHRMS m/z calculated for C13H22N2O2SNa (M + Na)+ 293.1300, 
found  293.1284. 
cis-Isomer: the cis isomer was identified in the mixture by characteristic signals 
at δ 5.87 (br s, 1H), 4.03 (dd, J = 5.5, 8.0 Hz, 1H), 3.80-3.73 (m, 1H), 3.48-3.41 
(m, 5H), 2.88 (dt, J = 4.5, 14.5 Hz, 1H), 2.83-2.74 (m, 3H), 2.24 (dd, J = 5.5, 16.0 
Hz, 1H), 1.37 (d, J = 7.0 Hz, 3H) in the 1H-NMR spectrum, and by δ 176.9, 169.4, 
48.3, 46.8, 43.2, 42.2, 35.9, 34.7, 27.3, 26.5, 25.7 in the 13C-NMR spectrum. 
cis- and trans-N-(2-Phenylethyl) (5-oxo-7- methyl -1,4-thiazepin-
6yl)acetamide (171).   
Chromatographic purification eluting with 4% methanol in dichloromethane 
afforded a pale yellow oil in 62 % yield as 1:1 cis:trans-mixture. 
trans-Isomer: IR (film) 1649 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.31 (t, J = 7.5 
Hz, 2H), 7.24-7.19 (m, 3H), 6.09 (br s, 1H), 5.96 (br s, 1H), 3.83-3.77 (m, 1H), 
3.66-3.59 (m, 1H), 3.57-3.44 (m, 3H), 2.87 (dt, J = 4.2, 19.7 Hz, 1H), 2.82-2.77 
(m, 4H), 2.52 (dd, J = 5.5, 15.0 Hz, 1H), 2.16 (dd, J = 4.7, 14.2 Hz, 1H), 1.33 (d, 
J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 176.0, 171.2, 139.2, 129.0, 126.7, 
49.2, 45.8, 42.2, 40.9, 38.6, 37.0, 36.2, 26.9, 20.3, 16.5; ESIHRMS m/z 
calculated for C16H22N2O2SNa (M + Na)+ 329.1300, found 329.1302. 
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cis-Isomer: the cis isomer was identified in the mixture by characteristic signals 
at δ 6.07 (br s, 1H), 5.94-5.90 (m, 1H), 3.89 (dd, J = 4.5, 9.5 Hz, 1H), 3.27-3.21 
(m, 1H), 2.94 (dd, J = 10.7, 15.0 Hz, 1H), 2.75-2.66 (m, 2H), 2.38 (dd, J = 3.7, 
14.2 Hz, 1H),1.38 (d, J = 7.0 Hz, 3H) in the 1H-NMR spectrum, and by δ 176.5, 
171.3, 139.1, 128.8, 126.6, 49.1, 40.8, 36.3, 35.9,28.9 in the 13C-NMR spectrum. 
cis- and trans-N-[(Benzo[b]-5-oxo-7-octanyl-1,4-thiazepin-
6yl)acetyl]piperidine (172). 
Chromatographic purification eluting with 70 % ethyl acetate in hexanes afforded 
a pale yellow oil in 67 % yield as 2:5 cis:trans-mixture. 
Trans-Isomer: IR (film) 1677 and 1641 cm-1;  1H NMR (500 MHz, CDCl3) δ 7.57 
(t, J = 8.0 Hz, 1H), 7.51 (br s, 1H), 7.34-7.31 (m, 1H), 7.23 (d, J = 8.0 Hz, 1H), 
7.17-7.12 (m, 1H), 3.53-3.36 (m, 4H), 3.19-3.09 (m, 1H), 3.00 (dt, , J = 2.0, 11.0 
Hz, 1H), 2.26 (d, J = 15.5 Hz, 1H), 1.84-1.70 (m, 1 H), 1.50-1.56 (m, 4H), 1.56-
1.40 (m, 5H), 1.40-1.14 (m, 9H), 0.92-0.83 (m, 3H); 13C NMR (125 MHz, CDCl3) δ 
175.3, 169.2, 141.8, 136.6, 130.6, 126.4, 126.3, 123.6, 54.2, 46.7, 44.6, 43.2, 
43.1, 34.9, 33.5, 32.0, 29.8, 29.4, , 26.5, 25.7, 24.8, 22.9, 14.3;  ESIHRMS m/z 
calculated for C23H34N2O2SNa (M + Na)+ 425.2239, found 425.2249. 
cis-Isomer: the cis isomer was identified in the mixture by characteristic signals 
at δ 7.65 (br s, 1H), 7.32 (t, J = 7.5 Hz, 3H), 7.05 (d, J = 7.5 Hz, 1H), 3.78-3.74 
(m, 1H), 2.16 (dd, J = 3.2, 16.2 Hz, 1H) in the 1H-NMR spectrum, and by δ 173.6, 
168.8,  135.1,  130.0,  128.1,  123.4, 53.6,  41.4,  32.7, 27.7, 26.4, 24.7 in the 
13C-NMR spectrum. 
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cis- and trans-N-(2-Phenylethyl) (Benzo[b]-5-oxo-7- octanyl -1,4-
thiazepin-6yl)acetamide (173).   
Chromatographic purification eluting with 70 % ethyl acetate in hexanes afforded 
a pale yellow oil in 61 % yield as 2:5 cis:trans-mixture. 
trans-Isomer: IR (film) 1672 cm-1;  1H NMR (500 MHz, CDCl3) δ 7.61-7.54 (m, 
2H), 7.38 (dt, J = 1.5, 7.5 Hz, 1H), 7.35-7.30 (m, 3H), 7.25-7.14 (m, 4H), 6.18 (br 
s, 1H), 3.54-3.41 (m, 2H), 3.06 (t, J = 10.0 Hz, 1H), 2.88-2.70 (m, 4H), 2.32 (dd, J 
= 2.5, 14.0 Hz, 1H),  1.67-1.52 (m, 2H), 1.45-1.20 (m, 10H), 0.92-0.88 (m, 3H); 
13C NMR (125 MHz, CDCl3) δ 175.2, 171.1, 141.4, 139.2, 136.7, 135.3, 130.6, 
129.0, 128.5, 126.8, 126.7, 123.6, 54.6, 45.3, 40.9, 36.6, 35.8, 34.7, 32.0, 29.7, 
29.4, 26.4, 22.9, 14.3; ESIHRMS m/z calculated for C26H34N2O2SNa (M + Na)+ 
461.2239, found 461.2261.  
cis-Isomer: the cis isomer was identified in the mixture by characteristic signals 
at δ 7.66 (br s, 1H), 7.07 (d, J = 8.0 Hz, 1H), 5.76 (br s, 1H), 3.77-3.72 (m, 1H), 
3.40-3.35 (m, 1H), 2.06 (dd, J = 3.7, 14.2 Hz, 1H), 1.78-1.72 (m, 1H) in the 1H-
NMR spectrum, and by δ 173.2, 170.8, 141.2, 139.0, 130.1, 126.4, 123.3, 53.8, 
42.2, 31.7, 27.5 in the 13C-NMR spectrum.  
cis- and trans-N-[(Benzo[b]-5-oxo-7-cyclopropyl-1,4-thiazepin-
6yl)acetyl]piperidine (174). 
Chromatographic purification eluting with 70 % ethyl acetate in hexanes afforded 
a pale yellow oil in 57 % yield as 2:3 cis:trans-mixture. 
trans-Isomer: IR (film) 1677 and 1638 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.55 
(dd, J = 1.0, 7.5 Hz, 1H), 7.38-7.31 (m, 2H), 7.24-7.12 (m, 2H), 3.58-3.35 (m, 5 
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H), 3.26 (dd, J = 3.0, 11.5 Hz, 1H), 3.20-3.15 (m, 1H), 3.09 (dd, J = 11.0, 16.0 Hz, 
1H), 2.46 (dd, J = 5.0, 16.5 Hz, 1H), 1.52-1.40 (m, 6H), 0.76-0.60(m, 2H), 0.35-
0.25 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 173.9, 169.0, 141.6, 135.1, 130.1, 
126.6, 123.5, 59.0, 45.3, 42.4, 32.8, 25.7, 24.7, 18.4, 12.5, 7.1, 3.9,; ESIHRMS 
m/z calculated for C19H24N2O2SNa (M + Na)+ 367.1456, found 367.1450. 
cis-Isomer: the minor cis isomer was identified in the mixture by characteristic 
signals at δ 7.63 (dd, J = 1.0, 4.5 Hz, 1H), 2.73-2.67 (m, 1H), 0.53-0.48 (m, 2H) in 
the 1H-NMR spectrum, and by δ 174.8, 169.4, 141.3, 136.1, 130.4, 128.7, 126.4, 
123.4, 59.4, 46.7, 43.1, 33.5, 26.5, 9.0, 3.1 in the 13C-NMR spectrum. 
cis- and trans-N-(2-Phenylethyl) (Benzo[b]-5-oxo-7-cyclopropyl-1,4-
thiazepin-6yl)acetamide (175). Chromatographic purification eluting with 70 % 
ethyl acetate in hexanes afforded a pale yellow oil in 60 % yield as 2:3 cis:trans-
mixture. 
trans-Isomer: IR (film) 1671 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.65 (dd, J = 1.0, 
7.5 Hz, 1H), 7.40-7.30 (m, 4H), 7.25-7.15 (m, 5H), 5.93 (br s, 1H), 3.53-3.45 (m, 
2H), 3.22-3.17 (m, 1H), 2.79 (q, J = 7.0 Hz, 2H), 2.70 (d, J = 7.0 Hz, 2H), 1.04-
0.97 (m, 1H), 0.77-0.59 (m, 3H), 0.32-0.22 (m, 2H). 13C NMR (125 MHz, CDCl3) δ 
174.6, 171.3, 140.8, 139.2, 136.2, 130.4, 129.0, 128.9, 128.8  126.4, 123.4, 59.5, 
45.9, 40.9, 36.7, 35.9, 31.5, 18.2, 9.0, 3.8; ESIHRMS m/z calculated 
forC22H24N2O2SNa (M + Na)+ 403.1456, found 403.1472. 
cis-Isomer: the minor cis isomer was identified in the mixture by characteristic 
signals at δ 7.56 (dd, J = 1.2, 7.7 Hz, 1H), 7.09 (d, , J = 7.5 Hz, 1H), 5.72 (br s, 
1H), 3.42-3.38 (m, 1H), 3.11 (dd, J = 5.5, 10.5 Hz, 1H), 3.00 (dd, J = 9.7, 14.7 Hz, 
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1H), 2.64 (dd, J = 9.5, 11.5 Hz, 1H), 2.26 (dd, J = 4.5, 14.5 Hz, 1H), 1.19-1.14 (m, 
1H), 0.92-0.86 (m, 1H), 0.51-0.46(m, 1H) in the 1H-NMR spectrum, and by δ 
173.5, 171.1, 141.2, 135.1, 130.2, 128.5, 126.8, 126.7, 123.5, 59.4, 43.1, 35.9,  
25.9, 12.4, 7.2, 3.0 in the 13C-NMR spectrum. 
2-[3-(tert-Butyloxycarbonylamino)-2-methylpropyl]succinic 
thioanhydride (176). Tris(trimethylsilyl)silane (373 mg, 1.5 mmol) and AIBN (33 
mg, 0.2 mmol)  in dry degassed toluene (5 mL) were added drop-wise to a stirred 
mixture of 165 (407 mg, 1.5 mmol) and 122 (142 mg, 1 mmol) in dry degassed 
toluene (10 mL) at 90 oC over 5 h by syringe pump under a N2 atmosphere.  
When the addition was complete, the reaction mixture was allowed to stir for an 
additional 1 h at 90 oC before it was cooled to room temperature and the solvent 
was removed under vacuum.  Rapid chromatographic purification over silica gel, 
pre-washed with acetone followed by hexanes, eluting with 30% ethyl acetate in 
hexanes afforded a colorless oil in 52% yield as a 3:1 inseparable diastereomeric 
mixture. IR (film): 1709 cm-1; 1H NMR (500 MHz, CDCl3) δ 4.58 (br s, 1H), 3.55-
3.02 (m, 4H), 2.88 (dd, J = 4.0, 6.5 Hz, 1H), 2.26-2.18 (m, 1H), 1.66-1.58 (m, 1H), 
1.54-1.41 (m, 10H), 1.04 (d, J = 7.0 Hz, 3H),; 13C NMR (125 MHz, CDCl3) δ 203.0, 
199.9, 156.2, 79.6, 57.4, 44.4, 38.6, 35.7, 33.3, 28.6, 17.2,; ESIHRMS m/z 
calculated for C13H21NO4SNa (M + Na)+ 310.1089, found 310.1082.  
cis-Isomer: the minor cis isomer was identified in the mixture by characteristic 
signals at δ 2.84 (dd, J = 4.0, 6.5 Hz, 1H), 2.44-2.36 (m, 1H), 0.96(d, J = 7.0 Hz, 
3H) in the 1H-NMR spectrum, and by δ 199.8, 56.9, 42.3, 38.3, 32.6, 31.5, 14.7 in 
the 13C-NMR spectrum. 
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General Procedure for Piperidinone Synthesis from the Radical Adduct 
176.  To a stirred solution of the 176 (145 mg, 0.5 mmol) in dicholoromethane (20 
mL) at 0 oC, trifluoroacetic acid (5 mL) was added drop-wise. Stirring was 
maintained for 1 h before the acid was removed by azeotropic distillation with 
toluene (5 mL x 3), after which the residue was dried under vacuum.  The residue 
was dissolved in DMF (20 mL) and cooled down to 0 oC before 2,4,6-collidine 
(0.090 mg, 0.75 mmol) was added drop-wise and the reaction mixture was stirred 
for 1 h at 0 oC. While the resulting reaction mixture was at 0 oC, Cs2CO3 (0.195 
mg, 0.6mmol) followed by sulfonamide (0.6 mmol) was added.  The reaction 
mixture was warmed to room temperature and stirred for 1.5 h before the solvent 
was removed under vacuum and the residue was dissolved in EtOAc (30 mL).  
The organic layer was washed successively with water and brine, dried over 
Na2SO4, concentrated and purified by silica gel column chromatography. 
N-(2-Phenylethyl) (4-Methyl-2-oxopiperidin-3-yl)acetamide (177). 
Chromatographic purification eluting with 4% methanol in dichloromethane 
afforded a pale yellow solid in 78% yield as a 3:1 trans:cis mixture.  
Trans-Isomer: IR (film) 1650 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.30 (t, J = 7.5 
Hz, 2H), 7.24-7.19 (m, 3H), 6.86 (br s, 1H), 5.78 (br s, 1H), 3.54-3.45 (m, 2H), 
3.38 (dt, J = 5.5, 11.5 Hz, 1H), 3.32-3.23 (m, 1H), 2.84-2.79 (m, 2H), 2.77-2.70 
(m, 1H), 2.28-2.21 (m, 1H), 2.09 (dd, J = 4.5, 14.5 Hz, 1H), 2.01-1.94 (m, 1H), 
1.88-1.78 (m, 2H), , 0.93 (d, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 174.7, 
172.6, 139.4, 129.0, 126.5, 43.4, 40.9, 39.1, 36.4, 35.9, 30.6, 28.9, 13.9; 
ESIHRMS m/z calculd for  C16H22N2O2Na (M + Na)+: 297.1579, found: 297.1591. 
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Cis-Isomer: the minor cis isomer was identified in the mixture by characteristic 
signals δ 6.50 (br s, 1H), 5.85 (br s, 1H), 2.50 (dd, J = 6.0, 14.5 Hz, 1H), 2.18-
2.14 (m, 1H), 1.72-1.66 (m, 1H) 1.1 (d, J = 6.5 Hz, 3H) in the 1H-NMR spectrum, 
and by δ 174.4, 171.9, 139.3, 129.0, 128.7, 46.6, 41.3, 40.7, 36.0, 35.8, 31.9, 
30.7, 20.4 in the 13C-NMR spectrum. 
N-[(4-Methyl-2-oxopiperidin-3-yl)acetyl]piperidine (178). 
Chromatographic purification eluting with 4% methanol in dichloromethane 
afforded trans and cis isomer with yields of 56 % and 19 % yield respectively. 
trans-Isomer.light yellow gum, IR (film) 1635 cm-1; 1H NMR (500 MHz, CDCl3) δ 
5.63 (br s, 1H), 3.64-3.59 (m, 1H), 3.56-3.39 (m, 4H), 3.34-3.29 (m, 1H), 3.14-
3.09 (m, 2H), 2.43-2.37 (m, 1H), 2.27 (dd, J = 9.7, 17.2 Hz, 1H), 2.09-2.03 (m, 
1H), 1.75-1.52 (m, 7.0H), 0.96 (d, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 
174.1, 170.0, 46.8, 43.1, 42.9, 38.9, 30.6, 29.3, 28.5, 26.7, 25.8, 24.9, 14.0; 
ESIHRMS m/z calcd for  C13H22N2O2Na (M + Na)+: 261.1579, found: 261.1561. 
cis-Isomer: light yellow gum, IR (film) 1646 cm-1;  1H NMR (500 MHz, CDCl3) δ 
5.72 (br s, 1H), 3.59-3.40 (m, 5H), 3.32-3.26 (m, 1H), 2.94 (dd, J = 5.5, 16.5 Hz, 
1H), 2.70 (dd, J = 3.2, 16.2 Hz, 1H), 2.26-2.20 (m, 1H), 2.17-2.12 (m, 1H), 1.85 
(dd, J = 3.2, 13.2 Hz, 1H), 1.68-1.50 (m, 7H), 1.02 (d, J = 7.0 Hz, 3H); 13C NMR 
(125 MHz, CDCl3) δ 174.6, 169.6, 46.7, 45.6, 43.0, 41.2, 37.9, 32.1, 31.5, 31.1, 
29.9, 26.6, 25.8, 24.8, 20.6; ESIHRMS m/z calcd for  C13H22N2O2Na (M + Na)+: 
261.1579, found: 261.1564. 
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Part-II 
CHAPTER 5 
INTRODUCTION 
5.1. Antifreeze Substances. 
Antifreeze substances are a class of molecules, that are produced in 
organisms living in polar regions, to mitigate the effect of subzero temperatures 
by lowering the freezing point of body fluids.128-135 
5.2. Antifreeze Proteins and Glycoproteins 
In order to adapt to various extreme conditions in nature, living organisms 
have evolved various mechanisms with the course of time. Freeze tolerance is 
one such evolution where organisms, inhabiting arctic seas, employ an anti-
freezing mechanism to mitigate the effect of subzero temperatures. Scholander 
et al. collected blood serum from Arctic fishe that exhibits and abnormally low 
freezing point and showed that this phenomenon was not colligative in nature, 
thus ruling out the role of sodium chloride.136  Ever since the early findings there 
have been numerous studies in this direction which conclude that there are 
mainly two families of natural antifreeze substances, namely, the antifreeze 
glycoproteins (AFGP) and the antifreeze proteins (AFP) which are responsible for 
freezing point depression.137,138 The predominant amino acid found in both the 
AFGP and the AFP is alanine, each family possessing about 67% of this amino 
acid. However, structurally, AFGP and AFP are completely different; AFGP has 
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Ala-Ala-Thr as the repeating unit with threonine being the second most 
predominant amino acid, whereas no regularity is found in AFP sequences.139-142 
In addition, AFGPs contain disaccharide groups extending from the Thr residues. 
The AFPs almost exclusively adopt secondary conformations that contain α-
helical chains, whereas AFGP typically have no α-helical content in their 
secondary structure.143-147  
5.3.2.1. Mechanism of Thermal Hysteresis  
The structural features of these proteins play a crucial role in their 
specialized function of reducing the freezing point. Although there is ample 
evidence of freezing point depression by these proteins, the melting point of 
those ices when they do finally form remains very close to 0 oC.137,138,148 This 
disparity between the melting point and the freezing point is known as thermal 
hysteresis (TH), and the presence of TH is indicative of a prevailing non-
colligative mechanism. The extent of this non-colligative activity, for some 
species, can be as high as 500 times that of colligative salts on a molar basis. It 
is noteworthy that the existing crystal morphology of ice and the level of solution 
supercooling play crucial roles in the function of AFPs of AFGPs.149-151 Given that 
crystal morphology differs significantly with extent of supercooling of the water, 
these observations have been interpreted as pointing towards the importance of 
a site coverage mechanism on the growth surface of the ice crystal. Raymond 
and Devries were the first to point out that AFGP molecules lodge onto the 
crystalline surface and obstruct the growth at that point.152-163 Furthermore, the 
growth is expected to have a radius of curvature that is smaller than that of the 
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main part of the crystal.141,164-169 Hence, the growth front will experience a 
freezing temperature lower than the bulk system. Later Knight and DeVries 
experimentally proved that growing ice significantly acquires AFGP or AFP 
molecules by adsorption, affording crystal facets that will not grow freely in 
solution.154,157,162,170-172 However this postulate does not explain in detail the 
irreversible nature of the adsorption and thus the thermal hysteresis. Li and Luo 
developed a Flory-Huggins model for the distinctly different interaction of 
polymers with solution and ice.173 It remains unexplained, however, why the 
AFPs or AFGPs do not prevent the nucleation of ice crystals and wait until the 
crystal forms before adsorbing onto their surface and perturbing the growth.174-182 
To address this question Franks et. al, and later Wilson and Leader argued 
based on the calculation of free energy in support of nucleation inhibition.183,184 
Nevertheless, the argument of nucleation prevention is persuasive from a 
functional point of view and the experimental evidence alluded to above tends to 
support the argument of prevention of ice growth by an adsorption-desorption 
mechanism.165,166,185,186 
Of the two families of TH producing biomolecules, AFGPs are known to 
contain disaccharides that are composed mainly of N-acetylgalactosamine and 
galactose linked with threonine residues of the peptide chain.  
5.3.2.2. Thermal Hysterisis Producing Xylomannan 
Walters et. al, very recently, isolated a new class of thermal hysteresis 
producing biomolecules from a freeze tolerant beetle, Upis ceramboides, which 
most unusually do not contain any protein.187 The isolated thermal hysteresis 
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producing molecule was reported, based on extensive NMR studies and 
carbohydrate analysis, to contain an alternating xylopyranose-mannopyranose 
glycan, as the likely structure with both linkage types being belonging to the β-
(1→4) class, as shown in Figure 8. 
 
 
Figure 8. Thermal hysteresis producing xylomannan. 
The sugar composition of the isolated antifreeze xylomannan was analyzed 
by gas chromatography/mass spectrometry (GC/MS) of the per-O-trimethylsilyl 
(TMS) derivatives of the monosaccharide methyl glycosides obtained on 
degradation of the oligomer with 1(M) HCl in methanol. The 1H and 13C NMR 
spectra of the antifreeze substance were assigned based on the combination of 
advanced 2-D NMR spectra, namely, COSY, TOCSY, HMQC and HMQC-
TOCSY. The assigned chemical shifts were in accordance with those of 
previously reported mannosyl- and xylosyl aldopyranosides, when chemical shift 
patterns and signal multiplicities were taken into account. The anomeric 
configuration of xylopyranoside unit was assigned based on the coupling 
constant between H1 and H2 (3JH1,H2) of 7.8 Hz, which is virtually identical to that 
reported for methyl β-D-xylopyranoside.188,189 The reduction of thermal hysterisis 
activity of the isolated antifreeze sample following enzymatic cleavage with endo 
β-(1→4)xylosidase further supported the assignment of the xylosyl anomeric 
configuration. The anomeric configuration of the mannopyranoside linkage was 
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assigned based on the singlet nature of H1, indicating a 3JH1,H2 of less than 1.0 
Hz and on an observed 1JC1H1 of 160 Hz, both of which are typical for a β-
mannopyranoside.188 For both the Manp and Xylp residues the location of the O-
glycosidic linkage was assigned based on the 13C chemical shifts of the ring 
carbons. When compared with the unsubstituted methyl pyranosides, a 7-10 ppm 
downfield shift of C4 was observed in both saccharides indicative of coupling to 
O4 and therefore of (1→4) linkages.188  
While both the enzymatic treatment and the chemical shift and coupling 
constants assure the β-(1→4) linkage for xylopyranoside moiety, the 
mannopyranosidic linkage was considered to be ambiguous for two reasons. 
Primarily because, as mentioned early, the confusion between mannose H3
 
and 
H4 leading to ambiquity in the Xylp-Manp linkage and secondly because line 
broadening could lead to a misleading 3JCH value which in turn would lead to an 
erroneous anomeric assignment.  
To set the scene for the synthetic chemistry a brief explanation of the 
glycosylation will be given with particular emphasis on β-mannosylation.  
5.3.3. Importance of Glycosylation Reaction 
In nature, monosaccharide units are assembled in two distinctive types of 
O-glycosidic bond, commonly defined as 1,2-trans and 1,2-cis, both of which are 
found as  α- and β-glycosides. Due to the anomeric effect the synthesis of α-
glycosides are typically easier than those of the corresponding β-
glycosides.190,191 The neighboring group participation concept also plays a major 
role in the stereocontrolled synthesis of 1,2-trans glycosidic bonds, which 
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facilitates the preparation of β-gluco- and α-mannopyranosides among others. In 
the absence of neighboring group participation, stereocontrolled glycosylation is 
inherently more difficult due to the dictates of the anomeric effect.191  
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Figure 9. 1,2-cis and trans pyranosides 
5.3.3.1. β-Mannosylation  
Breakthrough research by Crich group showed the use of 4,6-O-
benzylidene protected anomeric sulfoxides or sulfides as glycosyl donors to be 
efficient for the construction of β-mannosides with high yield and excellent 
stereoselectivity.191 In 1989, Kahne introduced the use of anomeric sulfoxides as 
glycosyl donors for the synthesis of glycosidic bonds under very mild conditions 
and with an impressive range of acceptors.192 Crich and Sun extended this 
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protocol by incorporating the 4,6-O-benzylidene protecting group in the donor to 
generate β-mannosides.193,194 According to the established mechanism, 
preactivation of the sulfoxide donor with trifluoromethanesulfonic anhydride 
generates the covalently bound α-mannosyl triflate, the actual glycosyl donor, 
which upon nucleophilic displacement by the glycosyl acceptor affords the  β-
mannoside with high stereocontrol.195 Crich and Smith then further demonstrated 
the use of thiomannoside donors to generate α-mannosyl triflates by means of an 
electrophilic promoter combination of 1-benzenesulfinyl piperidine (BSP)/Tf2O in 
presence of a non-participating hindered base, 2,4,6-tri-tert-butylpyrimidine.196,197 
 
Figure 10. BSP and TTBP 
 
To explain the observed stereochemical outcome of these reactions the 
general glycosylation mechanism depicted in Scheme 38, must be considered 
The ideal situation for complete β-selectivity involves the direct SN2 attack of the 
acceptor alcohol on the covalently bound α-glycosyl donor, i.e., the triflate. 
However, the tendency of the reaction to proceed via the intermediacy of a 
transient contact ion pair (CIP), or even a solvent separated ion pair (SSIP), 
renders the formation of the β-glycosylated product increasingly difficult. The 
nucleophilic attack of the acceptor alcohol on a contact ion pair, in which the 
counter ion (-OTf) is closely associated with the oxacarbenium ion and effectively 
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blocking one face of it, is functionally equivalent to the direct SN2 attack. 
However, the anomeric effect dictates that any reaction proceeding through the 
solvent separated ion pair is likely to lead in part to the axial glycoside, which is 
obviously the predominant product from any free oxocarbenium ions. The 4,6-O-
benzylidene protecting group, due to its disarming nature, shifts the whole series 
of equilibria in Figure 11 towards the left as much as possible.198 
 
Figure 11. Equilibria involved in mannosylation 
 
The disarming nature of the 4,6-O-benzylidene group was first recognized 
by Fraser-Reid and coworkers who invoked a torsional effect.199 Working in the 
gluco- series, they suggested that trans-fused 4,6-O-benzylidene protecting 
group restricts the flexibility of the pyranose ring, resulting in an oxocarbenium 
ion intermediate with a computed 20o twist in the ideally syn coplanar C5-O5-C1-
C2 system, thereby increasing the relative activation energy for the formation of 
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the oxocarbenium ion (Figure 12).200  In a subsequent paper, differential solvation 
was also computed to be of significance in these so-called torsional disarming 
effects.198,201 
 
Figure 12. Computed relative activation energies for formation of 
oxacarbenium ions from pentenyl glycosides 
 
More recently, Bols and coworkers provided experimental evidence in support of 
the notion that the disarming effect of the 4,6-O-acetal group is mainly due to the 
locking of the C5-C6 bond in the deactivating tg-conformation (Figure 13).202 
However, it was not clear whether the displacement by the alcohol occurs in an 
SN2 fashion or if the covalently bound triflate serves as a reservoir for the release 
of transient contact ion/triflate ion pairs. Recently, Crich has demonstrated 
through the use of the kinetic isotope effect that the substitution actually 
proceeds with substantial oxocarbenium ion character, i.e., via the contact ion 
pair.203 
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Figure 13. Hydroxymethyl group conformations of D-aldopyranoses. 
 
In contrast to the relatively difficult β-mannosylation, the β-xyloside linkage 
was considered accessible by a standard neighboring group participation, relying 
on the directing influence of carboxylate ester at the 2-positoin of the donor as 
shown in Scheme 58. 
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Scheme 58. β-Directing neighboring group participation in β-
xylopyranoisde formation 
 
5.4. Objective.  
The objective of the work described here was to chemically synthesize and 
verify the structure of the xylomannan antifreeze that was isolated from freeze 
tolerant Alaskan beetle Upis ceramboides. The results of this work are presented 
in the following chapter and the experimental chapter that follows it. 
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CHAPTER 6 
SYNTHESIS and STRUCTURAL VERIFICATION of a NONPROTEIN 
ANTIFREEZE OLIGOSACCHARIDE 
6.1. Background 
The Alaskan beetle Upis ceramboides is reported to possess a thermal 
hysterisis producing xylomannan, which is essential for its survival in extreme 
sub zero temperatures. As discussed in the introduction, following extensive 
NMR and MS analysis coupled with both chemical and enzymatic degradative 
studies, Serianni and coworkers proposed the isolated antifreeze substance to 
be an alternating xylopyranose-mannopyranose glycan with both linkage types 
being belonging to the β-(1→4) class: [→4)-β-D-Manp-(1→4)-β-D-Xylp-(1→]n.  
However the linkage isomer [→4)-β-D-Manp-(1→3)-β-D-Xylp-(1→]n, in which the 
xylopyranose residue was β-linked to the 3-position of the mannopyranose ring 
rather than to the 4-position could not be completely excluded on the basis of the 
spectroscopic evidence available.  Moreover, it was not convincingly determined 
whether the glycan consists of alternating sections of a mannan and a xylan or 
not. The goal of the studies described in this chapter was to provide by total 
synthesis authentic samples of short sections of xylomannan (Figure 14) 
corresponding to the proposed structure and some of its isomers, with a view to 
verifying the structure of the antifreeze substance. 
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Figure 14. Target xylomannan 
6.2. Retrosynthetic Analysis. 
Consideration of the various linear approaches possible and their inherent 
problems quickly focused attention on a convergent strategy for the synthesis of 
an octasaccharide in which a tetrasaccharyl donor would be coupled with a 
tetrameric acceptor. Moreover, a strategic choice was taken according to which 
the key convergent glycosidic bond forming step would involve coupling to a 
xylosyl donor, rather than to a mannosyl donor, as this would enable advantage 
to be taken of neighboring group participation and, thus, of a high degree of 
predictable stereocontrol in the formation of the key linkage (Scheme 59). 
 
 
 
Scheme 59. Retrosynthetic analysis for a convergent synthesis of a 
xylomannan. 
As shown in Scheme 52, upon ester directed xylosylation, the octasaccharyl 
xylomannan is expected to be formed selectively, from two tetrasaccharides, as 
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the β-anomer. Likewise, the necessary tetrasaccharyl building blocks were 
expected to be obtained by the β-directing xylosylation of two disaccharides 
(Scheme 60). Finally, both compound 191 and the precursor of 192 were 
considered to be obtainable by mannosylation following Crich’s protocol. 
 
 
 
Scheme 60. Retrosynthetic analysis of tetrasaccharyl acceptor 183 
6.3. Synthesis of Octasaccharide 179. 
6.3.1. Synthesis of Two 2,3-O-Isopropylidene Xylopyranosides. 
Synthesis began with the selective protection of the 2,3-diol of two readily 
available xylopyranosides. This was effected by treatment of methyl β-D-
xylopyranoside and phenyl β-D-thioxylopyranoside with 2-methoxypropene in 
DMF with a catalytic quantity of HCl at room temperature according to a literature 
protocol (Scheme 61).204-206  
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Scheme 61. Selective acetonylation of xylopyranosides. 
Upon chromatographic purification the products of these reactions were obtained 
as white foams, whose regiochemistry was determined by the combination of 
COSY, DEPT and HMQC studies. As shown in Figure 15, a combination of 
DEPT and HMQC COSY interactions enabled correlation of the methylene 
signals H5 with H4. The fact that H4 is coupled to the OH signal indicates that 
the acetonide group spans O2 and O3.  
 
 
 
Figure 15. Diagnostic couplings in compounds 194 and 195.  
 
6.3.2. [1+1] Coupling 
The 2,3-O-benzyl-4,6-O-benzylidene protected β-thiomannopyranoside 183 
was prepared from commercially available D-mannose following the standard 
procedure.194,207 The iterative coupling of this phenyl thiomannopyranoside donor 
and phenyl thioxylopyranoside was carried out using the BSP-Tf2O activation 
system (Scheme 62). Preactivation of the mannosyl donor was conducted with 
subsequent addition of 1-octene as a sacrificial olefin to ensure excess activated 
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BSP was quenched before the addition of the phenyl thioxylopyranoside.  In this 
manner premature activation of the thioxyloside was avoided. For the coupling of 
the methyl xylopyranoside acceptor, no such addition of octene was required.  
 
Scheme 62. Mannosylation of xylopyranosides 
 
That both of these coupling reactions proceeded extremely well is evident from 
their excellent yields and the fact that in each case only one isomer was isolated.   
The β-anomeric configuration of the mannopyranoside linkages was determined 
from the 3JC-H anomeric coupling constants of 157.6 Hz for compound 198 and 
157.2 Hz for compound 199.  
6.3.3 Selective cleavage of the acetonide group and subsequent 
esterfication. 
With the scene set for selective cleavage of an acetonide group in the 
presence of a benzylidene acetal, the disaccharides were heated in various 
solvent systems such as 1N HCl-CH3Cl, and acetic acid-water with monitoring by 
mass spectrometry. Unfortunately, in all cases the benzylidene group was 
cleaved along with the acetonide group. Finally, the disaccharides were heated in 
glacial acetic acid, which gratifyingly resulted in selective cleavage of the 
acetonide group. The optimum conditions for this selective cleavage involved 
142 
 
heating at 65 °C for 3 h. Upon completion of the reaction, the solvents were 
removed under vacuum, and benzoylation of the crude reaction mixture was 
performed immediately as shown in Scheme 63 to give the two disaccharides 
191 and 200.   
 
Scheme 63. Isopropylidene cleavage and benzoylation. 
 
6.3.4. Reductive cleavage of benzylidene acetals. 
The next challenging reaction was the selective reductive cleavage of the 
benzylidene acetal in compounds 191 and 200 so as to uncap mannose 4-OH, 
while leaving mannose O6 protected in the form of a benzyl ether. This reaction 
was carried out using sodium cyanoborohydride in the presence of 2M HCl in 
diethyl ether, during which anhydrous conditions were maintained using 3 Å 
molecular sieves.  Although a first attempt was successful, the reproducibility of 
this conversion was very variable. Indeed it was reported earlier that in the 
presence of multiple ether linkages this reaction tends to lead to 
decomposition.208 A careful analysis by mass spectrometry of the decomposed 
reaction mixture revealed that instead of selective reductive cleavage there was 
competing cleavage of the benzylidene acetals. This phenomenon was observed 
even with a large excess of sodium cyanoborohydride, and in all cases 
decomposition started once the reaction mixture was acidified. This observation 
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clearly indicated that the benzylidene group was cleaved owing to the presence 
of excess acid. The addition of HCl, thus, was conducted in a dropwise manner 
which resulted in a far more reproducible reaction and the yields reported in 
Scheme 64. 
 
Scheme 64. Selective reductive cleavage of benzylidene acetals. 
 
The molecular ion in the ESIHRMS spectra for compounds 201 and 202 (m/z 
827.3055 and 905.2987, respectively) expectedly shows an increase in mass of 
two units corresponding to the incorporation of by two protons as compared to 
the precursor benzylidene acetals. The loss of a benzylidene proton that appears 
at δ 5.46 for compound 191 and δ 5.42 for compound 200 in the 1H NMR spectra 
and appearance of two extra protons with a coupling constants of 12.5 Hz typical 
for diastereotopic benzylic protons, confirmed the selective reduction of 
benzylidene acetal. This was further confirmed by the loss of benzylidene carbon 
at δ 101.5 for both compounds 191 and 200 in the 13C NMR spectra and by the 
appearance of a broad singlet at δ 2.66 for compound 191 and δ 2.65 ppm for 
compound 200 in 1H NMR spectra corresponding to the alcoholic OH. The 
regioselectivity of these reductive cleavage reactions was determined based on a 
combination of COSY, HMQC, and DEPT NMR experiments. For compounds 
201 and 202 the correlation of the uncapped alcoholic proton to a methine proton 
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(H4) and not to a pair of methylene protons (H6) in the COSY NMR spectrum 
confirmed that the 4-OH was uncapped and not the 6-OH (Figure 16).  
 
Figure 16. Diagnostic correlations in compounds 201 and 202 for 
determination of regioselectivity 
6.3.5. NGP-Directed [2+2] β-Xylosylation. 
With a dimeric donor and two dimeric acceptors in hand, attention was 
turned to the synthesis of two tetrasaccharides. The neighboring group directed 
β-xylosylations were carried out using the BSP-Tf2O activation system in 
dichloromethane at -65 oC (Scheme 58). Initially, glycosylation was attempted in 
the presence of TTBP, but the reaction was not clean and yield was low. 
Presuming orthoester formation to be the problem, glycosylation subsequently 
was carried out in the absence of TTBP, conditions favorable for the 
rearrangement of orthoesters to glycosides. Similarly to the mannosylation of 
compound 197, when carrying out the glycosylation of 202, 1-octene was added 
as a sacrificial olefin,in order to obtain tetrasaccharide 204. 
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Scheme 65. Tetrasaccharide synthesis  
Both tetrameric xylomannans were isolated by normal chromatographic 
purification with excellent yield.  Only one anomer was obtained for both 
tetrasaccharides and the β-anomeric configuration of the xylp-manp linkage was 
determined by the 3JHH coupling constant between xylose H1 and H2, which was 
7.0 Hz for both compounds 203 and 204.  
6.3.6. Reductive cleavage of benzylidene acetal 203 to afford tetrameric 
acceptor 205.  
After successfully carrying out the [2+2] glycosylation reaction, the 4-OH at 
non-reducing end of the newly formed tetrasaccharide was uncapped by 
selective reductive cleavage of the 4,6-O-benzylidine acetal following the 
procedure discussed above in section 6.3.4. (Scheme 66). 
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Scheme 66. Reductive cleavage of benzylidene acetal of tetrasaccharide  
 
Compound 205 was obtained as a white foam upon purification by column 
chromatography and showed a molecular ion with two protons more than the 
substrate, thereby confirming the reduction. The loss of a benzylidene proton at 
5.43 ppm in the 1H NMR spectra and a carbon resonance at δ 101.9 the 13C 
spectrum further confirming the reductive cleavage of the benzylidene acetal. 
This was further underlined by the appearance of two extra benzylic protons with 
a geminal coupling constant 12.5 Hz and a broad singlet at 2.73 ppm in the 1H 
NMR spectrum corresponding to the new OH group.  A combination of COSY, 
HMQC and DEPT NMR studies, as discussed in section 6.3.4, confirmed the 
regioselectivity of this reduction. 
6.3.7. NGP-Directed [4+4] β-Xylosylation. 
With both tetrameric acceptor and donor in hand, the scene was set for a 
4+4 glycosylation to obtain the octasaccharide and again the BSP-Tf2O activation 
system was selected. The tetrameric donor 205 along with BSP, and 4 Å 
molecular sieves were dried under vacuum before cooling to -65 oC and addition 
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of freshly distilled Tf2O. After stirring for 30 minutes in dichloromethane the 
tetrameric acceptor followed by stirring for 3 h before the reaction was quenched 
with Et3N (Scheme 67).  
 
Scheme 67. [4+4] β-Xylosylation to give octasachharide 206 
 
.The 1H and 13C NMR spectra and the HRMS data of the isolated octasaccharide 
were in full agreement with those expected for the desired octasaccharide. 
Extenesive 2 D NMR studies of the deprotected octasaccharyl xylomannan, as 
discussed in section 6.3.8. below, determined the newly formed Xylp-Manp to 
have a β-linkage with a 3JHH coupling constant 7.5 Hz. 
6.3.8. NGP-Directed [4+2] β-Xylosylation. 
To gain a better understanding of how the NMR spectra of the oligomeric 
xylomannans are influenced by chain length a hexasaccharide was also 
synthesized by [4+2] glycosylation. Standard glycosylation using the BSP-Tf2O 
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activation system enabled coupling of donor 204 as with acceptor 201 to give the 
hexasaccharide 207 (Scheme 68).  
 
  
 
Scheme 68. [4+4] β-Xylosylation to afford hexasachcharide 207. 
6.3.9. Deprotection of Xylomannans.  
Deprotection of the various oligosaccharides assembled was accomplished 
by saponification with sodium methoxide in methanol, followed by hydrogenolysis 
over palladium on charcoal in methanol to afford the three xylomannans 208, 209, 
and 210 (Scheme 69).  
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Scheme 69. Deprotection of xylomannans. 
 
Clean glycans were obtained as white foams upon filtration and removal of 
the solvent with excellent yield in all cases (Scheme 62). The structures of the 
synthesized xylomannans were confirmed by 1H and 13C NMR spectroscopy and 
high resolution ESI mass spectrometry. All NMR spectra were recorded under 
similar conditions to those employed in the literature for the isolated xylomannan 
(D2O at 40 oC and pH 7.5) (Figures 17 and 18).  
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Figure 17. 1H NMR spectra of tetra-, hexa-, and octasaccharyl xylomannans 
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Figure 18. 13C NMR spectra of tetra-, hexa-, and octasaccharyl xylomannans 
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6.3.10. Assignments of 1H and 13C NMR Spectra. 
Extensive 2D NMR studies were carried out to assign the 1H and 13C NMR 
spectra of all three synthesized xylomannans. 1H spectrum was assigned based 
on DFQ-COSY along with TOCSY NMR and 13C NMR spectra was assigned 
based upon correlation of assigned 1H NMR signal with the carbon signals in 
HMQC spectra. The assigned 1H and 13C spectral data of all three xylomannans 
were tabulated and compared with the reported data of isolated xylomannan as 
shown in Tables 8, 9, 10, and 11. The 1H NMR spectrum of octasaccharide 210, 
that was recorded at 500 MHz, has four anomeric signals; three internal 
mannopyranosyl anomeric hydrogen grouped into 5.03 ppm, while the 
nonreducing mannopyranosyl anomeric hydrogen signal appeared at 5.02. Three 
internal xylopyranosyl anomeric protons grouped into 4.65 ppm, while the 
reducing end xylopyranosyl anomeric proton appeared at 4.57 ppm in 1H NMR 
spectra. The 13C spectrum of octasaccharide recorded at 125 MHz, has four set 
of anomeric carbons, similar to 1H spectra, with internal mannopyranosyl 
anomeric carbons appearing at 98.6 ppm and the nonreducing mannpyranosyl 
anomeric carbon appearing at 98.7 ppm. The xylopyranosyl anomeric carbons 
appeared at 103.6 and 104.1 ppm in 13C spectrum with the later coming from 
reducing end.  
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Table 10. 13C and 1H Chemical shifts (ppm) for the Internal Mannose 
Repeating Units of Isolated and Synthetic Xylomannans Recorded in D2O at 
pH 7.5 and 40 °C 
 
 
 
 
 
 
 
 
 
Glycan C1 (H1) 
C2 
(H2) 
C3 
(H3) 
C4 
(H4) 
C5 
(H5) 
C6 
(H6, 6’) 
[→4)-β-D-Manp-(1→4)-β-D-Xylp-(1→]n 
(isolated material) 
100.2 
(4.92) 
70.1 
(4.30) 
71.6 
(3.98) 
76.6 
(3.96) 
75.1 
(3.74) 
60.6 
(4.09, 
3.93) 
H[→4)-β-D-Manp-(1→4)-β-D-Xylp-
(1→]2OMe 
(208) 
98.4 
(5.08) 
70.9 
(4.29) 
71.6 
(4.01) 
76.5 
(3.84) 
75.3 
(3.69) 
60.4 
(4.18, 
3.99) 
H[→4)-β-D-Manp-(1→4)-β-D-Xylp-
(1→]3OMe 
(209) 
98.4 
(5.07) 
70.9 
(4.27) 
71.6 
(3.99) 
76.5 
(3.82) 
75.3 
(3.69) 
60.4 
(4.16, 
3.94) 
H[→4)-β-D-Manp-(1→4)-β-D-Xylp-
(1→]4OMe 
(210) 
98.6 
(5.03) 
70.8 
(4.25) 
71.8 
(3.98) 
76.7 
(3.82) 
75.5 
(3.63) 
60.7 
(4.16, 
3.97) 
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Table 11. 13C and 1H Chemical Shifts (ppm) for the Internal Xylose 
Repeating Units of Isolated and Synthetic Xylomannans Recorded in D2O at 
pH 7.5 and 40 °C 
 
Table 12. 13C and 1H Chemical Shifts (ppm) for the Nonreducing Terminal 
Mannose of the Synthetic Xylomannans Recorded in D2O at pH 7.5 and 40 
°C 
 
Glycan C1 (H1) 
C2 
(H2) 
C3 
(H3) 
C4 
(H4) 
C5 
(H5) 
C6 
(H6, 6’) 
H[→4)-β-D-Manp-(1→4)-β-D-Xylp-
(1→]2OMe 
(208) 
98.6 
(5.06) 
71.7 
(4.25) 
71.6 
(3.82) 
67.1 
(3.82) 
76.5 
(3.63) 
61.2 
(4.17, 3.97) 
Glycan C1 (H1) 
C2 
(H2) 
C3 
(H3) 
C4 
(H4) 
C5 
(H5, 5’) 
[→4)-β-D-Manp-(1→4)-β-D-Xylp-(1→]n 
(isolated material)a,b 
101.7 
(4.66) 
72.8 
(3.48) 
73.8 
(3.73) 
76.6 
(4.00) 
63.0 
(4.28, 3.55) 
H[→4)-β-D-Manp-(1→4)-β-D-Xylp-
(1→]2OMe 
(208) 
103.4 
(4.69) 
73.0 
(3.59) 
74.0 
(3.84) 
76.3 
(4.12) 
63.1 
(4.39, 3.65) 
H[→4)-β-D-Manp-(1→4)-β-D-Xylp-
(1→]3OMe 
(209) 
103.4 
(4.69) 
73.0 
(3.61) 
74.0 
(3.84) 
76.4 
(4.12) 
63.1 
(4.40, 3.66) 
H[→4)-β-D-Manp-(1→4)-β-D-Xylp-
(1→]4OMe 
(210) 
103.6 
(4.65) 
73.3 
(3.57) 
74.2 
(3.85) 
76.5 
(4.11) 
63.2 
(4.40, 3.67) 
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H[→4)-β-D-Manp-(1→4)-β-D-Xylp-
(1→]3OMe 
(209) 
98.2 
(5.07) 
71.4 
(4.25) 
72.5 
(3.87) 
66.9 
(3.82) 
76.2 
(3.66) 
61.2 
(4.18, 3.97) 
H[→4)-β-D-Manp-(1→4)-β-D-Xylp-
(1→]4OMe 
(210) 
98.7 
(5.02) 
71.1 
(4.23) 
71.8 
(3.89) 
67.2 
(3.78) 
75.5 
(3.62) 
61.4 
(4.15, 3.95) 
 
 
Table 13. 13C and 1H Chemical Shifts (ppm) for the Reducing Terminal 
Xylose of the Synthetic Xylomannans Recorded in D2O at pH 7.5 and 40 °C 
 
 
Since the NMR spectra of the oligomeric xylomannans are relatively insensitive 
to chain length, as is evident from Figures 10 and 11 and Tables 8-11, higher 
homologs were expected to have very similar spectra.  This being the case, the 
Glycan C1 (H1) 
C2 
(H2) 
C3 
(H3) 
C4 
(H4) 
C5 
(H5, 5’) 
OCH3 
OCH3 
H[→4)-β-D-Manp-(1→4)-β-D-
Xylp-(1→]2OMe 
(208) 
104.0 
(4.61) 
73.3 
(3.56) 
74.1 
(3.84) 
76.5 
(4.06) 
63.3 
(4.37, 3.65) 
 
57.5 
(3.79) 
H[→4)-β-D-Manp-(1→4)-β-D-
Xylp-(1→]3OMe 
(209) 
103.9 
(4.61) 
72.9 
(3.55) 
73.9 
(3.83) 
76.4 
(4.07) 
63.0 
(4.36, 3.63) 
 
57.3 
(3.80) 
H[→4)-β-D-Manp-(1→4)-β-D-
Xylp-(1→]4OMe 
(210) 
104.1 
(4.57) 
73.1 
(3.50) 
74.2 
(3.83) 
76.6 
(4.08) 
63.3 
(4.31, 3.55) 
 
57.5 
(3.76) 
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synthesis of higher homologs than the octasaccharide was not considered 
necessary.   
Comparison of the spectral data for 208-210 with the literature value of the 
antifreeze glycan reveals close homology between the synthetic and isolated 
material, with only minor differences being found for both the 1H and 13C 
chemical shifts at the mannopyranoside anomeric center. In particular, the 
literature 13C value for the mannopyranoside anomeric center of the isolated 
xylomannan is 100.2 ppm, while the observed value for the synthesized 
xylomannan is 98.6 ppm. Furthermore, the observed manopyranoside anomeric 
hydrogen at δ 5.03 differs by 0.11 ppm from the literature value. Other very minor 
differences associated with the mannopyranoside unit were found in the 13C 
chemical shift of C2, and in the 1H chemical shifts of H4 and H5. While the 1H 
NMR signal for the xylopyranoside anomeric proton of the synthesized glycan 
appeared almost at the same chemical shift as that of the literature data, the rest 
of the protons differed on average by 0.07 ppm from the literature data in the 1H 
NMR spectra. The xylopyranoside carbons, however, appeared almost at the 
same chemical shift to the literature value with only exception being the anomeric 
carbon which differs by 1.7 ppm from the reported value.  
These differences, however minor, left room for doubt as to the identity of 
the isolated xylomannan. Thus, the synthesis of three further structures, 
considered as possibilities for the isolated xylomannan by Serianni and 
coworkers, was undertaken.  These structures are the linkage isomers  H[→3)-β-
D-Manp-(1→4)-β-D-Xylp-(1→]2OMe (211), H[→4)-α-D-Manp-(1→4)-β-D-Xylp-
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(1→]2OMe (212) and H[→3)-α-D-Manp-(1→4)-β-D-Xylp-(1→]2OMe (213) (Figure 
19).  
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Figure 19. Alternative linkage isomers. 
6.4. Snthesis of Xylomannan (211) 
6.4.1. [1+1] β-Mannosylation and Subsequent Synthesis Acceptor. 
The donor, phenyl 2-O-benzyl-4,6-O-benzylidene-3-O-(2-
naphthalenylmethylthiomannopyranoside (214), was prepared according to a 
literature protocol209 and coupled by the standard protocol with activation by 
BSP-Tf2O at -65 oC in presence TTBP base in dichloromethane before addition 
of the acceptor 187 (Scheme 70).  
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Scheme 70. Preparation of disaccharide 213 
 
Compound 215 was obtained as a white foam in 86% yield. The β selectivity of 
the isolated disaccharide was established by its 3JCH coupling constant for the 
mannosyl anomeric carbon which is 157.5 Hz. Selective cleavage of the 
isopropylidene acetal in presence of a benzylidene acetal was carried out by 
heating the disaccharide 215 in glacial acetic acid at 65 oC for 3 h and was 
followed by acetylation to give 216 in 85% yield for the two steps (Scheme 71). 
 
 
Scheme 71. Isopropylidene cleavage and acetylation 
Following the standard literature procedure,210 compound 216, was treated with 
DDQ to uncap the mannopyranosyl 3-OH and provide compound 217 as shown 
in Scheme 72. 
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Scheme 72. Cleavage of a naphthalenylmethyl ether. 
6.4.2. NGP-Directed [2+2] β-Xylosylation and Subsequent Deprotection 
The ester directed β-xylosylation was carried out using the BSP-Tf2O 
activation system in dichloromethane at -60 oC (Scheme 73) in the absence of 
TTBP to avoid orthoester formation.  
 
Scheme 73. Synthesis of Glycan 211 
 
After saponification of the crude reaction mixture, purification gave 
tetrasaccharide 218 in 72% yield. Hydrogenolysis of the tetrasaccharide 218 over 
Pd on carbon in methanol afforded the unprotected tetrasaccharide 211 as a 
white foam in 99% yield. The 1H and 13C NMR spectra of glycan 211 were 
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recorded in D2O at 40 oC and pH 7.5 with the D2O peak being set at 4.80 ppm 
and suppressed (Figure 20).  
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Figure 20. 1H and 13C NMR spectra of glycan 211 
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6.5. Synthesis of Tetrasachharide 212 
6.5.2. Synthesis of Dimeric Donor 220 and Acceptor 221 via NGP Directing 
α-Mannosylation, Subsequent Acetonide Cleavage and Acetylation  
The 2,3-di-O-acetyl-4,6-O-benzylidene protected β-thiomannopyranoside 
219 was prepared following a standard procedure and was coupled to phenyl 
thioxylopyranoside 194 and methyl xylopyranoside 197 using the BSP-Tf2O 
activation system (Scheme 74).   
 
 
 
Scheme 74. [1+1] α-Mannosylation of xylopyranosides. 
 
The anomeric 3JCH coupling constant, which is 169.7 Hz and 170.2 Hz 
respectively for glycan 220 and 221, of both the isolated disaccharides 
determined the α-anomeric configuration Manp-Xylp bond in both the glycans. 
Selective cleavage of the isopropylidene was carried out, as discussed in 
section 6.3.3., by heating the glycans in glacial acetic acid at 65 oC for 3 h. Upon 
completion of the reaction, acetic acid was removed under vacuum to afford 
white residue which was acetylated by the treatment of acetic anhydride in 
pyridine (Scheme 75).  
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Scheme 75. Preparation if disaccharides 224 and 225 
Reductive cleavage of the benzylidene acetal in disaccharide 223 was 
carried out, as discussed in section 6.3.4., by treatment with sodium 
cyanoborohydride and 2M HCl in diethyl ether. Subsequent work up of the 
reaction mixture and chromatographic purification over silica gel gave acceptor 
224 (Scheme 76). 
 
Scheme 76. Reductive cleavage of the benzylidene acetal from 223. 
The ESIHRMS m/z, found 607.2003 for compound 224, expectedly shows mass 
excess by two protons as compared to its precursors. The loss of a benzylidene 
proton that appears at 5.57 ppm in 1H NMR spectra and appearance of two extra 
protons with a coupling constant 12.5, signatory to benzylic proton, confirmed the 
selective reduction of benzylidene acetal. This was further reassured by the loss 
of benzylidene carbon at 101.8 ppm in 13C NMR spectra and appearance of one 
broad duplet proton at 2.80 ppm in 1H NMR spectra. The regioselectivity of this 
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reaction was determined, as discussed in above section 6.3.4., based on a 
combination of COSY, HMQC, and CDEPT.  
6.5.3. Synthesis of Tetrasaccharide 212 via [2+2] NGP Controlled β-
Xylosylation, and Deprotection.  
With both donor 222 and acceptor 224 in hand the scene was set for a NGP 
controlled [2+2] β-xylosylation, which was carried out using the standard BSP-
Tf2O activation system (Scheme 77). 
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Scheme 77. Synthesis of tetrasachharide via [2+2] coupling and 
subsequent deprotection. 
The tetrasaccharide 225, whose structure was confirmed by1H and 13C NMR 
spectroscopy as well as HR mass spectrometry. It was then subjected to 
deprotection, which was accomplished by saponification with sodium methoxide 
in methanol, followed by hydrogenolysis over palladium on charcoal in methanol 
to afford the xylomannan 212. The structure of tetrasachharide 212 was 
confirmed by 1H and 13C NMR spectroscopy (Figure 21), HR mass spectrometry, 
and extensive 2-D NMR studies. 
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Figure 21. 1H and 13C NMR spectra of tetrasaccharide 212 
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6.6. Synthesis of Tetrasaccharide 213 
 
6.6.2. Synthesis of Disaccharide 227. 
The known phenyl thiomannopyranoside210 donor 226 was activated with 
BSP-Tf2O at -65 oC in dichloromethane and coupled to acceptor 195 leading to 
the isolation of disaccharide 227 in 82% yield (Scheme 78).  
 
 
Scheme 78. [1+1] α-Mannosylation  
The structure of purified disaccharide was confirmed by1H and 13C NMR 
spectroscopy as well as HR mass spectrometry. The selective cleavage of the 
isopropylidene group of compound 227 and subsequent acetylation were carried 
out following the same procedure discussed in section 6.3.3. (Scheme 79). 
 
 
Scheme 79. Isopropylidene cleavage and acetylation to afford 228 
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The mannopyranosyl 3-OH of 228 was uncapped by treatment with DDQ in 
chloroform-water mixture, to access the disaccharyl acceptor 229 (Scheme 80). 
 
Scheme 80. Cleavage of a naphthalylmethyl ether. 
6.4.2. NGP-Directed [2+2] β-Xylosylation and Subsequent Deprotection 
With both donor 222 and acceptor 229 ready, the ester directed β-
xylosylation was carried out using the BSP-Tf2O activation system in 
dichloromethane at -65 oC (Scheme 81). The crude coupling reaction mixture 
was immediately saponified, after which silica gel chromatography afforded 230 
in 73 % yield for the two steps (Scheme 81). 
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Scheme 81. Synthesis of Glycan 211 
The tetrasachharide 230, whose structure was confirmed by1H and 13C NMR 
spectroscopy and HR mass spectrometry, was subjected to hydrogenolysis over 
palladium on charcoal in methanol to afford  xylomannan 213. The structure of 
tetrasaccharide 213 was confirmed by 1H, 13C NMR spectroscopy (Figure 22), 
HR mass spectrometry, and extensive 2-D NMR studies. 
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Figure 22. 1H and 13C NMR spectra of tetrasaccharide 213 
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6.7. Assignments of 1H and 13C NMR Spectra of Synthesized Xylomannans 
and Subsequent Comparison with the isolated xylomannan. 
Extensive 2-D NMR studies were carried out to assign the 1H and 13C 
spectra of all three newly synthesized xylomannans. 1H NMR spectra were 
assigned based on DFQ-COSY coupled with TOCSY NMR.  The 13C NMR 
spectra were assigned based upon the correlation of assigned 1H NMR signals 
with the carbon signals in the HMQC spectrum. The assigned 1H and 13C 
spectral data of all three xylomannans were tabulated (Tables 14-17 ) along with 
three other synthesized xylomannans 208-210 and the differences with proton 
and carbon chemical shift of isolated xylomannan were compared as shown in 
Figures 23 and 24. 
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Table 14.13C and 1H Chemical Shifts (ppm) for the Repeating Internal 
Mannopyranoside Residues of Isolated and Synthetic Xylomannans. 
 
 
 
 
 
Glycan C1 (H1) 
C2 
(H2) 
C3 
(H3) 
C4 
(H4) 
C5 
(H5) 
C6 
(H6, 6’) 
[→4)-β-D-Manp-(1→4)-β-D-Xylp-(1→]n 
(isolated material)a,b 
100.2 
(4.92) 
70.1 
(4.30) 
71.6 
(3.98) 
76.6 
(3.96) 
75.1 
(3.74) 
60.6 
(4.09, 3.93) 
H[→4)-β-D-Manp-(1→4)-β-D-Xylp-
(1→]2OMe 
(15)c 
98.4 
(5.08) 
70.9 
(4.29) 
71.6 
(4.01) 
76.5 
(3.84) 
75.3 
(3.69) 
60.4 
(4.18, 3.99) 
H[→4)-β-D-Manp-(1→4)-β-D-Xylp-
(1→]3OMe 
(16)c 
98.4 
(5.07) 
70.9 
(4.27) 
71.6 
(3.99) 
76.5 
(3.82) 
75.3 
(3.69) 
60.4 
(4.16, 3.94) 
H[→4)-β-D-Manp-(1→4)-β-D-Xylp-
(1→]4OMe 
(17)c 
98.6 
(5.03) 
70.8 
(4.25) 
71.8 
(3.98) 
76.7 
(3.82) 
75.5 
(3.63) 
60.7 
(4.16, 3.97) 
H[→3)-β-D-Manp-(1→4)-β-D-Xylp-
(1→]2OMe 
(18)c 
98.5 
(5.09) 
68.4 
(4.48) 
80.1 
(4.14) 
65.1 
(3.97) 
76.5 
(3.72) 
61.2 
(4.21, 4.04) 
H[→4)-α-D-Manp-(1→4)-β-D-Xylp-
(1→]2OMe 
(19)c 
102.1 
(5.31) 
70.2 
(4.34) 
70.5 
(4.09) 
78.0 
(4.01) 
74.8 
(3.89) 
60.7 
(4.18, 4.02) 
H[→3)-α-D-Manp-(1→4)-β-D-Xylp-
(1→]2OMe 
(20)c 
101.5 
(5.45) 
70.1 
(4.58) 
78.0 
(4.28) 
67.6 
(4.07) 
74.8 
(3.98) 
61.1 
(4.20, 4.11) 
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Table 15.13C and 1H Chemical Shifts (ppm) for the Repeating Internal 
Xylopyranoside Residues of Isolated and Synthetic Xylomannans.  
 
 
 
 
 
 
 
 
 
 
Glycan C1 (H1) 
C2 
(H2) 
C3 
(H3) 
C4 
(H4) 
C5 
(H5, 5’) 
[→4)-β-D-Manp-(1→4)-β-D-Xylp-(1→]n 
(isolated material)a,b 
101.7 
(4.66) 
72.8 
(3.48) 
73.8 
(3.73) 
76.6 
(4.00) 
63.0 
(4.28, 3.55) 
H[→4)-β-D-Manp-(1→4)-β-D-Xylp-
(1→]2OMe 
(15)c 
103.4 
(4.69) 
73.0 
(3.59) 
74.0 
(3.84) 
76.3 
(4.12) 
63.1 
(4.39, 3.65) 
H[→4)-β-D-Manp-(1→4)-β-D-Xylp-
(1→]3OMe 
(16)c 
103.4 
(4.69) 
73.0 
(3.61) 
74.0 
(3.84) 
76.4 
(4.12) 
63.1 
(4.40, 3.66) 
H[→4)-β-D-Manp-(1→4)-β-D-Xylp-
(1→]4OMe 
(17)c 
103.6 
(4.65) 
73.3 
(3.57) 
74.2 
(3.85) 
76.5 
(4.11) 
63.2 
(4.40, 3.67) 
H[→3)-β-D-Manp-(1→4)-β-D-Xylp-
(1→]2OMe 
(18) 
100.9 
(4.86) 
72.8 
(3.69) 
74.0 
(3.87) 
76.5 
(4.11) 
63.0 
(4.41, 3.68) 
H[→4)-α-D-Manp-(1→4)-β-D-Xylp-
(1→]2OMe 
(19)c 
104.1 
(4.67) 
73.2 
(3.60) 
73.7 
(3.85) 
76.8 
(3.95) 
64.5 
(4.42, 3.65) 
H[→3)-α-D-Manp-(1→4)-β-D-Xylp-
(1→]2OMe 
(20)c 
101.8 
(4.89) 
72.9 
(3.74) 
74.8 
(3.97) 
77.7 
(4.09) 
64.2 
(4.47 3.78) 
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Table 16.  Coupling Constants (Hz) for the Repeating Mannopyranoside  
Residue of Synthetic Xylomannans. 
 
 
 
 
Glycan 3JH1,H2 3JH2,H3 3JH3,H4 3JH4,H5 3JH5,H6 3JH6,H6’ 1JC1,H1 
H[→4)-β-D-Manp-(1→4)-β-D-
Xylp-(1→]2OMe 
(15) 
1.0< 2.0 9.7 9.5 b 11.5 158.6 
H[→4)-β-D-Manp-(1→4)-β-D-
Xylp-(1→]3OMe 
(16) 
1.0< 2.0 9.5 9.0 b 11.5 158.2 
H[→4)-β-D-Manp-(1→4)-β-D-
Xylp-(1→]4OMe 
(17) 
1.0< 2.5 9.5 10.0 b 12.0 159.1 
H[→3)-β-D-Manp-(1→4)-β-D-
Xylp-(1→]2OMe 
(18) 
1.0< 2.5 8.0 b b 12.5 159.2 
H[→4)-α-D-Manp-(1→4)-β-D-
Xylp-(1→]2OMe 
(19) 
1.0< 1.5 b b b b 170.2 
H[→3)-α-D-Manp-(1→4)-β-D-
Xylp-(1→]2OMe 
(20) 
1.0< 3.0 9.5 b b 11.0 170.5 
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Table 17.  Coupling Constants (Hz) for the Repeating Xylopyranosides of 
Synthetic Xylomannans 
 
 
 
 
 
Glycan 3JH1,H2 3JH2,H3 3JH3,H4 3JH4,H5 3JH5,H5’ 1JC1,H1 
H[→4)-β-D-Manp-(1→4)-β-D-
Xylp-(1→]2OMe 
(15) 
8.0 9.2 9.5 b 12.0 164.3 
H[→4)-β-D-Manp-(1→4)-β-D-
Xylp-(1→]3OMe 
(16) 
7.5 7.5 9.5 b 11.7 162.1 
H[→4)-β-D-Manp-(1→4)-β-D-
Xylp-(1→]4OMe 
(17) 
7.5 7.5 9.0 b 11.7 160.6 
H[→3)-β-D-Manp-(1→4)-β-D-
Xylp-(1→]2OMe 
(18) 
8.0 8.5 9.2 b 11.5 155.7 
H[→4)-α-D-Manp-(1→4)-β-D-
Xylp-(1→]2OMe 
(19) 
7.5 8.7 8.0 b 12.0 161.1 
H[→3)-α-D-Manp-(1→4)-β-D-
Xylp-(1→]2OMe 
(20) 
8.0 8.5 9.5 b 11.2 160.4 
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Figure 23. Comparison of the 1H and 13C data of the synthetic xylomannan 
linkage isomers with the natural isolate. 
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Figure 24. Comparison of the 1H and 13C data of synthetic β-(1→4)-
xylomannans with the natural isolate  
 
6.8. Conclusion 
The NMR spectra of the repeating unit of the target glycan have been 
shown to be independent of chain length. A total of four linkage isomers of the 
target glycan were synthesized, their NMR spectra recorded and assigned and 
compared to those of the natural glycan. On this basis three of the isomers were 
excluded from further consideration and the structure originally favored by 
Walters and coworkers, [→4)-β-D-Manp-(1→4)-β-D-Xylp-(1→]n, deemed to be 
consistent with the data. This conclusion provides a solid basis for further 
investigations into the antifreeze properties of this glycans.
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CHAPTER 7 
EXPERIMENTAL 
General Procedure 1. [1+1] Coupling for the synthesis of compounds 4, 
102, 108 and 114. A mixture of phenyl thiomannopyranoside (0.3 mmol), BSP 
(76 mg, 0.36 mmol), TTBP (112 mg, 0.45 mmol, used only for compounds 4 and 
102), and 4 Å molecular sieves (170 mg) was dried under vacuum for 0.5 h. 
Freshly distilled dichloromethane (6 mL) was added and the reaction mixture was 
stirred for 0.5 h at room temperature under N2 before it was cooled to -65 oC and 
stirred for an additional 5 min. Tf2O (61 µL, 0.36 mmol) was added dropwise and 
the reaction mixture stirred for 30 min while the temperature was held between -
65 to -60 oC, after which a solution of methyl xylopyranoside 2 (67 mg, 0.33 
mmol) in dicholoromethane (3 mL) was added dropwise and the reaction mixture 
was stirred for 2.5 h at -60 oC before it was quenched with Et3N (0.5 mL) and 
then warmed to room temperature. The reaction mixture was filtered through 
Celite, concentrated and purified by chromatography over silica gel.  
Methyl 2,3-di-O-benzyl-4,6-O-benzylidene-β-D-mannopyranosyl-(1→4)-
2,3-O-isopropylidene-β-D-xylopyranoside (198). Obtained by protocol 1 from 
compounds 183 and 194. Chromatographic purification with 20% EtOAc in 
hexanes as eluent afforded disaccharide 198 (151 mg, 83%) as a white foam, 
[α]24D: -47.8 (c = 1.0, CH3Cl); 1H NMR (500 MHz, CDCl3) δ 7.53-7.50 (m, 2H), 
7.48-7.45 (m, 2H), 7.41-7.36 (m, 3H), 7.35-7.28 (m, 8H) 5.64 (s, 1H), 4.94 (d, J = 
12.5 Hz, 1H), 4.89 (d, J = 12.0 Hz, 1H), 4.76 (d, J = 12.5 Hz, 1H), 4.66 (d, J = 
12.0 Hz, 1H), 4.65 (s, 1H), 4.56 (d, J = 7.5 Hz, 1H), 4.28 (dd, J = 4.7, 10.2 Hz, 
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1H), 4.23 (t, J = 9.7 Hz, 1H), 4.05 (dd, J = 5.2, 12.2 Hz, 1H), 4.02-3.99 (m, 1H), 
3.96 (t, J = 10.2 Hz, 1H), 3.91 (d, J = 3.0 Hz, 1H), 3.76 (t, J = 9.2 Hz, 1H), 3.63 
(dd, J = 2.7, 9.7 Hz, 1H), 3.54 (s, 3H), 3.42-3.34 (m, 2H), 3.31 (dd, J = 7.5, 9.5 
Hz, 1H), 1.44 (s, 3H), 1.42 (s, 3H); 13C NMR (125.9 MHz, CDCl3): δ 138.5, 137.8, 
129.1, 128.9, 128.6, 128.4, 128.3, 127.9, 129.8, 126.2, 111.7, 102.6, 101.7 (1JC-H 
= 157.6 Hz), 100.3, 79.3, 78.9, 78.3, 76.9, 76.4, 76.3, 75.0, 72.8, 68.9, 67.8, 65.4, 
56.7, 27.0, 26.8; ESIHRMS m/z calcd for C36H42O10Na [M + Na]+ 657.2676, found 
657.2668. 
General procedure 2. [1+1] Coupling for the synthesis of phenyl 
thioglycosides 5 and 107. A mixture of phenyl thiomannopyranoside (0.25 
mmol), BSP (63 mg, 0.3 mmol), TTBP (93 mg, 0.37 mmol, used only for 
compound 5), 4 Å molecular sieves (150 mg) was dried under vacuum for 0.5 h. 
Freshly distilled dichloromethane (5 mL) was added and the reaction mixture was 
stirred for 0.5 h at ambient temperature under N2 atmosphere, then cooled to -65 
oC and stirred for an additional 5 min before the addition of Tf2O (61 µL, 0.36 
mmol). The reaction mixture was stirred for 30 min at -65 to -60 oC, then was 
cooled to -78 oC and stirred for 5 min before 1-octene (0.3 mL, 2 mmol) was 
added and stirring continued for 5 min more. A solution of thioxylopyranoside 
acceptor 3 (77 mg, 0.27 mmol) in dicholoromethane (3 mL) then was added 
dropwise, and the reaction mixture was stirred for 2.5 h at -60 oC before it was 
quenched with Et3N (0.5 mL) and warmed to room temperature. The reaction 
mixture was filtered through Celite, concentrated and purified by chromatography 
over silica gel.  
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Phenyl 2,3-di-O-benzyl-4,6-O-benzylidene-β-D-mannopyranosyl-(1→4)-
2,3-O-isopropylidene-1-thio-β-D-xylopyranoside(199). Obtained by protocol 2 
from compounds 83 and 197. Chromatographic purification with 20% EtOAc in 
hexanes as eluent afforded disaccharide 199 (153 mg, 86%) as a white foam, 
[α]24D: -55.6 (c = 1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.57 (dd, J = 3.0, 7.0 
Hz, 2H), 7.53-7.50 (m, 2H), 7.46-7.43 (m, 2H), 7.41-7.36 (m, 2H), 7.35-7.29 (m, 
12H), 5.63 (s, 1H), 4.92 (d, J = 12.5 Hz, 1H), 4.87 (d, J = 12.0 Hz, 1H), 4.82 (d, J 
= 9.5 Hz, 1H), 4.76 (d, J = 12.5 Hz, 1H),  4.66 (d, J = 12.5 Hz, 1H), 4.62 (s, 1H), 
4.27 (dd, J = 5.0, 10.5 Hz, 1H), 4.22 (t, J = 9.5 Hz, 1H), 4.12 (dd, J = 5.2, 11.7 Hz, 
1H), 3.99-3.93 (m, 2H), 3.89 (d, J = 2.5 Hz, 1H), 3.73 (t, J = 9.0 Hz, 1H), 3.61 (dd, 
J = 3.0, 9.5 Hz, 1H), 3.37-3.31 (m, 2H), 3.20 (t, J = 9.2 Hz, 1H), 1.47 (s, 3H), 1.41 
(s, 3H); 13C NMR (125.9 MHz, CDCl3): δ 138.5, 137.8, 133.2, 132, 129.1, 128.9, 
128.6, 128.4, 128.3, 127.9, 127.8, 126.2, 111.2, 101.7, 100.1 (1JC-H = 157.2), 
85.4, 81.2, 78.9, 78.3, 76.2, 75.6, 75.5, 75.0, 72.8, 68.8, 67.9, 67.8, 26.9,26.8; 
ESIHRMS m/z calcd for C41H44O9SNa [M + Na]+ 735.2604, found 657.2560. 
General procedure 3. Acidolysis of acetonide groups and subsequent 
benzoylation for the synthesis of compounds 6, 7, 103, 109, 110, and 115. A 
solution of disaccharide (0.1 mmol) in glacial acetic acid (10 mL) was stirred at 
65 oC for 3 h. Upon completion of the reaction, acetic acid was removed in vacuo 
at 30 oC to give a white residue that was taken up in pyridine (5 mL) and cooled 
down to 0 oC before it was treated dropwise with benzoyl chloride (47 µL, 0.4 
mmol). After stirring for 2 h the reaction mixture was concentrated in vacuo and 
the residue was dissolved in EtOAc (25 mL). The organic layer was successively 
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washed with water, saturated aqueous NaHCO3, and brine, and dried over 
Na2SO4. The product was purified by chromatography over silica gel. 
Methyl 2,3-di-O-benzyl-4,6-O-benzylidene-β-D-mannopyranosyl-(1→4)-
2,3-di-O-benzoyl-β-D-xylopyranoside (200). Obtained by protocol 3 from 
compound 198. Chromatographic purification over silica gel with 20 % EtOAc in 
hexanes as eluent afforded disaccharide 200 (71 mg, 89%) as a white foam, 
[α]24D: -38.8 (c = 1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.05 (d, J = 7.0 Hz, 
2H), 8.01 (d, J = 7.0 Hz, 2H), 7.56-7.51 (m, 2H), 7.49-7.47 (m, 2H), 7.44-7.37 (m, 
9H), 7.35-7.27 (m, 8H), 5.74 (t, J = 8.2 Hz, 1H), 5.46 (s, 1H), 5.36 (dd, J = 6.7, 
8.2 Hz, 1H), 4.91 (d, J = 12.0 Hz, 1H), 4.77 (d, J = 12.0 Hz, 1H), 4.71 (d, J = 12.5 
Hz, 1H), 4.66 (d, J = 7.0 Hz, 1H), 4.62 (s, 1H), 4.61 (d, J = 11.0 Hz, 1H), 4.21 (dd, 
J = 4.7, 11.7 Hz, 1H), 4.17-4.13 (m, 1H), 4.03 (t, J = 9.7 Hz, 1H), 4.00 (dd, J = 
5.0, 10.5 Hz, 1H), 3.90 (d, J = 3.0 Hz, 1H), 3.61-3.56 (m, 2H), 3.55 (s, 3H), 3.40 
(t, J = 10.2 Hz, 1H), 3.23 (dt, J = 5.0, 9.7 Hz, 1H); 13C NMR (125.9 MHz, CDCl3): 
δ 165.6, 165.5, 138.5, 138.4, 137.5, 133.2, 130.0, 129.9, 129.9, 129.8, 129.5, 
128.9, 128.5, 128.4, 128.2, 128.1, 127.6, 127.5, 126.1, 101.9, 101.3, 101.0, 78.3, 
77.6, 77.4, 77.2, 76.9, 76.1, 74.6, 72.3, 71.9, 71.1, 68.2, 67.6, 62.8, 56.9, ; 
ESIHRMS m/z calcd for C47H46O12SNa [M + Na]+ 825.2887, found 825.2873. 
Phenyl 2,3-di-O-benzyl-4,6-O-benzylidene-β-D-mannopyranosyl-(1→4)-
2,3-di-O-benzoyl-1-thio-β-D-xylopyranoside (191). Obtained by protocol 3 from 
compound 199. Chromatographic purification over silica gel with 20% EtOAc in 
hexanes as eluent afforded disaccharide 191 (72 mg, 87%) as a white foam, 
[α]24D: -34.8 (c = 1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.07-8.02 (m, 4H), 
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7.57-7.50 (m, 4H), 7.46-7.39 (m, 7H), 7.38-7.32 (m, 9H), 7.31-7.26 (m, 6H), 5.74 
(t, J = 7.2 Hz, 1H), 5.42 (s, 1H), 5.39 (t, J = 7.2 Hz, 1H), 5.17 (d, J = 7.0 Hz, 1H), 
4.87 (d, J = 12.5 Hz, 1H), 4.74 (d, J = 12.5 Hz, 1H), 4.69 (d, J = 12.5 Hz, 1H), 
4.62 (s, 1H), 4.59 (d, J = 12.5 Hz, 1H), 4.42 (dd, J = 4.2, 12.2 Hz, 1H), 4.09-3.97 
(m, 3H), 3.87 (d, J = 3.0 Hz, 1H), 3.66 (d, J = 8.0, 12.0 Hz, 1H), 3.55 (dd, J = 3.0, 
9.5 Hz, 1H), 3.34 (t, J = 10.2 Hz, 1H), 3.26-3.21 (m, 1H); 13C NMR (125.9 MHz, 
CDCl3): δ 165.7, 165.6, 138.7, 138.6, 137.8, 133.5, 133.3, 132.9, 130.4, 130.2, 
129.9, 129.6, 129.3, 129.1, 128.7, 128.6, 1285, 128.4, 128.3, 127.8, 127.7, 126.3, 
101.5, 86.9, 78.5, 77.8, 76.4, 74.9, 74.5, 72.5, 72.1, 70.5, 68.5, 67.8, 65.4; 
ESIHRMS m/z calcd for C52H48O11Na [M + Na]+ 903.2815, found 903.2803. 
General precedure 4.  Synthesis of compounds 8, 9, 12 and 111 by 
reductive cleavage of benzylidene acetals. Oligosaccharide (0.1 mmol) was 
mixed with dry 3 Å molecular sieves (150 mg) and stirred in vacuo for 0.5 h. THF 
(2 mL) was added and the reaction mixture was stirred for 5 min before it was 
cooled to 0 oC followed by the addition of sodium cyanoborohydride (32 mg, 0.5 
mmol) (for 12 63 mg, 1 mmol). The reaction mixture was stirred at 0 oC for 1 h 
(for 12 overnight), followed by very slow dropwise addition of dry HCl in diethyl 
ether  (2N, 1.5 mL) until effervescence ceased, after which the reaction mixture 
was warmed to room temperature and diluted with chloroform (30 mL). The 
organic layer was successively washed with water and brine, dried over Na2SO4. 
Chromatographic purification over silica gel afforded the pure product.  
 
183 
 
Methyl 2,3,6-tri-O-benzyl-β-D-mannopyranosyl-(1→4)-2,3-di-O-benzoyl- β-D-
xylopyranoside (201). Obtained by protocol 4 from compound 200. 
Chromatographic purification over silica gel with 30% EtOAc in hexanes as 
eluent afforded disachharide 201 (68 mg, 85%) as a white foam, [α]24D: -31.2 (c = 
1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.02 (dd, J = 1.0, 8.5 Hz, 2H), 7.93 (dd, 
J = 1.0, 8.0 Hz, 2H), 7.51-7.44 (m, 2H), 7.37-7.27 (m, 16 H), 7.22-7.20 (m, 3H), 
5.72 (t, J = 8.2 Hz, 1H), 5.34 (dd, J = 6.7, 8.2 Hz, 1H), 4.82 (d, J = 12.5 Hz, 1H), 
4.63-4.58 (m, 3H), 4.52-4.43 (m, 3H), 4.38 (d, J = 12.0 Hz, 1H), 4.27-4.20 (m, 
2H), 3.88 (dt, J = 1.5, 9.5 Hz, 1H), 3.84 (d, J = 3.0 Hz, 1H), 3.63-3.56 (m, 3H), 
3.52 (s, 3H), 3.40-3.36 (m, 1H), 3.30 (dd, J = 3.0, 9.5 Hz, 1H), 2.65 (br s, 1H); 
13C NMR (125.9 MHz, CDCl3): δ 166.0, 165.6, 138.9, 138.2, 138.1, 133.3, 133.2, 
130.2, 130.1, 129.9, 129.7, 128.7, 128.6, 128.5, 128.4, 128.3, 128.0, 127.9, 
127.5, 102.2, 99.8, 81.3, 75.3, 74.2, 73.9, 73.6, 72.1, 71.4, 71.0, 68.6, 62.9, 57.0; 
ESIHRMS m/z calcd for C47H48O12Na [M + Na]+ 827.3043, found 827.3055. 
Phenyl 2,3,6-tri-O-benzyl-β-D-mannopyranosyl-(1→4)-2,3-di-O- benzoyl-
1-thio-β-D-xylopyranoside (202). Obtained by protocol 4 from compound 
191. Chromatographic purification over silica gel with 30% EtOAc in hexanes as 
eluent afforded disaccharide 202 (79 mg, 89%) as a white foam, [α]24D: -54.2 (c = 
1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.05 (dd, J = 1.5, 8.5 Hz, 2H), 7.99 (dd, 
J = 1.5, 8.5 Hz, 2H), 7.53 (dd, J = 3.0, 6.5 Hz, 2H), 7.51-7.47 (m, 2H), 7.36-7.26 
(m, 19H), 7.22-7.19 (m, 3H), 5.76 (t, J = 7.5 Hz, 1H), 5.40 (t, J = 7.2 Hz, 1H), 
5.15 (d, J = 7.0 Hz, 1H), 4.81 (d, J = 12.5 Hz, 1H), 4.61 (s, 1H), 4.60 (d, J = 14.0 
Hz, 1H), 4.52-4.43 (m, 4H), 4.39 (d, J = 12.0 Hz, 1H), 4.18-4.14 (m, 1H), 3.88 (t, 
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J = 9.5 Hz, 1H), 3.85 (d, J = 3.0 Hz, 1H), 3.70 (dd, J = 7.7, 12.2 Hz, 1H), 3.62-
3.55 (m, 2H), 3.42-3.37( m, 1H), 3.30 (dd, J = 2.7, 9.2 Hz, 1H), 2.66 (br s, 1H); 
13C NMR (125.9 MHz, CDCl3): δ 165.8, 165.6, 138.9, 138.2, 138.1, 133.4, 133.3, 
132.9, 130.3, 130.2, 129.7, 129.3, 128.7, 128.6, 128.5, 128.4, 128.3, 128.0, 
127.9, 127.5, 100.2, 87.0, 81.3, 77.5, 77.3, 77.0, 75.3, 74.2, 74.0, 73.9, 73.4, 
72.2, 71.4, 71.0, 70.7, 68.6, 65.4; ESIHRMS m/z calcd for C52H50O11Na [M + Na]+ 
905.2972, found 905.2987.   
General Procedure 5.  Synthesis of compounds 10, 13, 14, 105, 112 and 
117 by glycosidic bond formation. The phenyl thioglycoside (100 µmol) was 
mixed with BSP (27 mg, 120 µmol), and oven dried 4 Å molecular sieves (150 
mg) and dried under vacuum for 0.5 h before dichloromethane (3 mL) was added 
under N2 and the reaction mixture stirred for 0.5 h at room temperature then 
cooled to -65 oC and stirred for an additional 5 min.  Tf2O (22 µL, 120 µmol) was 
added dropwise and the reaction mixture stirred for 30 min between -65 and -60 
oC, then it was cooled to -70 oC and a solution of polysaccharide acceptor (100 
µmol) in dichloromethane (2 mL) was added dropwise. The reaction mixture was 
stirred at -60 oC for 2.5 h before it was quenched by addition of Et3N (500 µL) 
and warmed to room temperature. The quenched reaction mixture was filtered 
through Celite, concentrated and purified by silica gel column chromatography. 
Methyl 2,3-di-O-benzyl-4,6-O-benzylidene-β-D-mannopyranosyl-(1→4)-
2,3-di-O-benzoyl-β-D-xylopyranosyl-(1→4)-2,3,6-tri-O-benzyl-β-D-
mannopyranosyl-(1→4)-2,3-di-O-benzoyl-β-D-xylopyranoside (203). Obtained 
by protocol 5 from compounds 191 and 201. Chromatographic purification over 
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silica gel with 30% EtOAc in hexanes as eluent afforded disachharide 203 (127 
mg, 81%) as a white foam, [α]24D: -43.6 (c = 1.0, CHCl3); 1H NMR (500 MHz, 
CDCl3) δ 7.99 (d, J = 7.0 Hz, 2H), 7.93 (d, J = 8.0 Hz, 4H), 7.86 (d, J = 8.0 Hz, 
2H), 7.54-7.44 (m, 6H), 7.39-7.32 (m, 18H), 7.29-7.23 (m, 10H), 7.21-7.14 (m, 
8H), 5.67 (t, J = 8.2 Hz, 1H), 5.52 (t, J = 9.0 Hz, 1H), 5.43 (s, 1H), 5.30-5.26 (m, 
2H), 4.81 (d, J = 12.5 Hz, 1H), 4.81 (d, J = 7.0 Hz, 1H), 4.76 (d, J = 12.5 Hz, 1H), 
4.67-4.63 (m, 4H), 4.58-4.55 (m, 3H), 4.49 (s, 1H), 4.43 (s, 1H), 4.35 (d, J = 11.5 
Hz, 1H), 4.18-4.13 (m, 3H), 4.07 (d, J = 12.0 Hz, 1H), 4.05-3.99 (m, 1H), 3.97-
3.90 (m, 3H), 3.80 (dd, J = 3.2, 9.7 Hz, 2H), 3.54-3.46 (m, 7H), 3.43 (dd, J = 3.0, 
9.5 Hz, 1H), 3.36 (t, J = 10.5 Hz, 1H), 3.24-3.20 (m, 1H), 3.15-3.09 (m, 2H); 13C 
NMR (125.9 MHz, CDCl3): δ 165.7, 165.5, 165.4, 165.2, 138.7, 138.6, 138.5, 
138.4, 137.5, 133.2, 133.1, 133.0 129.9, 129.8, 129.7, 129.5, 129.4, 129.3, 128.8, 
128.4, 128.3, 128.2, 128.1, 128.0, 127.9, 127.8, 127.5, 127.4, 127.3, 127.1, 
126.0, 101.9, 101.3, 100.8, 100.6, 99.3, 80.1, 78.2, 76.8, 76.0, 75.8, 74.6, 74.3, 
73.7, 73.2, 73.1, 72.7, 72.2, 72.0, 72.9, 72.3, 68.5, 68.2, 67.5, 63.0, 62.6, 56.7; 
ESIHRMS m/z calcd for C93H90O23Na [M + Na]+ 1597.5771, found 1597.5748.   
Phenyl 2,3-di-O-benzyl-4,6-O-benzylidene-β-D-mannopyranosyl-(1→4)-
2,3-di-O-benzoyl-β-D-xylopyranosyl-(1→4)-2,3,6-tri-O-benzyl-β-D-
mannopyranosyl-(1→4)-2,3-di-O-benzoyl-1-thio-β-D-xylopyranoside (204). 
Phenyl thioglycoside 191 (88 mg, 100 µmol), BSP (27 mg, 120 µmol) and 4 Å 
molecular sieves (150 mg) was mixed and dried under vacuum for 0.5 h after 
which freshly distilled dichloromethane (3 mL) was added and the reaction 
mixture was stirred for 0.5 h at room temperature under N2 before it was cooled 
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to -65 oC and stirred for 5 min more.  Tf2O (22 µL, 120 µmol) was added dropwise 
and the reaction mixture was stirred for 30 min between -65 to -60 oC then 
cooled to -78 oC and stirred for 5 min before 1-octene (0.15 mL, 1 mmol) was 
added. After stirring for 5 min a solution of the acceptor 202 (90 mg, 50 µmol) in 
dicholoromethane (2 mL) was added dropwise and thereaction mixture stirred for 
2.5 h at -60 oC before it was quenched by addition of Et3N (0.1 mL) and warmed 
to room termperature.  The reaction mixture was filtered through Celite, 
concentrated and subjected to chromatographic purification with 30 % EtOAc in 
hexanes as eluent to afford tetrasaccharide 204 (139 mg, 79%) as a light yellow 
oil, [α]24D: -28.4 (c = 1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.03 (d, J = 7.5 Hz, 
2H), 7.95-7.91 (m, 6H), 7.55-7.48 (m, 7H), 7.47-7.43 (m, 3H), 7.40-7.33 (m, 16H), 
7,31-7.22 (m, 15H), 7.18-7.12 (m, 6H), 5.71 (t, J = 7.5 Hz, 1H), 5.52 (t, J = 9.0 Hz, 
1H), 5.44 (s, 1H), 5.35 (t, J = 7.5 Hz, 1H), 5.28 (dd, J = 7.2, 8.7 Hz, 1H), 5.10 (d, 
J = 7.5 Hz, 1H), 4.83 (d, J = 12.0 Hz, 1H), 4.81 (d, J = 7.0Hz, 1H), 4.76 (d, J = 
12.5 Hz, 1H), 4.68-4.63 (m, 4H), 4.58 (s, 1H), 4.57 (d, J = 13.0 Hz, 1H), 4.50 (s, 
1H), 4.44 (s, 1H), 4.38 (dd, J = 4.0, 12.0 Hz, 1H), 4.34 (d, J = 11.5 Hz, 1H), 4.17 
(t, J = 9.5 Hz, 1H), 4.13-4.09 (m, 1H), 4.06 (d, J = 12.0 Hz, 1H), 4.05-4.00 (m, 
1H), 3.98-3.89 (m, 3H), 3.80 (dd, J = 3.0, 7.5 Hz, 2H), 3.61 (dd, J = 8.0, 12.0 Hz, 
1H), 3.53-3.47 (m, 3H), 3.43 (dd, J = 3.2, 9.2 Hz, 1H), 3.37 (t, J = 10.5 Hz, 1H), 
3.25-3.21 (m, 1H), 3.16-3.08 (m, 2H); 13C NMR (125.9 MHz, CDCl3): δ 165.5, 
165.3, 165.2, 138.7, 138.5, 138.3, 137.5, 133.2, 133.1, 133.0, 132.7, 132.4, 
130.0, 129.8, 129.3, 129.3, 129.0, 128.8, 128.4, 128.3, 128.2, 128.1, 128.0, 
127.9, 127.8, 127.5, 127.4, 127.2, 126.0, 101.3, 100.8, 100.6, 99.7, 86.7, 80.1, 
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78.2, 77.4, 75.9, 75.8, 74.6, 74.3, 73.7, 73.2, 72.9, 72.8, 72.2, 72.0, 70.5, 68.5, 
68.2, 67.6, 65.2, 63.0; ESIHRMS m/z calcd for C98H92O22Na [M + Na]+ 1675.5699, 
found 1675.5793. 
Methyl 2,3,6-tri-O-benzyl-β-D-mannopyranosyl-(1→4)-2,3-di-O-benzoyl-
β-D-xylopyranosyl-(1→4)-2,3,6-tri-O-benzyl-β-D-mannopyranosyl-(1→4)-2,3-
di-O-benzoyl-β-D-xylopyranoside (205). Obtained by protocol 4 from 
compound 203. Chromatographic purification with 50% EtOAc in hexanes as 
eluent afforded the tetrasaccharide 205 (137 mg, 87%) as a white foam, [α]24D: 
36.2  (c = 1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.07 (d, J = 7.5 Hz, 2H), 
8.02-7.93 (m, 4H), 7.91 (d, J = 7.5 Hz, 2H), 7.52 (t, J = 7.2 Hz, 1H), 7.47 (t, J = 
7.5 Hz, 1H), 7.43-7.33 (m, 7H), 7.31-7.20 (m, 27H), 7.16-7.14 (m, 6H), 5.75 (t, J 
= 7.5 Hz, 1H), 5.63 (t, J = 7.7 Hz, 1H), 5.31 (t, J = 6.7 Hz, 1H), 5.16 (t, J = 6.7 Hz, 
1H), 4.82 (d, J = 12.0 Hz, 1H), 4.75 (d, J = 11.0 Hz, 1H), 4.73 (d, J = 12.5 Hz, 
1H), 4.71 (d, J = 8.0 Hz, 1H), 4.67-4.59 (m, 4H), 4.53 (d, J = 6.0 Hz, 1H),  4.52 (d, 
J = 5.5 Hz, 1H), 4.49-4.39 (6H), 4.23 (dd, J = 4.0, 12.0 Hz, 1H), 4.17-4.10 (m, 
2H), 3.96 (d, J = 9.0 Hz, 1H), 3.92-3.82 (m, 5H), 3.75 (dd, J = 5.5, 11.0 Hz, 1H), 
3.63-3.53 (m, 3H), 3.51 (s, 3H), 3.50-3.46 (m, 2H), 3.42-3.38 (m, 2H), 3.34 (dd, J 
= 2.7, 9.2 Hz, 1H), 2.73 (br s, 1H); 13C NMR (125.9 MHz, CDCl3): δ 165.9, 165.8, 
165.4, 139.0, 138.8, 138.5, 138.3, 138.2, 133.4, 133.2, 133.1, 130.4, 130.1, 
129.9, 129.8, 128.7, 128.6, 128.5,  128.4, 128.2, 128.1, 128.0, 127.9, 127.6, 
127.5, 127.4, 101.5, 100.6, 100.1, 99.6, 82.2, 81.2, 75.9, 75.2, 75.1, 74.6, 74.3, 
74.2, 74.1, 74.0, 73.9, 73.6, 73.4, 71.6, 71.3, 71.0, 70.9, 68.8, 68.3, 62.1, 56.8; 
ESIHRMS m/z calcd for C93H92O23Na [M + Na]+ 1599.5927, found 1599.5914.  
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Methyl 2,3-di-O-benzyl-4,6-O-benzylidene-β-D-mannopyranosyl-(1→4)-
2,3-di-O-benzoyl-β-D-xylopyranosyl-(1→4)-2,3,6-tri-O-benzyl-β-D-
mannopyranosyl-(1→4)-2,3-di-O-benzoyl-β-D-xylopyranosyl-(1→4)-2,3,6-tri-
O-benzyl-β-D-mannopyranosyl-(1→4)-2,3-di-O-benzoyl-β-D-xylopyranoside 
(207). Obtained by protocol 5 from compounds 204 and 201. Chromatographic 
purification with 30% EtOAc in hexanes as eluent afforded the hexasaccharide 
207 (157 mg, 67%) as a white foam, [α]24D: -32.7 (c = 1.0, CHCl3); 1H NMR (500 
MHz, CDCl3) δ 7.98 (d, J = 8.0 Hz, 2H), 7.93-7.89 (m, 6H), 7.85 (d, J = 8.0 Hz, 
2H), 7.81 (d, J = 7.5 Hz, 2H), 7.54-7.41 (m, 9H), 7.40-7.30(m, 25 H), 7.29-7.23 
(m, 17H), 7.21-7.11 (m, 12H), 5.65 (t, J = 8.0 Hz, 1H), 5.48 (t, J = 9.5 Hz, 1H), 
5.46 (t, J = 9.5 Hz, 1H), 5.43 (s, 1H), 5.29-5.23 (m, 3H), 4.82-4.70 (m, 4H), 4.68-
4.52 (m, 10H), 4.46 (s, 1H), 4.42 (s, 1H), 4.35-4.31 (m, 2H), 4.27 (s, 1H), 4.18-
4.09 (m, 4H), 4.08-3.98 (m, 4H), 3.97-3.86 (m, 3H), 3.78 (s, 2H), 3.72 (s, 1H), 
3.53-3.49 (m, 3H), 3.48 (s, 3H), 3.47-3.33 (m, 8H), 3.22-3.18 (m, 1H), 3.14-
3.02(m, 4H); 13C NMR (125.9 MHz, CDCl3): δ 165.7, 165.6, 165.5, 165.4, 165.2, 
138.7, 138.7, 138.6, 138.4, 138.3, 137.5, 133.2, 133.1, 133.0, 132.8, 129.9, 
129.8, 129.7, 129.5, 129.4, 129.2, 128.8, 128.4, 128.3, 128.2, 128.1, 127.9, 
127.8, 127.5, 127.4, 127.3, 127.1, 126.0, 101.9, 101.2, 100.9, 100.8, 100.6, 99.2, 
99.0, 80.0, 79.8, 78.2, 75.9, 74.5, 74.4, 74.3, 74.2, 73.7, 73.6, 73.2, 73.1, 73.0, 
72.7, 72.1, 72.0, 71.9, 71.3, 68.4, 68.2, 67.5, 62.9, 62.6, 56.8; ESIHRMS m/z 
calcd for C139H134O34Na [M + Na]+ 2369.8654, found 2369.8691.  
Methyl 2,3-di-O-benzyl-4,6-O-benzylidene-β-D-mannopyranosyl-(1→4)-
2,3-di-O-benzoyl-β-D-xylopyranosyl-(1→4)-2,3,6-tri-O-benzyl-β-D-
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mannopyranosyl-(1→4)-2,3-di-O-benzoyl-β-D-xylopyranosyl-(1→4)-2,3,6-tri-
O-benzyl-β-D-mannopyranosyl-(1→4)-2,3-di-O-benzoyl-β-D-xylopyranosyl-
(1→4)-2,3,6-tri-O-benzyl-β-D-mannopyranosyl-(1→4)-2,3-di-O-benzoyl-β-D-
xylopyranoside (206). Obtained by protocol 5 from compounds 204 and 205. 
Chromatographic purification with 40% EtOAc in hexanes as eluent afforded the 
octasaccharide 206 (196 mg, 63%) as a white foam, [α]24D: -35.1 (c = 1.0, 
CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.98 (d, J = 7.5 Hz, 2H), 7.94-7.89 (m, 8H), 
7.86 (d, J = 7.0 Hz, 4H), 7.81 (d, J = 8.5 Hz, 2H), 7.53-7.48 (m, 5H), 7.46-7.43 (m, 
3H), 7.38-7.32 (m, 26H), 7.30-7.23 (m, 27H), 7.21-7.17 (m, 7H), 7.16-7.10 (m, 
16H), 5.66 (t, J = 8.0 Hz, 1H), 5.54-5.46 (m, 2H), 5.43 (s, 1H), 5.32-5.22 (m, 4H), 
4.83-4.69 (m, 8H), 4.67-4.52 (m, 12H), 4.47-4.40 (m, 3H), 4.36-4.31 (m, 3H), 
4.27 (s, 1H), 4.26 (s, 1H), 4.18-4.08 (m, 5H), 4.07-3.95 (m, 7H), 3.92-3.86 (m, 
3H), 3.82-3.76 (m, 3H), 3.71 (dd, J = 2.7, 11.2 Hz, 2H), 3.54-3.49 (m, 2H), 3.48 (s, 
3H), 3.47-3.43 (m, 4H), 3.41-3.32 (m, 6H), 3.19 (dd, J = 3.7, 8.7 Hz, 1H), 3.16-
3.06 (m, 5H) 3.03 (t, J = 10.7 Hz, 1H); 13C NMR (125.9 MHz, CDCl3): δ 165.7, 
165.6, 165.5, 165.4, 165.2, 138.7, 138.6, 138.4, 138.3, 137.5, 133.2, 133.1, 
133.0, 132.8, 129.9, 129.8, 129.7, 129.5, 129.4, 129.2, 128.8 128.4, 128.3, 128.2, 
128.1, 128.0, 127.9, 127.8, 127.6, 127.5, 127.4, 127.3, 127.2, 127.1, 126.0, 
101.9, 101.2, 100.9, 100.8, 100.6, 99.2, 99.0, 80.0, 79.9, 78.2, 75.8, 74.6, 74.5, 
74.4, 74.3, 74.2, 73.7, 73.6, 73.2, 73.1, 73.0, 72.7, 72.1, 72.0, 71.9, 71.3, 68.4, 
68.3, 68.2, 67.5, 62.9, 62.6, 56.8; ESIHRMS m/z calcd for C185H178O45Na [M + 
Na]+ 3142.1538, found 3142.1489.  
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General Procedure 6. Final deprotection to give oligosaccharides 15, 
16, 17, 18, 19 and 20. The protected oligosaccharide (0.02 mmol) was dissolved 
in methanol (2 mL) and treated with a 25% solution of NaOMe in methanol (0.1 
mL) at 0 oC. Upon completion of the reaction, the reaction mixture was 
neutralized by the addition of Amberlite IR 120 (H+) followed by filtration through 
Celite. The filtrate was concentrated under reduced pressure at room 
temperature to give a white foam that was taken forward without further 
purification. The saponified oligosaccharide was dissolved in methanol (2 mL) 
and Pd-C (20 mg) and 1 drop of glacial acetic acid was added to it. The reaction 
mixture was shaken under 40 psi H2 at room temperature for 12 h after which it 
was filtered through Celite and then concentrated under reduced pressure at 
room temperature to afford the oligosaccharide. 
Methyl β-D-mannopyranosyl-(1→4)-β-D-xylopyranosyl-(1→4)-β-D-
mannopyranosyl-(1→4)-β-D-xylopyranoside (208). Obtained by protocol 6 
from compound 10. Removal of solvent afforded 15 (11.5 mg 93%) as white 
amorphous solid, [α]24D: 52.4 (c = 1.0, 1:4 H2O:MeOH); ESIHRMS m/z calcd for 
C23H40O19Na [M + Na]+ 643.2061, found 643.2084.  For 1H and 13C data see 
Tables 14-17.   
Methyl β-D-mannopyranosyl-(1→4)-β-D-xylopyranosyl-(1→4)-β-D-
mannopyranosyl-(1→4)-β-D-xylopyranosyl-(1→4)-β-D-mannopyranosyl-
(1→4)-β-D-xylopyranoside (209). Obtained by protocol 6 from compound 13. 
Removal of solvent afforded 16 (17.2 mg, 94%) as white amorphous solid, [α]24D: 
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12.7 (c = 0.5, 1:4 H2O:MeOH); ESIHRMS m/z calcd for C34H56O28Na [M + Na]+ 
937.3012, found 937.3029.  For 1H and 13C data see Tables 14-17. 
Methyl β-D-mannopyranosyl-(1→4)-β-D-xylopyranosyl-(1→4)-β-D-
mannopyranosyl-(1→4)-β-D-xylopyranosyl-(1→4)-β-D-mannopyranosyl-
(1→4)-β-D-xylopyranosyl-(1→4)-β-D-mannopyranosyl-(1→4)-β-D-
xylopyranoside (210). Obtained by protocol 6 from compound 14. Removal of 
solvent afforded 17 (22.1 mg 94%) as white amorphous solid, [α]24D: -16.8 (c = 
0.4, 1:4 H2O:MeOH); ESIHRMS m/z calcd for C45H76O37Na [M + Na]+ 1231.3963, 
found 1231.3958. For 1H and 13C data see Tables 14-17.   
Methyl 2-O-benzyl-4,6-O-benzylidene-3-O-(2-naphthalenylmethyl)-β-D-
mannopyranosyl-(1→4)-2,3-O-isopropylidine-β-D-xylopyranoside (215). 
Obtained by protocol 1 from compounds 214 and 197. Chromatographic 
purification over silica gel with 20% EtOAc in hexanes as eluent afforded 
disaccharide 215 (176 mg, 86%) as a light yellow oil, [α]24D: -27.8 (c = 1.0, 
CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.85-7.83 (m, 1H), 7.80-7.75 (m, 2H), 7.73-
7.69 (m, 1H), 7.56-7.52 (m, 2H), 7.49-7.45 (m, 4H), 7.43-7.39 (m, 4H), 7.37-7.31 
(m, 3H),  5.66 (s, 1H), 4.97 (d, J = 12.0 Hz, 1H), 4.91 (d, J = 12.0 Hz, 1H), 4.88 
(d, J = 13.0 Hz, 1H), 4.81 (d, J = 13.0 Hz, 1H), 4.62 (s, 1H), 4.55 (d, J = 7.5 Hz, 
1H), 4.30-4.24 (m, 2H), 4.04 (dd, J = 5.2, 11.7 Hz, 1H), 4.01-3.95 (m, 2H), 3.92 
(d, J = 2.5 Hz, 1H), 3.75 (t, J = 9.2 Hz, 1H), 3.66 (dd, J = 2.7, 10.2 Hz, 1H), 3.53 
(m, 3H), 3.41-3.34 (m, 2H), 3.29 (dd, J = 7.7, 9.7 Hz, 1H), 1.43 (s, 3H), 1.40 (s, 
3H); 13C NMR (125.9 MHz, CDCl3): δ 138.5, 137.8, 135.9, 133.4, 133.2, 129.1, 
129.0, 128.5, 128.4, 128.1, 127.9, 126.6, 126.4, 126.3, 126.2, 125.9, 111.7, 
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102.6, 101.8, 100.3 (1JC-H = 157.5 Hz), 79.3, 78.9, 78.0, 76.8, 76.4, 76.1, 75.0, 
72.7, 68.9, 67.8, 65.3, 56.7, 27.0, 26.8; ESIHRMS m/z calcd for C40H40O10Na [M 
+ Na]+ 707.2832, found 707.2813. 
Methyl 2-O-benzyl-4,6-O-benzylidene-3-O-(2-naphthalenylmethyl)-β-D-
mannopyranosyl-(1→4)-2,3-di-O-acetyl-β-D-xylopyranoside (216). Obtained 
by protocol 3 from compound 215. Chromatographic purification over silica gel 
with 20% EtOAc in hexanes as eluent afforded disaccharide 216 (64 mg, 88%) 
as a light yellow oil, [α]24D: -34.9 (c = 1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δ 
7.84-7.82 (m, 1H), 7.79-7.76 (m, 2H), 7.71-7.69 (m, 1H), 7.53 (dd, J = 2.0, 7.5 Hz, 
2H), 7.50-7.46 (m, 4H), 7.42-7.38 (m, 4H), 7.36 (t, J = 7.5 Hz, 2H), 7.32 (d, J = 
7.5 Hz, 1H), 5.64 (s, 1H), 5.21 (t, J = 8.7 Hz, 1H), 4.92 (d, J = 12.0 Hz, 1H), 4.87 
(dd, J = 7.0, 9.0 Hz, 1H), 4.84 (d, J = 13.0 Hz, 1H), 4.79 (d, J = 12.0 Hz, 1H), 
4.78 (d, J = 12.5 Hz, 1H), 4.50 (s, 1H), 4.38 (d, J = 7.0 Hz, 1H), 4.32 (dd, J = 5.0, 
10.5 Hz, 1H), 4.21 (t, J = 9.5 Hz, 1H), 4.03 (dd, J = 5.0, 12.0 Hz, 1H), 3.97-3.92 
(m, 1H), 3.89 (t, J = 10.0 Hz, 1H), 3.85 (d, J = 3.0 Hz, 1H), 3.62 (dd, J = 3.2, 10.0, 
Hz, 1H), 3.48 (s, 3H), 3.35-3.28 (m, 2H), 2.05 (s, 3H), 2.01 (s, 3H); 13C NMR 
(125.9 MHz, CDCl3): δ 170.1, 169.7, 138.5, 137.5, 135.7, 133.2, 132.9, 128.9, 
128.5, 128.3, 128.2, 128.1, 127.9, 127.7, 127.6, 126.3, 126.1, 125.9, 125.6, 
101.9, 101.5, 100.1, 78.5, 75.9, 74.6, 73.5, 72.2, 72.1, 71.0, 68.5, 67.7, 62.6, 
56.8, 20.9, 20.8; ESIHRMS m/z calcd for C41H44O12Na [M + Na]+ 751.2730, found 
751.2741. 
General Procedure 7.  Synthesis of compounds 104 and 116 by 
removal of naphthalenylmethyl ethers with DDQ. To a stirred solution of 
193 
 
disaccharide (0.07 mmol) in dichloromethane (10 mL) and water (0.5 mL), DDQ 
(40 mg, 0.18 mmol) was added at room temperature. The reaction mixture was 
stirred for 3 h before it was quenched with a saturated aqueous solution of 
NaHCO3 and diluted with dicholoromethane (20 mL). The organic layer was 
successively washed with water and brine, dried over Na2SO4, concentrated and 
purified by chromatography over silica gel. 
Methyl 2-O-benzyl-4,6-O-benzylidene-β-D-mannopyranosyl-(1→4)-2,3-
di-O-acetyl- β-D-xylopyranoside (217). Obtained by protocol 7 from compound 
216. Chromatographic purification over silica gel with 40% EtOAc in hexanes as 
eluent afforded disaccharide 217 (35 mg, 85%) as a white foam, [α]24D: -34.9 (c = 
1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.48 (dd, J = 2.2, 7.2 Hz, 2H), 7.41-
7.30 (m, 8H), 5.54 (s, 1H), 5.24 (t, J = 9.0 Hz, 1H), 4.99 (d, J = 11.5 Hz, 1H), 4.90 
(dd, J = 7.2, 8.7 Hz, 1H), 4.64 (s, 1H), 4.57 (d, J = 12.0 Hz, 1H), 4.40 (d, J = 7.0 
Hz, 1H), 4.34 (dd, J = 5.0, 10.5 Hz, 1H), 4.11 (dd, J = 5.2, 11.7 Hz, 1H), 4.01-
3.96 (m, 1H), 3.87 (d, J = 2.5 Hz, 1H), 3.84-3.77 (m, 3H), 3.50 (s, 3H), 3.41 (dd, J 
= 9.5, 12.0 Hz, 1H), 3.35-3.31 (m, 1H), 2.43 (d, J = 8.5 Hz, 1H), 2.06 (s, 3H), 
2.03 (s, 3H); 13C NMR (125.9 MHz, CDCl3): δ 170.4, 169.9, 138.3, 137.3, 129.4, 
128.8, 128.5, 128.2, 126.5, 102.3, 102.2, 100.5, 79.4, 78.6, 75.7, 74.0, 72.3, 71.2, 
70.9, 68.7, 67.5, 62.8, 57.1, 21.1, 21.0; ESIHRMS m/z calcd for C30H36O12Na [M 
+ Na]+ 611.2104, found 611.2117. 
Methyl 2,3,6-tri-O-benzyl-β-D-mannopyranosyl-(1→4)-β-D-
xylopyranosyl-(1→3)-2-O-benzyl-4,6-O-benzylidine-β-D-mannopyranosyl-
(1→4)-β-D-xylopyranoside (218). Obtained by protocol 5 from compounds 202 
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and 217 followed by methanolysis. Chromatographic purification over silica gel 
with 3% methanol in chloroform as eluent afforded tetrasaccharide 218 (80 mg, 
72%) as a light yellow oil, [α]24D: -53.8 (c = 1.0, CHCl3); 1H NMR (500 MHz, 
CDCl3) δ 7.50 (dd, J = 2.0, 7.5 Hz, 2H), 7.42-7.37 (m, 5H), 7.35-7.28 (m, 18H), 
5.63 (s, 1H), 4.89 (d, J = 11.5 Hz, 1H), 4.88 (d, J = 12.5 Hz, 1H), 4.84 (d, J = 12.5 
Hz, 1H), 4.83 (d, J = 12.5 Hz, 1H), 4.76 (d, J = 12.5 Hz, 1H), 4.70 (br s, 1H), 4.64 
(d, J = 12.5 Hz, 1H), 4.64 (d, J = 11.5 Hz, 1H), 4.58 (d, J = 11.5 Hz, 1H), 4.54 (d, 
J = 11.5 Hz, 1H), 4.53 (d, J = 11.5 Hz, 1H), 4.50 (s, 1H), 4.47 (s, 1H), 4.40 (d, J = 
7.5 Hz, 1H), 4.32 (dd, J = 5.0, 10.5 Hz, 1H), 4.25-4.22 (m, 2H), 4.16 (t, J = 9.5 Hz, 
1H), 3.99-3.95 (m, 2H), 3.94-3.89 (m, 3H), 3.81 (dd, J = 7.5, 10.5 Hz, 1H), 3.75 
(dd, J = 4.0, 12.0 Hz, 1H), 3.61-3.56 (m, 3H), 3.55 (s, 3H), 3.54-3.50 (m, 2H), 
3.47 (dd, J = 3.0, 9.5 Hz, 1H), 3.43-3.30 (m, 3H), 3.19 (br s 1H), 3.06 (dd, J = 
10.0, 11.0 Hz, 1H), 2.48 (br s, 1H); 13C NMR (125.9 MHz, CDCl3): δ 138.3, 138.1, 
138.0, 137.7, 137.5, 129.2, 128.9, 128.7, 128.6, 128.6, 128.5, 128.4, 128.2, 
128.1, 128.0, 127.9, 127.9, 127.8, 126.3, 103.9, 103.2, 102.3, 101.8, 101.6, 81.0, 
80.5, 78.5, 77.9, 76.1, 75.2, 75.1, 74.7, 74.4, 74.3, 74.0, 73.2, 73.0, 72.9, 72.1, 
69.7, 68.3, 67.9, 63.8, 63.7, 57.1; ESIHRMS m/z calcd for C58H68O19Na [M + Na]+ 
1091.4252, found 1091.4265. 
Methyl β-D-mannopyranosyl-(1→4)-β-D-xylopyranosyl-(1→3)-β-D-
mannopyranosyl-(1→4)-β-D-xylopyranoside (211). Obtained by protocol 6 
from compound 105. Removal of the solvent afforded 218 (11.4 mg, 99%) as 
white amorphous solid, [α]24D: 44.1 (c = 0.5, 1:4 H2O:MeOH); ESIHRMS m/z 
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calcd for  C23H40O19Na [M + Na]+ 643.2061, found 643.2089.  For 1H and 13C 
data see Tables 14-17.   
Phenyl 2,3-di-O-acetyl-4,6-O-benzylidene-α-D-mannopyranosyl-(1→4)-
2,3-O-isopropylidene-1-thio-β-D-xylopyranoside (220). Obtained by protocol 1 
from compound 219 and 197. Chromatographic purification over silica gel with 
20% EtOAc in hexanes as eluent afforded disaccharide 220 (122 mg, 79%) as a 
light yellow oil, [α]24D: -26.5 (c = 1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.59-
7.56 (m, 2H), 7.47-7.45 (m, 2H), 7.39-7.36 (m, 3H), 7.35-7.32 (m, 3H), 5.58 (s, 
1H), 5.43 (dd, J = 1.5, 3.5Hz, 1H), 5.35 (dd, J = 3.5, 10.5 Hz, 1H), 5.10 (d, J = 1.0 
Hz, 1H), 4.81 (d, J = 9.5 Hz, 1H), 4.29 (dd, J = 3.0, 8.5 Hz, 1H), 4.18 (dd, J = 5.0, 
12.0 Hz, 1H), 4.04 (t, J = 9.7 Hz, 1H), 3.99 (dt, J = 5.5, 9.0 Hz, 1H), 3.93-3.84 (m, 
2H), 3.63 (t, J = 9.0 Hz, 1H), 3.39 (dd, J = 9.2, 11.7 Hz, 1H), 3.23 (t, J = 9.0 Hz, 
1H), 2.18 (s, 3H), 2.02 (s, 3H), 1.49 (s, 3H), 1.42 (s, 3H); 13C NMR (125.9 MHz, 
CDCl3): δ 169.9, 169.7, 136.9, 133.0, 131.6, 129.2, 128.9, 128.3, 128.2, 126.1, 
111.6, 101.9, 98.1 (1JC-H = 169.7 Hz), 85.2, 81.6, 75.9, 75.2, 73.4, 69.7, 68.6, 
68.1, 64.4, 26.7, 26.6, 20.9, 20.8; ESIHRMS m/z calcd for C31H36O11SNa [M + 
Na]+ 639.1876, found 639.1887.  
Methyl 2,3-di-O-acetyl-4,6-O-benzylidene-α-D-mannopyranosyl-(1→4)-
2,3-O-isopropylidene-β-D-xylopyranoside (221). Obtained by protocol 2 from 
compounds 219 and 194. Chromatographic purification over silica gel with 30% 
EtOAc in hexanes as eluent afforded disachharide 221 (136 mg, 84%) as a white 
foam, [α]24D: -7.6 (c = 1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.48-7.46 (m, 
2H), 7.39-7.36 (m, 3H), 5.59 (s, 1H), 5.44 (dd, J = 1.5, 3.0 Hz, 1H), 5.38 (dd, J = 
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3.5, 10.5 Hz, 1H), 5.12 (br s, 1H), 4.56 (d, J = 7.5 Hz, 1H), 4.31 (dd, J = 4.0, 10.0 
Hz, 1H), 4.12 (dd, J = 5.0, 12.0 Hz, 1H), 4.08-4.02 (m, 2H), 3.93 (dt, J = 4.0, 9.0 
Hz, 1H), 3.88 (t, J = 10.0 Hz, 1H), 3.63 (t, J = 9.0 Hz, 1H), 3.55 (s, 3H), 3.41 (dd, 
J = 7.7, 12.2 Hz, 1H), 3.34 (t, J = 8.2 Hz, 1H), 2.19 (s, 3H), 2.03 (s, 3H), 1.46 (s, 
3H), 1.44 (s, 3H); 13C NMR (125.9 MHz, CDCl3): δ 169.9, 169.8, 136.9, 129.2, 
128.3, 126.1, 112.0, 102.5, 102.9, 97.9 (1JC-H = 170.2 Hz), 79.8, 76.6, 78.0, 73.9, 
69.7, 68.6, 68.1, 65.4, 64.3, 56.6, 29.7, 26.6, 20.9; ESIHRMS m/z calcd for 
C26H34O12Na [M + Na]+ 561.1948, found 561.1959. 
Phenyl 2,3-di-O-benzyl-4,6-O-benzylidene-α-D-mannopyranosyl-(1→4)-
2,3-O-di-O-acetyl-1-thio-β-D-xylopyranoside (222). Obtained by protocol 3 
from compound 220. Chromatographic purification over silica gel with 20% 
EtOAc in hexanes as eluent afforded disaccharide 222 (55 mg, 84%) as a light 
yellow oil, [α]24D: -23.2 (c = 1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.49-7.47 
(m, 2H), 7.46-7.43 (m, 2H), 7.38-7.35 (m, 3H), 7.34-7.32 (m, 3H), 5.57 (s, 1H), 
5.36 (dd, J = 3.7, 10.2 Hz, 1H), 5.19-5.16 (m, 2H), 4.93-4.92 (d, J = 7.5 Hz, 1H),  
4.89 (d, J = 11.0 Hz, 1H), 4.80 (d, J = 9.0 Hz, 1H), 4.24 (t, J = 11.2 Hz, 1H), 4.23 
(t, J = 11.5 Hz, 1H), 4.04 (t, J = 10.0 Hz, 1H), 3.93 (dt, J = 4.5, 9.5 Hz, 1H), 3.83 
(t, J = 10.5 Hz, 1H), 3.79 (dt, J = 5.0, 8.5 Hz, 1H), 3.54 (dd, J = 9.0, 11.7 Hz, 1H), 
2.17 (s, 3H), 2.12 (s, 3H), 2.11 (s, 3H), 2.01 (s, 3H); 13C NMR (125.9 MHz, 
CDCl3): δ 169.9, 169.8, 169.7, 169.6, 136.9, 132.6, 132.4, 129.2, 129.1, 128.3, 
128.2, 126.1, 101.9, 99.5, 86.4, 76.0, 74.8, 73.3, 70.2, 70.0, 68.4, 67.6, 66.9, 
64.5, 20.8, 20.7; ESIHRMS m/z calcd for C32H36O13SNa [M + Na]+ 683.1774, 
found 683.1785. 
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Methyl 2,3-di-O-acetyl-4,6-O-benzylidene-α-D-mannopyranosyl-(1→4)-
2,3-di-O-acetyl-β-D-xylopyranoside (223). Obtained by protocol 3 from 
compound 221. Chromatographic purification over silica gel with 20% EtOAc in 
hexanes as eluent afforded disachharide 110 (48 mg, 87%) as a colorless oil, 
[α]24D: -8.4 (c = 1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.47-7.43 (m, 2H), 
7.38-7.35 (m, 3H), 5.57 (s, 1H), 5.37 (dd, J = 3.5, 10.5 Hz, 1H), 5.17 (br s, 1H), 
5.14 (t, J = 8.7 Hz, 1H), 4.92 (d, J = 1.0 Hz, 1H), 4.84 (dd, J = 7.0, 9.0 Hz, 1H), 
4.37 (d, J = 7.0 Hz, 1H), 4.25 (dd, J = 4.7, 10.0 Hz, 1H), 4.08-4.02 (m, 2H), 3.93 
(dt, J = 4.5, 9.7 Hz, 1H), 3.85-3.78 (m, 2H), 3.49-3.46 (m, 1H), 3.47 (s, 3H), 2.16 
(s, 3H), 2.09 (s, 3H), 2.06 (s, 3H), 2.03 (s, 3H); 13C NMR (125.9 MHz, CDCl3): δ 
170.0, 169.8, 169.6, 136.9, 129.2, 128.2, 126.1, 101.8, 101.7, 99.5, 76.0, 75.2, 
72.8, 71.0, 70.2, 68.4, 67.6, 64.5, 63.6, 56.8, 20.8, 20.6; ESIHRMS m/z calcd for 
C27H34O14Na [M + Na]+ 605.1846, found 605.1832.  
Methyl di-2,3,-O-acetyl-6-O-benzyl-α-D-mannopyranosyl-(1→4)-2,3-di-
O-acetyl-β-D-xylopyranoside (224). Obtained by protocol 4 from compound 223. 
Chromatographic purification over silica gel with 40% EtOAc in hexanes as 
eluent afforded disaccharide 224 (51 mg, 87%) as a colorless oil, [α]24D: -12.1 (c 
= 1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.36-7.32 (m, 4H), 7.31-7.28 (m, 1H), 
5.13-5.09 (m, 2H), 5.03 (dd, J = 1.5, 3.0 Hz, 1H), 4.91 (br s, 1H), 4.82 (dd, J = 
7.2, 9.0 Hz, 1H), 4.63 (d, J = 12.0 Hz, 1H), 4.56 (d, J = 12.0 Hz, 1H), 4.33 (d, J = 
7.0 Hz, 1H), 4.12 (dd, J = 5.2, 11.7 Hz, 1H), 3.97 (dt, J = 1.5, 9.5 Hz, 1H), 3.81-
3.77 (m, 2H), 3.76-3.73 (m, 2H), 3.45 (s, 3H), 3.42-3.36 (m, 1H), 2.80 (d, J = 3.5 
Hz, 1H), 2.09 (s, 3H), 2.07 (s, 3H), 2.06 (s, 3H), 2.04(s, 3H); 13NMR (125.9 MHz, 
198 
 
CDCl3): δ 170.8, 180.2, 170.0, 169.8, 137.8, 128.4, 127.8, 127.6, 101.7, 98.8, 
75.3, 73.7, 73.0, 72.0, 71.2, 71.1, 69.9, 69.7, 66.9, 63.7, 56.8, 20.9, 20.8, 20.7, 
20.6; ESIHRMS m/z calcd for C27H36O14Na [M + Na]+ 607.2003, found 607.1968.  
Methyl 2,3-di-O-acetyl-6-O-benzyl-α-D-mannopyranosyl-(1→4)-2,3-di-O-
benzoyl-β-D-xylopyranosyl-(1→4)-6-O-benzyl-2,3-di-O-benzyl-α-D-
mannopyranosyl-(1→4)-2,3-di-O-acetyl-β-D-xylopyranoside (112). Obtained 
by protocol 5 from compounds 222 and 224. Chromatographic purification over 
silica gel with 30% EtOAc in hexanes as eluent afforded tetrasaccharide 225 (96 
mg, 85%) as a colorless oil, [α]24D: -18.3 (c = 1.0, CHCl3); 1H NMR (500 MHz, 
CDCl3) δ 7.47-7.44 (m, 2H), 7.43-7.41 (m, 2H), 7.40-7.36 (m, 6H), 5.58 (s, 1H), 
5.38 (dd, J = 3.5, 10.5 Hz, 1H), 5.25 (dd, J = 3.0, 9.7 Hz, 1H), 5.17 (dd, J = 1.5, 
3.0 Hz, 1H), 5.11 (t, J = 9.0 Hz, 1H), 5.00-4.95 (m, 3H), 4.89 (s, 1H), 4.83 (dd, J 
= 7.5, 9.0 Hz, 1H), 4.76 (d, J = 12.0 Hz, 1H), 4.70 (dd, J = 7.0, 8.0 Hz, 1H), 4.49 
(d, J = 12.0 Hz, 1H), 4.37 (d, J = 7.0 Hz, 1H), 4.34 (d, J = 7.5 Hz, 1H), 4.23 (dd, J 
= 4.0, 10.0 Hz, 1H), 4.07-4.02 (m, 3H), 3.95-3.88 (m, 2H), 3.84 (t, J = 10.0 Hz, 
1H), 3.81-3.67 (m, 4H), 3.65 (d, J = 10.0 Hz, 1H), 3.45 (s, 3H), 3.44-3.39 (m, 1H), 
3.26 (dd, J = 9.5, 12.0 Hz, 1H), 2.16 (s, 3H), 2.13 (s, 3H), 2.07 (s, 3H), 2.06 (s, 
3H), 2.05 (s, 3H), 2.04 (s, 3H), 2.01 (s, 3H), 1.96 (s, 3H); 13NMR (125.9 MHz, 
CDCl3): δ 170.0, 169.8, 169.6, 169.4, 137.7, 136.8, 129.2, 128.6, 128.3, 128.1, 
127.9, 126.0, 101.8, 101.7, 100.4, 99.3, 98.6, 77.3, 77.2, 77.0, 76.7, 75.9, 75.1, 
74.7, 73.7, 73.4, 72.9, 72.7, 71.7, 71.1, 71.0, 70.3, 70.1, 68.4, 67.7, 67.5, 64.5, 
63.6, 63.4, 56.8, 20.9, 20.8, 20.7, 20.6; ESIHRMS m/z calcd for C53H66O27Na [M 
+ Na]+ 1157.3689, found 1157.3663  
199 
 
Methyl α-D-mannopyranosyl-(1→4)-β-D-xylopyranosyl-(1→4)-α-D-
mannopyranosyl-(1→4)-β-D-xylopyranoside(212). Obtained by protocol 6 from 
compound 225. Removal of solvent afforded 212 (11.4 mg 92%) as white 
amorphous solid, [α]24D: 24.5[c =1, H2O:MeOH(1/4)]; ESIHRMS m/z calcd for  
C23H40O19Na [M + Na]+ 643.2061, found 643.2079.  For 1H and 13C data see 
Tables 14-17.   
Methyl 2,4-di-O-acetyl-6-O-benzyl-3-O-(2-naphthalenylmethyl)-α-D-
mannopyranosyl-(1→4)-2,3-O-isopropylidene-β-D-xylopyranoside (227). 
Obtained by protocol 1 from compounds 195 and 226. Chromatographic 
purification over silica gel with 25% EtOAc in hexanes as eluent afforded 
disachharide 227 (167 mg, 82%) as a colorless oil, [α]24D: -22.7 (c = 1.0, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 7.85-7.80 (m, 3H), 7.73 (s, 1H), 7.52-7.46 (m, 2H), 
7.38 (dd, J = 1.5, 8.5 Hz, 1H), 7.35-7.31 (m, 5H), 5.53 (br s, 1H), 5.25 (t, J = 10.2 
Hz, 1H), 5.18 (s, 1H), 4.83 (d, J = 12.0 Hz, 1H), 4.59-4.52 (m, 4H), 4.15 (dd, J = 
5.5, 12.0 Hz, 1H), 4.06-4.03 (m, 1H), 3.87 (dd, J = 3.2, 9.7 Hz, 1H), 3.84-3.80 (m, 
1H), 3.60 (t, J = 9.0 Hz, 1H), 3.58-3.53 (m, 2H), 3.52 (s, 3H), 3.36-3.32 (m, 2H), 
2.17 (s, 3H), 1.92 (s, 3H), 1.48 (s, 3H), 1.45 (s, 3H); 13NMR (125.9 MHz, CDCl3): 
δ 170.3, 169.8, 137.8, 135.3, 133.2, 132.9, 129.2, 128.8, 128.3, 128.1, 127.9, 
127.7, 127.6, 126.5, 126.2, 126.0, 125.7, 112.0, 102.4, 97.5 (1JC-H = 170.6 Hz), 
79.6, 74.7, 74.4, 73.6, 71.3, 70.5, 69.4, 68.1, 67.9, 65.5, 56.4, 26.7, 26.4, 21.1, 
20.9; ESIHRMS m/z calcd for C37H44O12Na [M + Na]+ 703.2730, found 703.2756. 
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Methyl 2,4-di-O-acetyl-6-O-benzyl-3-O-(2-naphthalenylmethyl)-α-D-
mannopyranosyl-(1→4)-2,3-di-O-acetyl-β-D-xylopyranoside (228). Obtained 
by protocol 3 from compound 227. Chromatographic purification over silica gel 
with 25% EtOAc in hexanes as eluent afforded disaccharide 228 (61 mg, 85%) 
as a colorless oil, [α]24D: -15.8 (c = 1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δ 
7.87-7.81 (m, 3H), 7.74 (s, 1H), 7.52-7.47 (m, 2H), 7.38 (d, J = 8.5 Hz, 1H), 7.35-
7.29 (m, 5H), 5.24 (t, J = 10 Hz, 1H), 5.20 (br d, J = 2.7 Hz, 1H), 5.13 (t, J = 9.0 
Hz, 1H), 4.96 (s, 1H), 4.86 (dd, J = 7.2, 9.2 Hz, 1H), 4.77 (d, J = 12.0 Hz, 1H), 
4.56 (d, J = 12.5 Hz, 1H), 4.54-4.53 (m, 2H), 4.31 (d, J = 7.5 Hz, 1H), 4.21 (dd, J 
= 5.0, 11.5 Hz, 1H), 3.84-3.78 (m, 3H), 3.56-3.49 (m, 2H), 3.46 (s, 3H), 3.34 (dd, 
J = 10.0, 11.5 Hz, 1H), 2.13 (s, 3H), 2.09 (s, 3H), 2.06 (s, 3H), 1.90 (s, 3H); 13C 
NMR (125.9 MHz, CDCl3): δ 170.6, 170.1, 169.9, 138.0, 135.3, 133.5, 133.2, 
128.6, 128.4, 128.3, 127.9, 127.0, 126.4, 126.2, 126.0, 102.1, 99.6, 76.7, 74.3, 
73.8, 73.4, 71.6, 71.4, 70.9, 69.5, 68.5, 68.1, 64.2, 57.0, 21.2, 21.1, 21.0, 20.9; 
ESIHRMS m/z calcd for C38H44O14Na [M + Na]+ 747.2629, found 747.2641.  
Methyl 2,4-di-O-acetyl-6-O-benzyl-α-D-mannopyranosyl-(1→4)-2,3-di-O-
acetyl-β-D-xylopyranoside (229). Obtained by protocol 7 from compound 228. 
Chromatographic purification over silica gel with 40% EtOAc in hexanes as 
eluent afforded disaccharide 229 (36 mg, 88%) as a white foam, [α]24D: -11.4 (c = 
1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.36-7.29 (m, 5H), 5.13 (t, J = 9.0 Hz, 
1H), 5.11 (t, J = 10.0 Hz, 1H), 5.01 (d, J = 1.0 Hz, 1H), 4.90 (dd, J = 1.5, 3.5 Hz, 
1H), 4.85 (dd, J = 7.5, 9.5 Hz, 1H), 4.63 (d, J = 12.0 Hz, 1H), 4.49 (d, J = 12.5 Hz, 
1H), 4.33 (d, J = 7.0 Hz, 1H), 4.17 (dd, J = 5.5, 11.5 Hz, 1H), 3.96 (br d, J = 8.0 
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Hz, 1H), 3.85-3.78 (m, 2H), 3.57-3.51 (m, 2H), 3.47 (s, 3H), 3.36 (dd, J = 10.0, 
11.5 Hz, 1H), 2.23 (br s, 1H), 2.14 (s, 3H), 2.12 (s, 3H), 2.06 (s, 3H), 1.99 (s, 3H); 
13C NMR (125.9 MHz, CDCl3): δ 171.2, 170.4, 170.3, 169.7, 137.7, 128.4, 127.8, 
127.8, 101.9, 98.8, 76.0, 73.5, 73.0, 72.3, 71.2, 70.1, 69.5, 68.4, 64.0, 56.8, 21.0, 
20.9, 20.8, 20.7; C27H36O14Na [M + Na]+ 607.2003, found 607.2023. 
Methyl 4,6-O-benzylidene-α-D-mannopyranosyl-(1→4)-β-D-
xylopyranosyl-(1→3)-6-O-benzyl-α-D-mannopyranosyl-(1→4)-β-D-
xylopyranoside (230). Obtained by protocol 5 from compounds 222 and 229 
followed by methanolysis. Chromatographic purification over silica gel with 5% 
methanol in chloroform as eluent afforded disaccharide 230 (59 mg, 74%)as a 
white foam, [α]24D: -21.7 (c = 1.0, CHCl3); 1H NMR (500 MHz, CD3OD) δ 7.48-
7.43 (m, 3H), 7.41-7.35 (m, 7H), 5.58 (s, 1H), 5.58 (s, 1H), 5.40-5.33 (m, 1H), 
5.30-5.23 (m, 1H), 5.18 (s, 1H), 5.14-5.09 (m, 2H), 5.03-4.93 (m, 2H), 4.90 (s, 
1H), 4.83 (t, J = 7.7 Hz, 1H), 4.78-4.67 (m, 2H), 4.51 (t, J = 6.5 Hz, 1H), 4.33 (d, 
J = 7.2 Hz, 1H), 4.27-4.22 (m, 2H), 4.09-3.99 (m, 4H), 3.96-3.88 (m, 2H), 3.85-
3.69 (m, 6H), 3.53-3.39 (m, 4H), 3.37-3.26 (m, 1H), 2.18 (s, 3H), 2.15 (s, 3H), 
2.14 (s, 3H), 2.11 (s, 3H), 2.05 (s, 3H), 2.03 (s, 3H), 2.01 (s, 3H), 1.99 (s, 3H); 
13C NMR (125.9 MHz, CD3OD): δ 138.5, 138.1, 128.7, 128.2, 127.9, 127.6, 126.3, 
104.7, 103.9, 103.3, 102.2, 78.9, 78.1, 78.0, 76.8, 75.8, 75.7, 73.8, 73.6, 73.3, 
71.5, 71.2, 70.1, 69.7, 69.1, 68.5, 68.2, 64.7, 64.6, 64.5, 56.1; C53H66O27Na [M + 
Na]+ 821.2844, found 821.2857. 
Methyl α-D-mannopyranosyl-(1→4)-β-D-xylopyranosyl-(1→3)-α-D-
mannopyranosyl-(1→4)-β-D-xylopyranoside (213). Obtained by protocol 6 
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from compound 230. Removal of solvent afforded 213 (11.7 mg, 99%) as white 
amorphous solid, [α]24D: 32.1 (c = 0.5, 1:4 H2O:MeOH); ESIHRMS m/z calcd for 
C23H40O19Na [M + Na]+ 643.2061, found 643.2082.  For 1H and 13C data see 
Tables 14-17.  
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CHAPTER 8 
Conclusions  
α,β-Unsaturated cyclic monothioanhydrides, be they of an endocyclic nature 
as in thiomaleic anhydride or an exocylic nature as in thiitaconic anhydride, are 
excellent Michael acceptors for thiols and for carbon centered radicals. 
Thiomaleic anhydride is also capable of taking part in Diels-Alder cyclo-additions. 
When the various adducts formed in this manner carry a suitably placed 
protected amine or alcohol, deprotection of the nucleophilic functionality results in 
cyclization onto the anhydride with formation of a new ring and liberation of a 
thioacid. These cyclizations take place so as to form the smaller of the two rings 
possible and liberated thioacids can be captured by a variety of amide and 
carbon-carbon bond forming processes. In this manner a number of amide 
substituted thiazines, benzothiazines, lactones, lactams, thiazepines, 
benzothiazepins, and oxazatricyclodecanes were prepared in minimal of steps by 
multicomponent coupling sequences either from monothiomaleic anhydride or 
from substituted monothioitaconic anhydrides.  
The total synthesis of a series of tetra, hexa, and octasaccharyl mimics of 
the proposed structure of a novel antifreeze oligosaccharide have been 
synthesized in a convergent manner, along with tetrasaccharyl mimics of various 
possible linkage isomers. These synthetic studies enabled a structure of 
antifreeze oligosaccharide to be confirmed as one composed of a repeating units 
made up of one xylopyranose and one mannopyranose both β-linked through the 
4-position.  
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This dissertation consists of two parts of which the first develops the utility 
of α,β-unsaturated monothioanhydrides as a linchpins in multicomponent 
coupling reactions by processes involving addition to the double bond, cyclization 
onto the anhydride, and finally exploitation of the rich chemistry of the thioacid 
liberated in the cyclization. The second part of the thesis is concerned with 
verification of the structure of a nonprotein antifreeze oligosaccharide by the total 
synthesis of various authentic oligosaccharides and the comparison of 
spectroscopic data. 
 Chapter one starts with the introduction of the general characteristics and 
reactivity of thioacids, and their potential for application to the chemical synthesis 
of peptides and proteins. It continues with an overview of the solution and solid-
phase synthesis of peptidyl thioacids and thioesters, and problems associated 
with them. Finally the chapter ends with an overview of cyclic thioanhydrides with 
emphasis on the potential for exploration of thiomaleic anhydride. 
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Chapter two of part one describes a series of multicomponent coupling 
reactions starting from thiomaleic anhydride. These processes begin either by 
Michael addition, radical addition, or cycloaddition onto the alkene and, following 
deprotection of a latent nucleophile in the adducts, continue with cylization onto 
the anhydride and concomitant liberation of a thioacid. Finally the thioacid is 
captured in a range of a amide or carbon carbon bond forming processes. In this 
manner a range of thiazines, benzothiazines, lactones, lactams, and 
oxazatricyclodecanes were prepared efficiently.  
Chapter three extends a type of multicomponent coupling processes 
described in chapter two by the replacement of thiomaleic anhydride with various 
substituted thiitaconic anhydrides. To this end an efficient synthesis of 
substituted thioitaconic anhydride was first developed. Applying similar protocols 
to those developed with thiomaleic anhydride then enabled the synthesis of a 
range of thiazepines, benzothiazepins, and lactams. 
The experimental procedures and characterization data for the all 
synthesized compounds discussed in part one of this dissertation are 
documented in chapter four. 
Part two of this dissertation starts with chapter five which presents a brief 
overview of antifreeze substances before focusing on the ambiguous structure of 
a novel antifreeze oligosaccharide isolated recently from the Alaskan beetle Upis 
ceramboides. The chapter continues with an overview of a chemistry necessary 
for the synthesis of assorted oligosaccharides necessary for the verification of 
structure of the substance.   
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Chapter six opens with the retro synthetic analysis of mimics of the 
oligosaccharide by a convergent route before outlining the actual synthesis. Tetra, 
hexa, and octa saccharides corresponding to a proposed structure were 
synthesized along with tetrasaccharyl mimics of various possible linkage isomers. 
Extensive spectroscopic investigation of these oligosaccharides and comparison 
of the data with that of the natural isolate enabled the structure to be confirmed 
as [→4)-β-D-Manp-(1→4)-β-D-Xylp-(1→]n. 
In chapter seven, the experimental procedures and characterization data 
for the synthesized compounds discussed in chapter five are documented, while 
in chapter eight the overall conclusions of the dissertation are presented. 
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